脳腫瘍治療学

出版社： 金芳堂
著者：
発行日： 2016-12-05
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784765317061
電子書籍版： 2016-12-05 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

13,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,200 円(税込)

購入する

商品紹介

我が国のNeuro-oncology黎明期から脳腫瘍治療に携わってきた著者が、脳腫瘍についてさらに深い知識を得ようという臨床医に、内外の文献を整理し、著述したものである。脳腫瘍の増殖・増大様式（腫瘍自然史）を可能な限り分析してある。治療目標（戦略）をたて、どのような治療方法（戦術）を考える材料になる一冊。

目次

  • 脳腫瘍治療学

    ―目次―

    第1章　総論，脳腫瘍WHO 2016分類，全国脳腫瘍集計調査報告
    第2章　Diffuse astrocytic and oligodendroglial tumors
    第3章　その他の astrocytic tumor
    第4章　小児のglioma
    第5章　Ependymal tumors
    第6章　その他のglioma
    第7章　Choroid plexus tumor
    第8章　Neuronal and mixed neuronal-glial tumors
    第9章　胎児性脳腫瘍
    第10章　Cancer predisposition syndrome
    第11章　Germ cell tumor
    第12章　松果体部腫瘍
    第13章　脳の悪性リンパ腫
    第14章　髄膜腫
    第15章　間葉系腫瘍（髄膜腫を除く）
    第16章　脊索腫，過誤腫，類表皮腫と類皮腫
    第17章　下垂体腺腫
    第18章　Craniopharyngioma
    第19章　神経鞘腫
    第20章　転移性腫瘍

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 総論, 脳腫瘍WHO2016分類, 全国脳腫瘍集計調査報告

P.19 掲載の参考文献
1. Scherer HJ : Cerebral astrocytomas and their derivatives. Am J Cancer 40 : 159-198, 1940
 
1. Ikizler Y, van Meyel DJ, Ramsay DA, et al. : Gliomas in families. Can J Neurol Sci 19 (4) : 492-497, 1992
 
2. Lossignol D, Grossman SA, Sheidler VR, et al. : Familial clustering of malignant astrocytomas. J Neurooncol 9 (2) : 139-145, 1990
PubMed
2. Zulch KJ : Brain tumors. Their bioloby and pathology. 2nd ed. Springer Pub. Co., Inc. NY pp.326, 1965
 
3. Russell DS, Rubinstein LJ : Pathology of tumours of the nervous system. 3rd ed. Edward Arnold Pub. LTD, London, pp429, 1971
 
4. 所安夫 : 脳腫瘍, 医学書院, 東京, 934頁, 昭和34年
 
5. Okazaki H, Scheithauer B : Atlas of Neuropathology. Gower Medical Publishing, New York, London, Philadelphia, 1988
 
6. Schiffer D, Giordana MT, Soffietti R, et al. : Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy. Acta Neuropathol (Berl) 58 : 291-299, 1982
PubMed
7. Burger PC, Mahaley MS, Dudka L, et al. : The morphologic effects of radiation administrated therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44 : 1256-1272, 1979
 
8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarell-Branger D, Perry A, Reifenberger G, von Deimling A (Eds.) : WHO classification of tumours of the central nervous system, Revised 4th Edition. International Agency for Reserach on Cancer (IARC), Lyon, pp.408, 2016
 
9. 菅野晴夫 : 癌の病理組織学. 癌の生物学 第1巻, 南江堂, 1980
 
10. The Committee of Brain Tumor Registry of Japan : Report of Brain Tumor Registry of Japan (2001-2004), 13th Edition. Neurol Med Chir (Tokyo), vol. 54, Supplement 1, 2014
 
11. Ostrom QT, Gittleman H, Farah P, et al. : CBTRUS statistical report : Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 Suppl 2 : ii1-56, 2013
 
12. McCarthy BJ, Surawicz T, Bruner JM, et al. : Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol 4 (2) : 134-45, 2002
PubMed
13. Ostrom QT, de Blank PM, Kruchko C, et al. : Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol 16 Suppl 10 : x1-x36, 2015
 
14. Jooma R, Hayward RD, Grant DN : Intracranial neoplasms during the first year of life : analysis of one hundred consecutive cases. Neurosurgery 14 (1) : 31-41, 1984
PubMed
15. Annegers JF, Schoenberg BS, Okazaki H, Kurland LT : Epidemiologic study of primary intracranial neoplasms. Arch Neurol 38 (4) : 217-219, 1981
PubMed
16. Solitare GB, Krigman MR : Congenital intracranial neoplasms. A case report and review of the literature. J Neuropathol Exp 23 : 280-292, 1964
PubMed
17. Wakai S, Arai T, Nagai M : Congenital brain tumors. Surg Neurol 21 : 597-609, 1984
PubMed
18. Preston-Martin S, Yu MC, Benton B, Henderson BE : N-Nitroso compounds and childhood brain tumors : a case-control study. Cancer Res 42 (12) : 5240-5245, 1982
PubMed
19. INTERPHONE Study Group : Brain tumour risk in relation to mobile telephone use : results of the INTERPHONE international case-control study. Int J Epidemiol 39 : 675-694, 2010
 
20. Coureau G, Bouvier G, Lebailly P, et al. : Mobile phone use and brain tumours in the CERENAT case-control study. Occup Environ Med 71 : 514-522, 2014
PubMed
21. Modan B, Baidatz D, Mart H, et al. : Radiation-induced head and neck tumors. Lancet 1 : 277-279, 1974
PubMed
22. 長崎大学原爆後障害医療研究所 (刊) : 長崎原子爆弾の医学的影響, 第7版. (株) 昭和堂, 2013
 

第2章 Diffuse astrocytic and oligodendroglial tumors

P.26 掲載の参考文献
1. Arita H, Narita Y, Fukushima S, et al. : Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126 (2) : 267-76, 2013
PubMed
2. Heaphy CM, de Wilde RF, Jiao Y, et al. : Altered telomeres in tumors with ATRX and AXX mutations. Science 333 (6041) : 425, 2011
 
3. Killela PJ, Reitman ZJ, Jiao Y, et al. : TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci 110 (15) : 6021-6026, 2013
 
P.30 掲載の参考文献
1. Parsons DW1, Jones S, Zhang X, et al. : An integrated genomic analysis of human glioblastoma multiforme. Science 321 (5897) : 1807-1812, 2008
 
2. Kleihues P, Ohgaki H : Genetics of glioma progression and the definition of primary and secouncary glioblastoma. Brain Pathol 7 : 1131-1136, 1997
 
3. 市村幸一, 有田英之, 成田善孝 : 遺伝子変異からみた神経膠腫の発生機序. 脳外誌 23 (7) : 532-540, 2014
 
4. Ichimura K, Pearson DM, Kocialkowski S, et al. : Neuro Oncol 11 : 341-347, 2009
PubMed
5. Hartmann C, Meyer J, Balss J, et al. : Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age : a study of 1,010 diffuse gliomas. Acta Neuropathol 118 : 469-474, 2009
PubMed
6. Ohgaki H, Kleihues P : Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol 28 : 177-183, 2011
PubMed
7. Killela PJ, Pirozzi CJ, Healy P, et al. : Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget 5 (6) : 1515-1525, 2014
PubMed
8. Dubbink HJ, Taal W, van Marion R, et al. : IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology 73 : 1792-1795, 2009
PubMed
9. Ahmadi R, Stockhammer F, Becker N, et al. : No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas. J Neurooncol 109 (1) : 15-22, 2012
 
10. The Cancer Genome Atlas Research Network : Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372 (26) : 2481-2498, 2015
 
11. Yan H, Parsons DW, Jin G, et al. : IDH1 and IDH2 mutations in gliomas. N Engl J Med 360 : 765-773, 2009
PubMed
12. Beiko J, Suki D, Hess KR, et al. : IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 16 (1) : 81-91, 2014
PubMed
13. Scherer HJ : Cerebral astrocytomas and their derivatives. Am J Cancer 40 : 159-198, 1940
 
P.78 掲載の参考文献
1. Scherer HJ : The forms of growth in gliomas and their practical significance. Brain 63 : 1-35, 1940
 
2. Barnard RO, Geddes JF : The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer 60 : 1519-1531, 1987
PubMed
3. Showalter TN, Andrel J, Andrews DW, et al. : Multifocal glioblastoma multiforme : prognostic factors and patterns of progression. Int J Radiat Oncol BiolPhys 69 : 820-824, 2007
 
4. Lun M, Lok E, Gautam S, et al. : The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol 105 (2) : 261-273, 2011
PubMed
5. Steinhoff H, Lanksh W, Kazner E, et al. : Computed tomography in the diagnosis and differential diagnosis of glioblastomas. A qualitative study of 295 cases. Neuroradiology 14 : 193-200, 1977
 
6. Burger PC : Pathologic anatomy and CT correlations in the glioblastoma multiforme. Appl Neurophysiol 46 : 180-187, 1983
PubMed
7. Albert FK, Forsting M, Sartor K, et al. : Early postoperative magnetic resonance imaging after resection of malignant glioma : objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34 : 45-61, 1994
PubMed
8. Ulmer S, Braga TA, Barker FG 2nd, et al. : Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 67 : 1668-1670, 2006
PubMed
9. Wen PY, Macdonald DR, Reardon DA, et al. : Updated response assessment criteria for high-grade gliomas : response assessment in neuro-oncology working group. J Clin Oncol 28 : 1963-1972, 2010
 
10. Silbergeld DL, Dostomily RC, Alvord ECJr : The case of death in patients with glioblastoma in multiactorial : clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neuro-Oncol 10 : 179-185, 1991
 
11. Matsukado Y, MacCarty CS, Kernohan JW : The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg 18 : 636-644, 1961
PubMed
12. Simpson JR, Horton J, Scott C, et al. : Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme : results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26 : 239-244, 1993
PubMed
13. Vinjamuri M, Adumala RR, Altaha R, et al. : Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl) -1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients. J Neurooncol 91 (2) : 221-225, 2009
PubMed
14. Lacroix M, Abi-Said D, Fourney DR, et al. : A multivariate analysis of 416 patients with glioblastoma multiforme : prognosis, extent of resection, and survival. J Neurosurg 95 : 190-198, 2001
PubMed
15. Sanai N, Polley MY, McDermott MW, et al. : An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115 (1) : 3-8, 2011
PubMed
16. Stummer W, Meinel T, Ewelt C, et al. : Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery. J Neurooncol 108 (1) : 89-97, 2012
PubMed
17. Kaur G, Bloch O, Jian BJ, et al. : A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival. J Neurosurg 115 : 754-759, 2011
PubMed
18. Stupp R, Wong ET, Kanner AA, et al. : NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma : a randomised phase III trial of a novel treatment modality. Eur J Cancer 48 (14) : 2192-202, 2012
PubMed
19. Burger PC, Heinz RH, Shibata T, et al. : Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68 : 698-704, 1988
 
20. Halperin EC, Bentel G, Heinz ER, et al. : Radiation therapy treatment planning in supratentorial glioblastoma multiforme : an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 17 : 1347-1350, 1989
PubMed
21. Gaspar LE, Fisher BJ, Macdonard DR, et al. : Supratentorial malignant glioma : patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24 : 55-57, 1992
 
22. Wallner KE, Galicich JH, Krol G, et al. : Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat oncol biol Phys 16 : 1405-1409, 1989
PubMed
23. Silbergeld DL, Chicoine MR : Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86 (3) : 525-531, 1997
 
24. Onda K, Tanaka R, Takahashi H, et al. : Cerebral glioblastoma with cerebrospinal fluid dissemination : a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25 (4) : 533-540, 1989
PubMed
25. Pedersen PH, Rucklidge GJ, Mork SJ, et al. : Leptomeningeal tissue : a barrier against brain tumor cell invasion. J Natl Cancer Inst 86 (21) : 1593-1599, 1994
 
26. Brandes AA, Tosoni A, Franceschi E, et al. : Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma : correlation with MGMT promoter methylation status. JCO 27 : 1275-1279, 2009
 
27. Nowosielski M, Wiestler B, Goebel G, et al. : Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma. Neurology 82 (19) : 1684-1692, 2014
 
28. Parsa AT, Wachhorst S, Lamborn KR, et al. : Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102 : 622-628, 2005
PubMed
29. Elliott JP, Keles GE, Waite M, et al. : Ventricular entry during resection of malignant gliomas : effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80 : 834-839, 1994
PubMed
30. Tsuboi K, Yoshii Y, Nakagawa K, et al. : Regrowth pattern of supratentorial gliomas : estimation from computed tomographic scans. Neurosurgery 19 : 946-951, 1986
 
31. Vecht CJ, Avezaat CJJ, Putten WLJV, et al. : The influence of the extent of surgery on the neurological function and survival in malignant glioma A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53 : 466-471, 1990
 
32. Frazier JL, Johnson MW, Burger PC, et al. : Rapid malignant transformation of low-grade astrocytomas : report of 2 cases and review of the literature. World Neurosurg 73 (1) : 53-62, 2010
PubMed
33. Ideguchi M, Kajiwara K, Goto H, et al. : MRI findings and pathological features in early-stage glioblastoma. J Neurooncol. 2015 May 5., 2015
PubMed
34. Pirzkall A, McGue C, Saraswathy S, et al. : Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology 11 : 842-852, 2009
PubMed
35. Swanson KR, Alvord EC Jr, Murray JD : Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 86 (1) : 14-18, 2002
 
36. Walker MD, Alexander E Jr, Hunt WE, et al. : Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. a cooperative clinical trial. J Neurosurg 49 : 333-343, 1978
PubMed
37. Stupp R, Hegi ME, Mason WP, et al. : Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10 : 459-466, 2009
 
38. Imperato JP, Paleologos NA, Vick NA : Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28 : 818-822, 1990
PubMed
39. Scott JN, Rewcastle NB, Brasher PM, et al. : Long-term glioblastoma multiforme survivors : a population-based study. Can J Neurol Sci 25 : 197-201, 1998
PubMed
40. Schiffer D, Giordana MT, Soffietti R, et al. : Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy. Acta Neuropathol (Berl) 58 : 291-299, 1982
PubMed
41. 松谷雅生, 河野武, 松田忠義, 他 : Glioblastomaの放射線感受性-組織学的照射効果の検討. 放治システム 2 : 63-69, 1985
 
42. 藤巻高光, 松谷雅生, 高倉公朋 : Glioblastomaにおける放射線照射前後の Bromodeoxyuridine (BUdR) Labelingと臨床経過の検討. 日放腫会誌 2 : 263-273, 1990
 
43. Alsner J, Hoyer M, Sorensen SB, et al. : Interaction between potential doubling time and TP53 mutation : predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phy 49 : 519-525, 2001
 
44. Begg AC, Hofland I, Moonen L, et al. : The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors : an interim report. Int J Radiat Oncol Biol Phys 19 : 1449-1453, 1990
 
45. Shibuya M, Ito S, Davis RL, Hoshino T : Immunohistochemical double staining with immunogoldsilver and alkaline phosphatase to identify nuclear markers of cellular proliferation. Biotech Histo chem 68 (1) : 17-19, 1993
 
46. Schiffer S, Giordana MT, Buoncristiani P : Human malignant gliomas treated with chemotherapy : a pathological study. Neurosurgery 3 : 344-347, 1978
 
47. Burger PC, Mahaley MS, Dudka L, et al. : The morphologic effects of radiation administrated therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44 : 1256-1272, 1979
 
48. Gilbert M, O'Neill A, Grossman S, et al. : A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme : an Eastern Cooperative Oncology Group study (E2393). J Neurooncol 47 : 145-152, 2000
 
49. Gilbert MR, Friedman HS, Kuttesch JF, et al. : A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro-Oncology 4 : 261-267, 2002
PubMed
50. Durando X, Lemaire JJ, Tortochaux J, et al. : High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas : a retrospective analysis of 114 patients. Bone Marrow Transplant 31 (7) : 559-564, 2003
PubMed
51. Grossman SA, O'Neill A, Grunnet M, et al. : Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme : Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21 (8) : 1485-1491, 2003
PubMed
52. Lou E, Peters KB, Sumrall AL, et al. : Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma. Cancer Med 2 (2) : 185-195, 2013
PubMed
53. Peters KB, Lou E, Desjardins A, et al. : Phase II Trial of upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma. Oncologist 20 (7) : 727-728, 2015
PubMed
54. Yavas C, Zorlu F, Ozyigit G, et al. : Health-related quality of life in high-grade glioma patients : a prospective single-center study. Support Care Cancer 20 (10) : 2315-2325, 2012
PubMed
55. Walker MD, Alexander E Jr, Hunt WE, et al. : Evaluation of mithramycin in the treatment of anaplastic gliomas. J Neurosurg 44 (6) : 655-667, 1976
PubMed
56. Takakura K, Abe H, Tanaka R, et al. : Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64 : 53-57, 1986
PubMed
57. Laperriere N, Zuraw L, Cairncross G, et al. : Radiotherapy for newly diagnosed malignant glioma in adults : a systematic review. Radiother Oncol 64 (3) : 259-573, 2002
PubMed
58. Shapiro WR, Green SB, Burger PC, et al. : Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71 : 1-9, 1989
PubMed
59. Bleehen NM, Stenning SP : A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64 (4) : 769-774, 1991
PubMed
60. Sano K, Sato F, Hoshino T, Nagai M : Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy). Neurol Med Chir (Tokyo) 7 : 51-72, 1965
PubMed
61. Glioma Meta-analysis Trialists (GMT) Group : Chemotherapy in adult high-grade glioma : a systemic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359 : 1011-1018, 2002
 
62. Curran WJJr, Scott CB, Horton J, et al. : Recursive partitioning analysis of prognostic factors in three oncology group malingnant glioma trialas. J Natl cancer Inst 85 : 704-710, 1993
 
63. Stupp R, Dietrish P-Y, Ostermann Kraljevic S, et al : Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20 : 1375-1382, 2002
 
64. Stupp R, Mason WP, van den Brent MJ, et al. : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 : 987-996, 2005
 
65. Lai A, Tran A, Nghiemphu PL, et al. : Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 29 : 142-148, 2011
PubMed
66. Chinot OL, Wick W, Mason W, et al. : Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370 (8) : 709-722, 2014
PubMed
67. Gilbert MR, Dignam JJ, Armstrong TS, et al. : A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370 (8) : 699-708, 2014
PubMed
68. Matsutani M, Nakamura O, Nakamura M, et al. : Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults. J Neuro-Oncol 19 : 227-237, 1994
 
69. Kochii M, Kitamura I, Goto T, et al. : Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma. J Neurooncol 49 (1) : 63-70, 2000
PubMed
70. Shibui S, Narita Y, Mizusawa J, et al. : Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer Chemother Pharmacol 71 (2) : 511-521, 2013
PubMed
71. Kumabe T, Saito R, Kanamori M, et al. : Treatment results of glioblastoma during the last 30 years in a single institute. Neurol Med Chir (Tokyo) 53 : 786-796, 2013
 
72. Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Members JCOG BTSG : JCOG0911 INTEGRA Trial : a randomized screening phase II trial of chemoradiotherapy with interferon β plus temozolomide versus chemoradiotherapy with temozolomide alone for newly-diagnosed glioblastoma. Neuro Oncol 16 (suppl 5) : v11, 2014
 
73. Thumma SR, Fairbanks RK, Lamoreaux WT, Mackay AR, Demakas JJ, Cooke BS, Elaimy AL, Hanson PW, Lee CM : Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme : a Surveillance Epidemiology and End Results (SEER) population analysis. World J Surg Oncol 10 : 75, 2012
PubMed
74. Mao P, Smith L, Xie W, Wang M : Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3-mediated pathway. Oncol Lett 5 (5) : 1615-1620, 2013
 
75. Bao S, Wu Q, McLendon RE, et al. : Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (7120) : 756-760, 2006
PubMed
76. Osuka S, Sampetrean O, Shimizu T, et al. : IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells. Stem Cells 31 (4) : 627-640, 2013
PubMed
77. 廣瀬雄一, 佐野公俊 : DNAメチル化剤temozolomideの分子薬理学. No Shinkei Geka 35 : 117-129, 2007
 
78. Tolcher AW, Gerson SL, Denis L, et al. : Marked inactivation of O6-alkylguanine-DNA alkyltrans ferase activity with protracted temozolomide schedules. Br J Cancer 88 (7) : 1004-1011, 2003
 
79. Hegi ME, Diserens A-C, Gorlia T, et al. : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 : 997-1003, 2005
PubMed
80. Gilbert MR, Wang M, Aldape KD, et al. : Dose-Dense temozolomide for newly diagnosed glioblastoma : a randomized phase III clinical trial. J Clin Oncol. 2013 Oct 7., 2013
PubMed
81. Natsume A, Ishii D, Wakabayashi T, et al. : IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65 (17) : 7573-7579, 2005
PubMed
82. Wakabayashi T, Kayama T, Nishikawa R, et al. : A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study) : the final report. J Neurooncol 104 (2) : 573-577, 2011
 
83. Darefsky AS, King JT Jr, Dubrow R : Adult glioblastoma multiforme survival in the temozolomide era : a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer 118 (8) : 2163-2172, 2012
 
84. Dubrow R, Darefsky AS, Jacobs DI, et al. : Time trends in glioblastoma multiforme survival : the role of temozolomide. Neuro Oncol 15 (12) : 1750-1761, 2013
PubMed
85. Barazzuol L, Burnet NG, Jena R, et al. : A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects. J Theor Biol 262 (3) : 553-565, 2010
PubMed
86. Darlix A, Baumann C, Lorgis V, G et al. : Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma. Anticancer Res 33 (8) : 3467-3474, 2013
 
87. Glas M, Happold C, Rieger J, et al. : Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. Clin Oncol 27 (8) : 1257-1261, 2009
PubMed
88. Chamberlain MC, Glantz MJ, Chalmers L, et al. : Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82 : 81-83, 2007
PubMed
89. Taal S, Brandsma D, de Bruin HG, et al. : Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 113 : 405-410, 2008
 
90. Gerstner ER, McNamara MB, Norden AD, et al. : Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression. J Neurooncol 94 : 97?101, 2009
 
91. de Wit MC, de Bruin HG, Eijkenboom W, et al. : Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63 (3) : 535-537, 2004
PubMed
92. Hoffman WF, Levin VA, Wilson CB : Evaluation of malignant glioma patients during the postoperative period. J Neurosurg 50 : 624-628, 1979
 
93. Nishikawa R, Cheng SY, Nagashima R, et al. : Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 96 (5) : 453-462, 1998
PubMed
94. Chaudhry IH, O'Donovan DG, Brenchley PE, et al. : Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39 (4) : 409-415, 2001
PubMed
95. Huang H, Held-Feindt J, Buhl R, et al. : Expression of VEGF and its receptors in different brain tumors. Neurol Res 27 (4) : 371-377, 2005
PubMed
96. Johnson DR, Leeper HE, Uhm JH : Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab : A population-based analysis. Cancer 2013 Jul 18, 2013
PubMed
97. Omuro A, Beal K, Gutin P, et al. : Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clin Cancer Res 20 (19) : 5023-5031, 2014
 
98. Vredenburgh JJ, Desjardins A, Reardon DA, et al. : The addition of Bevacizumab to standard radiation therapy and Temozolomide followed by Bevacizumab, Temozolomide, and Irinotecan for newly diagnosed glioblastoma. Clin Cancer Res 17 : 4119-4124, 2011
PubMed
99. Sandmann T, Bourgon R, Garcia J, Li C, et al. : Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide : retrospective analysis of the AVAglio trial. J Clin Oncol. 2015 Jun 29., 2015
 
100. https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000019185&type=summary&language=J
 
101. Brem H, Piantadosi S, Burger PC, et al. : Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345 (8956) :1008-1012, 1995
PubMed
102. Westphal M, Hilt DC, Bortey E, et al. : A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5 (2) : 79-88, 2003
 
103. Aoki T, Nishikawa R, Sugiyama K, et al. : A multicenter phase I/II study of the BCNU implant (Gliadel(R) Wafer) for Japanese patients with malignant glioma. Neurol Med Chir (Tokyo) 54 (4) : 290-301, 2014
 
104. Gutenberg A, Lumenta CB, Braunsdorf WE, et al. : The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience. J Neurooncol 113 (2) : 163-74, 2013
PubMed
105. Kirson ED, Dbaly V, Tovarys F, et al. : Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A 104 (24) : 10152-10157, 2007
PubMed
106. Mrugala MM, Engelhard HH, Dinh Tran D, et al. : Clinical practice experience with NovoTTF-100A(TM) system for glioblastoma: The Patient Registry Dataset (PRiDe). Semin Oncol 41 Suppl 6 : S4-S13,2 014
 
107. Jaeckle KA, Ballman K, Furth A, Buckner JC : Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 73 (15) : 1207-1213, 2009
PubMed
108. Li XN, Shu Q, Su JM, et al. :Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther 4 : 1912-1922, 2005
PubMed
109. Eyal S, Yagen B, Sobol E, et al. :The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45 : 737-744, 2004
PubMed
110. Weller M, Gorlia T, Cairncross JG, et al. : Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 77 (12) : 1156-64, 2011
PubMed
111. Kerkhof M, Dielemans JC, van Breemen MS, et al. : Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol 15 (7) : 961-967, 2013
PubMed
112. Milano MT, Okunieff P, Donatello RS, et al. : Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 78 (4) : 1147-1155, 2010
PubMed
113. Clarke JL, Ennis MM, North American Brain Tumor Consortium : Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?. Neuro Oncol 13 : 1118-1124, 2011
PubMed
114. De Bonis P, Fiorentino A, Anile C, et al. : The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clin Neurol Neurosurg 115 (7) : 883-886, 2013
 
115. Wong ET, Hess KR, Gleason MJ, et al. : Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17 : 2572-2578, 1999
PubMed
116. Lamborn KR, Yung WKA, North American Brain Tumor Consortium : Progression-free survival : an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro-Oncology 10 : 162-170, 2008
PubMed
117. Yung WKA, Albright RE, Olson J, et al. : A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.. Br J Cancer 83 : 588-593, 2000
 
118. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, et al. : Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25 : 4722-4729, 2007
PubMed
119. Friedman HS, Prados MD, Wen PY, Mikkelsen T, et al. : Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27 : 4733-4740, 2009
PubMed
120. Kreisl TN, Kim L, Moore K, et al. : Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27 : 740-745, 2009
PubMed
121. Nagane M, Nishikawa R, Narita Y, et al. : Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma. Jpn J Clin Oncol 42 (10) : 887-895, 2012
PubMed
122. Wong ET, Gautam S, Malchow C, et al. : Bevacizumab for recurrent glioblastoma multiforme : a meta-analysis. J Natl Compr Canc Netw 9 (4) : 403-407, 2011
PubMed
123. Reardon DA, Herndon JE 2nd, Peters KB, et al. : Bevacizumab continuation beyond initial bevaci zumab progression among recurrent glioblastoma patients. Br J Cancer 107 (9) : 1481-1487, 2012
 
124. Taal W, Oosterkamp HM, Walenkamp AM, et al. : Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial) : a randomised controlled phase 2 trial. Lancet Oncol 15 (9) : 943-953, 2014
 
125. Aoki T, Mizutani T, Nojima K, et al. : Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. J Neurosurg 112 (1) : 50-56, 2010
PubMed
126. Burger PC, Green SB : Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59 : 1617-1625, 1987
PubMed
127. Brandes AA, Franceschi E, Tosoni A, et al. : Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma : correlation with MGMT promoter methylation status. Cancer 115 (15) : 3512-3518, 2009
PubMed
128. Kita D, Ciernik IF, Vaccarella S, et al. : Age as a predictive factor in glioblastomas : populationbased study. Neuroepidemiology 33 (1) : 17-22, 2009
PubMed
129. Iwamoto FM, Reiner AS, Panageas KS, et al. : Patterns of care in elderly glioblastoma patients. Ann Neurol 64 (6) : 628-634, 2008
PubMed
130. Scott JG, Suh JH, Elson P, et al. : Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older : a retrospective review of 206 cases. Neuro Onco 13 (4) : 428-436, 2011
PubMed
131. Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J : Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) 145 (1) : 5-10, 2003
PubMed
132. Chaichana KL, Garzon-Muvdi T, Parker S, et al. : Supratentorial glioblastoma multiforme : the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 18 (1) : 239-245, 2011
PubMed
133. Scott JG, Bauchet L, Fraum TJ, et al. : Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118 (22) : 5595-5600, 2012
PubMed
134. Brandes AA, Vastola F, Basso U, et al. : A prospective study on glioblastoma in the elderly. Cancer 97 : 657-662, 2003
PubMed
135. Chinot OL, Barrie M, Frauger E, et al. : Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100 (10) : 2208-2214, 2004
 
136. Laigle-Donadey F, Figarella-Branger D, Chinot O, et al. : Up-front temozolomide in elderly patients with glioblastoma. J Neurooncol 99 (1) : 89-94, 2010
PubMed
137. Gallego Perez-Larraya J, Ducray F, et al. : Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status : an ANOCEF phase II trial. J Clin Oncol 29 : 3050-3055, 2011
PubMed
138. Barker CA, Chang M, Chou JF, et al. : Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol 109 (2) : 391-397, 2012
PubMed
139. Minniti G, Lanzetta G, Scaringi C, et al. : Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83 (1) : 93-99, 2012
PubMed
140. Keime-Guibert F, Chinot O, Taillandier L, et al. : Radiotherapy for glioblastoma in the elderly. N Engl J Med 356 : 1527-1535, 2007
PubMed
141. Roa W, Brasher PM, Bauman G, et al. : Abbreviated course of radiation therapy in older patients with glioblastoma multiforme : a prospective randomized clinical trial. J Clin Oncol 22 (9) : 1583-1588, 2004
PubMed
142. Wick W, Platten M, NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society : Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly : the NOA-08 randomised, phase 3 trial. Lancet Oncol 13 (7) : 707-715, 2012
 
143. Malmstrom A, Gronberg BH, Nordic Clinical Brain Tumour Study Group (NCBTSG) : Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma : the Nordic randomised, phase 3 trial. Lancet Oncol 13 (9) : 916-926, 2012
 
144. Laperriere N, Weller M, Stupp R, et al. : Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 39 (4) : 350-357, 2013 144. Laperriere
 
145. Behm T, Horowski A, Schneider S, et al. : Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients. Clin Neurol Neurosurg 115 (10) : 2142-2146, 2013
PubMed
146. Sijben AE, McIntyre JB, Roldan GB, et al. : Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89 (1) : 97-103, 2008
PubMed
147. Taphoorn MJ, Henriksson R, Bottomley A, et al. : Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma. J Clin Oncol 33 (19) : 2166-217, 2015
 
148. Chaichana KL, Pendleton C, Chambless L, et al. : Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci 20 (10) : 1422-1426, 2013
PubMed
149. Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, R et al. : Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 16 (1) : 113-122, 2014
 
150. Huang RY, Rahman R, Hamdan A, et al. : Recurrent glioblastoma : volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab. Cancer 119 (19) : 3479-3488, 2013
 
151. Barker CA, Bishop AJ, Chang M, et al. : Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86 (3) : 504-509, 2013
PubMed
152. 松谷雅生 : TTF (TumorTreatingField) : 新しい膠芽腫治療機器, 日本臨牀74巻増刊号「脳腫瘍学」, 2016年9月発行予定
 
153. 金子貞洋, 岡村達憲, 金子貞男 : Tumor Treating Fieldを用いた膠芽腫の治療. 脳神経外科速報 26 (5) : 482-488, 2016
 
154. Happold C, Gorlia T, Chinot O, et al. : Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. J Clin Oncol 34 (7) : 731-739, 2016
PubMed
155. Muragaki Y, Akimoto J, Maruyama T, et al. : Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 119 (4) : 845-852, 2013
PubMed
156. Hatanaka H, Amano K, Sano K et al. : Boron-neutron capture therapy in relation to immunotherapy. Acta Neurochir (Wien) 42 (1-2) : 57-72, 1978
 
157. Miyatake SI, Kawabata S, Hiramatsu R, et al. : Boron neutron capture therapy for malignant brain tumors. Neurol Med Chir (Tokyo). 2016 May 31., 2016
 
158. 特定非営利活動法人 日本脳腫瘍学会編集 : 脳腫瘍診療ガイドライン 1. 金原出版株式会社, pp.133, 東京, 2016
 
159. Stupp R, Taillibert S, Kanner AA, et al. : Maintenance therapy with Tumor-Treating Fields plus temozolomide vs temozolomide alone for glioblastoma : a randomized clinical trial. JAMA 314 (23) : 2535-2543, 2015
PubMed
160. van den Bent M, Gorlia T, Bendszus M, et al. : EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine versus lomustine in patients with first progression of a glioblastoma. Neuro-Oncology 18 (Suppl. 4) : iv1, 2016
 
P.90 掲載の参考文献
1. Temme A, Geiger KD, Wiedemuth R, et al. : Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.. J Neuropathol Exp Neurol 69 (6) : 632-642, 2010
PubMed
2. Kozak KR, Moody JS : Giant cell glioblastoma : a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro Oncol 11 (6) : 833-841, 2009
PubMed
3. Karremann M, Butenhoff S, Rausche U, et al. : Pediatric giant cell glioblastoma : New insights into a rare tumor entity. Neuro Oncol 11 (3) : 323-329, 2009
PubMed
4. Oh JE, Ohta T, Nonoguchi N, et al. : Genetic alterations in gliosarcoma and giant cell glioblastoma. Brain Pathol. 2015 Oct 7. [Epub ahead of print], 2015
 
P.91 掲載の参考文献
1. Kozak KR, Mahadevan A, Moody JS : Adult gliosarcoma : epidemiology, natural history, and factors associated with outcome. Neuro Oncol 11 (2) : 183-191, 2009
PubMed
2. Lee D, Kang SY, Suh YL, et al. : Clinicopathologic and genomic features of gliosarcomas. J Neurooncol 107 (3) : 643-650, 2012
PubMed
3. Winkler PA, Buttner A, Tomezzoli A, Weis S : Histologically repeatedly confirmed gliosarcoma with long survival : review of the literature and report of a case. Acta Neurochir (Wien) 142 (1) : 91-9, 2000
PubMed
4. Oh JE, Ohta T, Nonoguchi N, et al. : Genetic alterations in gliosarcoma and giant cell glioblastoma. Brain Pathol. 2015 Oct 7. [Epub ahead of print], 2015
 
P.92 掲載の参考文献
1. Kleinschmidt-DeMasters BK, Aisner DL, et al. : Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37 (5) : 685-698, 2013
PubMed
2. Broniscer A, Tatevossian RG, Sabin ND, K et al. : Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. Neuropathol Appl Neurobiol 40 (3) : 327-336, 2014
 
3. Liebelt BD, Boghani Z, Takei H, et al. : Epithelioid glioblastoma presenting as massive intracerebral hemorrhage : Case report and review of the literature. Surg Neurol Int 6 (Suppl 2) : S97-S100, 2015
 
P.99 掲載の参考文献
1. Ohgaki H, Dessen P, Jourde B, Kleihues P, et al. : Genetic pathways to glioblastoma : A populationbased study. Cancer research 64 : 6892-6899, 2004
PubMed
2. The Cancer Cenome Atlas Research Network : Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 : 1061-8, 2008
 
3. Brennan CW, Verhaak RG, McKenna A, et al. : The somatic genomic landscape of glioblastoma. Cell 155 (2) : 462-477, 2013
PubMed
4. Sugawa N, Ekstrand AJ, James CD, Collins VP : Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA. 87 (21) : 8602-8606, 1990
PubMed
5. Verhaak RG, Hoadley KA, Purdom E, et al : Integrated genomic analysis identifies clinically rele vant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDHl, EGFR, and NFl. Cancer Cell 17 : 98-110, 2010
 
6. Sottoriva A, Spiteri I, Piccirillo SG, et al. : Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci 110 (10) : 4009-4014, 2013
PubMed
7. Johnson BE, Mazor T, Hong C, et al. : Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343 (6167) : 189-193, 2014
PubMed
8. Suzuki H, Aoki K, Chiba K, et al. : Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47 (5) : 458-468, 2015
PubMed
9. Wang J, Cazzato E, Ladewig E, et al. : Clonal evolution of glioblastoma under therapy. Nat Genet 48 (7) : 768-776, 2016
PubMed
P.123 掲載の参考文献
1. Schomas DA, Laack NNI, Rao RD, et al. : Intracranial low-grade gliomas in adults : 30-year experience with long-term follow-up at Mayo Clinic. Neuro-Oncology 11 : 437-445, 2009
 
2. Bauman G, Fisher B, Watling C, et al. : Adult supratentorial low-grade glioma : long-term experience at a single institution. Int J Radiat Oncol Biol Phys 75 (5) : 1401-1407, 2009
 
3. Johannesen JO, Langmark F, Lote K : Progress in long-term survival in adult patients with supratentorial low-grade gliomas : a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 99 : 854-862, 2003
 
4. Pallud J, Capelle L, Taillandier L, et al. : Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro-Oncology 11 : 176-182, 2009
PubMed
5. Kondziolka D, Lunsford LD, Martinez AJ : Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79 : 533-536, 1993
PubMed
6. Barker II FG, Chang SM, Huhn SL, et al. : Age and the risk of anaplasia in magnetic resonancenonenhancing supratentorial cerebral tumors.. Cancer. 80 : 936-941, 1997
 
7. Chang EF, Smith JS, Chang SM, et al. : Preoperative prognostic classification system for hemispheric low-grade gliomas in adults : Clinical article. J Neurosurg 109 : 817-824, 2008
PubMed
8. Chamberlain MC, Murovic JA, Levin VA : Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38 : 1371-1374, 1988
 
9. van den Bent MJ, Wefel JS, Schiff D, et al. : Response assessment in neuro-oncology (a report of the RANO group) : assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12 (6) : 583-593, 2011
PubMed
10. Scherer HJ : Cerebral astrocytomas and their derivatives. Am J Cancer 40 : 159-198, 1940
 
11. Kleihues P, Ohgaki H : Genetics of glioma progression and the definition of primary and secouncary glioblastoma. Brain Pathol 7 : 1131-1136, 1997
 
12. Peiffer J, Kleihues P : Hans-Joachim Scherer (1906-1945), pioneer in glioma research. Brain Pathol 9 : 241-245, 1999
 
13. Burger PC, Heinz RH, Shibata T, Kleihues P : Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68 : 698-704, 1988
 
14. Kracht LW, Miletic H, Busch S, et al. : Delineation of brain tumor extent with [11C] L-methionine positron emission tomography : local comparison with stereotactic histopathology. Clin Cancer Res 10 (21) : 7163-7170, 2004
PubMed
15. Bauman G, Lote K, Larson D, et al. : Pretreatment factors predict overall survival for patients with low-grade glioma : a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45 : 923-929, 1999
PubMed
16. Shaw E, Arusell R, Scheithauer B, et al. : Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma : initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20 : 2267-2276, 2002
 
17. Claus EB, Horlacher A, Hsu L, et al. : Survival rates in patients with lw-grade glioma after intraoperative resonance image guidance. Cancer 103 : 1227-1233, 2006
 
18. van den Bent MJ, Afra D, Witte O, Hassel MB, et al. : Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults : the EORTC 22845 randomised trial. Lancet 366 : 985-990, 2005
 
19. Smith JS, Chang EF, Lamborn KR, et al. : Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26 : 1338-1345, 2008
 
20. Rees J, Watt H, Jager HR, et al. : Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol 72 : 54-64, 2009
PubMed
21. Chang EF, Clark A, Jensen RL, et al. : Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg 111 : 203-210, 2009
PubMed
22. Brasil Caseiras G, Ciccarelli O, et al. : Low-grade gliomas : six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 253 : 505-512, 2009
PubMed
23. Pallud J, Fontaine D, Duffau H, et al. : Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68 : 727-733, 2010
PubMed
24. Chaichana KL, McGirt MJ, Laterra J, et al. : Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 112 : 10-17, 2010
PubMed
25. Mandonnet E, Pallud J, Fontaine D, et al. : Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev 33 : 91-96, 2010
PubMed
26. Potts MB, Smith JS, Molinaro AM, Berger MS : Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg 116 : 365-372, 2012
PubMed
27. Pallud J, Llitjos JF, Dhermain F, et al. : Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol 14 (4) : 496-505, 2012
PubMed
28. Goze C, Bezzina C, Goze E, et al. : 1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth. J Neurooncol 108 (1) : 69-75, 2012
 
29. Shaw EG, Wang M, Coons SW, et al. : Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma : Initial results of RTOG 9802. J Clin Oncol 30 : 3065-3070, 2012
PubMed
30. Babu R, Bagley JH, Park JG, et al. : Low-grade astrocytomas : the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. J Neurosurg 119 (2) : 434-441, 2013
PubMed
31. Jakola AS, Unsgard G, Myrmel KS, et al. : Surgical strategy in grade II astrocytoma : a populationbased analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochir (Wien) 155 (12) : 2227-2235, 2013
PubMed
32. Pallud J, Mandonnet E, Club de Neuro-Oncologie de la Societe Francaise de Neurochirurgie (SFNC), Association des Neuro-Oncologues d'Expression Francaise (ANOCEF) : Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol 67 : 398-404, 2010
 
33. Muller W, Afra D, Schroder R : Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir 37 : 75-91, 1977
PubMed
34. Leighton C, Fisher B, Bauman G, et al. : Supratentorial low-grade glioma in adults : an analysis of prognostic factors and timing of radiation. J Clin Oncol 15 (4) : 1294-1301, 1997
PubMed
35. Laws ERJr, Taylor WF, Clifton MB, Okazaki H : Neurosurgical management of low-grade astrocytoma of the cerebral hemisphere. J Neurosurg 61 : 665-673, 1984
 
36. Piepmeier JM : Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 67 : 177-181, 1987
PubMed
37. Soffietti R, Chio A, Giordana MT, et al. : Prognostic factors in well-differentiated cerebral astrocytomas in the adults. Neurosurgery 24 : 686-692, 1989
PubMed
38. Vertosick FT, Selker RG, Arena VC : Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 28 : 496-501, 1991
PubMed
39. McCormack BM, Miller DC, Budzilovich GN, et al. : Treatment and survival of low-grade astrocytoma in adults--1977-1988. Neurosurgery 31 (4) : 636-642, 1992
PubMed
40. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF : Supratentorial low-grade astrocytomas in adults. Neurosurgery 32 : 554-559, 1993
PubMed
41. Afra D, Osztie E : Histologically confirmed changes on CT of reoperated low-grade astrocytomas. Neuroradiology 39 : 804-810, 1997
 
42. van den Bent MJ, Afra D, Witte O, Hassel MB, et al. : Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults : the EORTC 22845 randomised trial. Lancet 366 : 985-990, 2005
 
43. Shaw EG, Berkey B, Coons SW, et al. : Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma : results of a prospective clinical trial. J Neurosurg 109 : 835-841, 2008
PubMed
44. Berger MS, Deliganis AV, Dobbins J, Keles GE : The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74 : 1784-1791, 1994
PubMed
45. Schmidt MH, Berger MS, Lamborn KR, et al. : Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg 98 : 1165-1169, 2003
PubMed
46. Broniscer A, Baker SJ, West AN, et al. : Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25 : 682-689, 2007
 
47. Sahm F, Capper D, Jeibmann A, et al. : Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol 69 (4) : 523-526, 2012
PubMed
48. Jakola AS, Unsgard G, Myrmel KS, et al. : Surgical strategy in grade II astrocytoma : a populationbased analysis of survival and morbidity with a strategy of early resection as compared to watchful waiting. Acta Neurochir (Wien) 155 (12) : 2227-2235, 2013
PubMed
49. Pallud J, Varlet P, Devaux B, et al. : Diffuse low-grade oligodendrogliomas extend beyond MRIdefined abnormalities. Neurology 74 : 1724-1731, 2010
PubMed
50. Shaw EG, Daumas-Duport C, Scheithauer BW, Gilbertson DT, O'Fallon JR, Earle JD, Laws ERJr, Okazaki K : Radiation therapy in tne management of low-grade supratentorial astrocytomas. J Neurosurg 70 : 853-861, 1989
 
51. Shibamoto Y, Kitakabu Y, Takahashi M, et al. : Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables. Cancer 72 : 190-195, 1993
PubMed
52. Bauman G, Lote K, Larson D, et al. : Pretreatment factors predict overall survival for patients with low-grade glioma : a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45 : 923-929, 1999
PubMed
53. Eyre HJ, Crowley JJ, Townsend JJ, et al. : A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas : a Southwest Oncology Group Study. J Neurosurg 78 : 909-914, 1993
 
54. Karim AB, Maat B, Hatlevoll R, et al. : A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma : European Organization for Research and Treatment of Cancer (EORTC) Study 22844.. Int J Radiat Oncol Biol Phys 36 : 549-56, 1996
PubMed
55. Buckner JC, Pugh SL, Shaw EG, et al. : Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma : RTOG 9802 with Alliance, ECOG, and SWOG. J Clin Oncol 32 : 5s, 2014 ASCO Annual Meeting Abstracts, #2000, 2014
 
56. Buckner JC, Shaw EG, Pugh SL, et al. : R9802 : Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma : results by histologic type. Neuro Oncol 16 (suppl 5) : v11, 2014
 
57. Kiebert GM, Curran D, Aaronson NK, et al. : Quality of life after radiation therapy of cerebral lowgrade gliomas of the adult : results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34 : 1902-1909, 1998
PubMed
58. Brown PD, Buckner JC, O'Fallon JR, et al. : Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein mini-mental state examination. J Clin Oncol 21 : 2519-2524, 2003
PubMed
59. Klein M, Heimans JJ, Aaronson NK, et al. : Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas : a comparative study. Lancet 360 : 1361-68, 2002
 
60. Prabhu RS, Won M, Shaw EG, et al. : Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma : secondary analysis of RTOG 98-02. J Clin Oncol 32 (6) : 535-541, 2014
PubMed
61. Douw L, Klein M, Fagel SS, et al. : Cognitive and radiological effects of radiotherapy in patients with low-grade glioma : long-term follow-up. Lancet Neurol 8 : 810-818, 2009
PubMed
62. Swennen MHJ, Bromberg JEC, Witkamp ThD, et al. : Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma.. J Neuro-Oncol 66 : 333-339, 2004
 
63. Quinn JA, Reardon DA, Friedman AH, et al. : Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21 (4) : 646-65, 2003
PubMed
64. Tosoni A, Franceschi E, Ermani M, et al. : Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas. J Neurooncol 89 : 179-185, 2008
PubMed
65. Pace A, Vidiri A, Galie E, et al. : Temozolomide chemotherapy for progressive low-grade glioma : clinical benefits and radiological response. Ann Oncol 14 : 1722-1726, 2003
PubMed
66. Taal W, Dubbink HJ, Zonnenberg CBL, et al. : First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy : molecular characteristics in relation to response. Neuro-Oncology 13 : 235-241, 2011
PubMed
67. Brada M, Viviers L, Abson C, et al. : Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14 : 1715-1721, 2003
PubMed
68. Baumert BG, Mason WP, Ryan G, et al. : Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma : A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033). J Clin Oncol 31 (suppl) ; 2013 ASCO Annual Meeting Abstracts, #2007, 2013
 
69. Fisher BJ, Hu C, Macdonald DR, Lesser GJ, et al. : Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas : preliminary results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys 91 (3) : 497-504, 2015.
PubMed
70. Osoba D, Brada M, Yung WK, Prados M : Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 18 (7) : 1481-1491, 2000
PubMed
71. Pignatti F, Bent M, Curran D, et al. : Prognostic factors for survival in adult patirnts with cerebral low-grade glioma. J Clin Oncol 20 : 2076-2084, 2002
 
72. Gorlia T, Wu W, Wang M, et al. : New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review : a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro Oncol 15 (11) : 1568-1579, 2013
PubMed
73. Daniels TB, Brown PD, Felten SJ, et al. : Validation of EORTC prognostic factors for adults with low-grade glioma : a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81 (1) : 218-224, 2011
PubMed
74. Chang EF, Clark A, Jensen RL, et al. : Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg 111 : 203-210, 2009
PubMed
75. Suzuki H, Aoki K, Chiba K, et al. : Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47 (5) : 458-468, 2015
PubMed
76. Johnson BE, Mazor T, Hong C, et al. : Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343 (6167) : 189-193, 2014
PubMed
77. Sottoriva A, Spiteri I, Piccirillo SG, et al. : Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci 110 (10) : 4009-4014, 2013
PubMed
78. Reuss DE, Sahm F, Schrimpf D, et al. : ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129 (1) : 133-146, 2015
PubMed
P.131 掲載の参考文献
1. Babu R, Bagley JH, Park JG, et al. : Low-grade astrocytomas : the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. J Neurosurg 119 (2) : 434-441, 2013
PubMed
2. Hoshino T, Wilson BC, Ellis WG : Gemistocytic astrocytes in gliomas. An autoradiographic study. Neuropathol Exp Neurol 34 (3) : 263-281, 1975
PubMed
3. Martins DC, Malheiros SM, Santiago LH, Stavale JN : Gemistocytes in astrocytomas : are they a significant prognostic factor?. J Neurooncol 80 (1) : 49-55, 2006
PubMed
4. Krouwer HG, Davis RL, Silver P, Prados M : Gemistocytic astrocytoma : a reappraisal. J Neurosurg 74 : 399-406, 1991
PubMed
5. Okamoto Y, Patre PL, Burkhard C, et al. : Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathologica 108 : 49-56, 2004
 
6. Ohta T, Kim YH, Oh JE, et al. : Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.. J Neuropathol Exp Neurol 73 (10) : 908-915, 2014
PubMed
7. Yang HJ, Kim JE, Paek SH, et al. : The significance of gemistocytes in astrocytoma. Acta Neurochir (Wien) 145 (12) : 1097-1103, 2003
PubMed
8. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H. : p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol 95 (6) : 559-564, 1998
PubMed
9. Reis RM, Hara A, Kleihues P, Ohgaki H : Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathol 102 (5) : 422-425, 2001
PubMed
P.136 掲載の参考文献
1. Nevin S : Gliomatosis cerebri. Brain 61 : 170-191, 1938
 
2. Scheinker IM, Evans JP : Diffuse cerebral glioblastosis. J Neuropathol Exp Neurol 2 (2) : 178-189, 1943
 
3. Barnard RO, Geddes JF : The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer 60 : 1519-1531, 1987
PubMed
4. 山本良裕, 辻武寿, 須賀正和, : Diffuse cerebrospinal gliomatosis の1剖検例. Neurol Med Chir (Tokyo) 31 : 1023-1029, 1991
 
5. Taillibert S, Chodkiewicz C, Laigle-Donadey F, et al. : Gliomatosis cerebri : a review of 296 cases from the ANOCEF database and the literature. J Neurooncol 76 (2) : 201-205, 2006
PubMed
6. Chen S, Tanaka S, Giannini C, et al. : clinical characteristics, management, and outcomes. J Neurooncol 112 (2) : 267-275, 2013
PubMed
7. Chappe C, Riffaud L, Treguier C, et al. : Primary gliomatosis cerebri involving gray matter in pediatrics : a distinct entity? A multicenter study of 14 cases. Childs Nerv Syst 29 (4) : 565-571, 2013
 
8. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G : Gliomatosis cerebri : clinical and histological findings. Clin Neuropathol 4 (4) : 135-148, 1985
PubMed
9. Jennings MT, Frenchman M, Shehab T, et al. : Gliomatosis cerebri presenting as intractable epilepsy during early childhood. Child Neurol 10 (1) : 37-45, 1995
PubMed
10. Spagnoli MV, Grossman RI, Packer RJ, et al. : Magnetic resonance imaging determination of gliomatosis cerebri. Neuroradiology 29 : 15-18, 1987
PubMed
11. Rogers LR, Weinstein MA, Estes M, et al. : Diffuse bilateral cerebral astrocytomas with atypical neuroimaging studies. J Neurosurg 81 : 817-821, 1994
PubMed
12. Kaloshi G, Guillevin R, Martin-Duverneuil N, et al. : Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri. Neurology 73 (6) : 445-449, 2009
PubMed
13. Herrlinger U, Jones DT, Glas M, Hattingen E, et al. : Gliomatosis cerebri : no evidence for a separate brain tumor entity. Acta Neuropathol 131 (2) : 309-319, 2016
PubMed
14. Seiz M, Tuettenberg J, Meyer J, et al. : Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component : evidence for molecular subtypes. Acta Neuropathol 120 (2) : 261-267, 2010
PubMed
15. Narasimhaiah D, Miquel C, Verhamme E, et al. : IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri. Neuropathology 32 (1) : 30-37, 2011
PubMed
16. Herrlinger U, Felsberg J, Kuker W, et al. : Gliomatosis cerebri : molecular pathology and clinical course. Ann Neurol 52 (4) : 390-399, 2002
PubMed
17. Mawrin C, Aumann V, Kirches E, et al. : Gliomatosis cerebri : post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55 (1) : 11-17, 2001
 
18. Broniscer A, Chamdine O, Hwang S, et al. : Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas. Acta Neuropathol 131 (2) : 299-307, 2016
PubMed
P.150 掲載の参考文献
1. The Cancer Genome Atlas Research Network : Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372 (26) : 2481-2498, 2015
 
2. Killela PJ, Pirozzi CJ, Reitman ZJ, et al. : The genetic landscape of anaplastic astrocytoma. Oncotarget 5 (6) : 1452-1457, 2014
PubMed
3. Suzuki H, Aoki K, Chiba K, et al. : Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47 (5) : 458-468, 2015
PubMed
4. Reuss DE, Mamatjan Y, Schrimpf D, et al. : IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival : a grading problem for WHO. Acta Neuropathol 129 (6) : 867-873, 2015
PubMed
5. Scott CB, Nelson JS, Farnan NC, Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02. Cancer 76 : 307-313, 1995
PubMed
6. Tortosa A, Vinolas N, Villa S, et al. : Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97 (4) : 1063-1071, 2003
PubMed
7. Matar E, Cook RJ, Fowler AR, et al. : Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma. J Clin Neurosci 17 (8) : 993-996, 2010
PubMed
8. Curran WJJr, Scott CB, Horton J, et al. : Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF) - A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neuro-Oncol 12 : 219-227, 1992
 
9. Chang CH, Horton J, Schoenfeld D, et al. : Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52 : 997-1007, 1983
PubMed
10. Nagy M, Schulz-Ertner D, Bischof M, et al. : Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas. Tumori 95 (3) : 317-324, 2009
PubMed
11. Shapiro WR, Green SB, Burger PC, et al. : Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71 : 1-9, 1989
PubMed
12. Nelson DF, Curran WJ, Scott C, et al. : Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma-possible advantage observed at 72.0 Gy in 1.2 Gy b.i.d. fractions : Report of the Radiation Terapy Oncolgy Group protocol 8302. Int J Radiat Oncol Biol Phys 25 : 193-207, 1993
 
13. Hildebrand J, Gorlia T, Kros JM, et al. : Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma : results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882). Eur J Cancer 44 (9) : 1210-2116, 2008
PubMed
14. Perry A, Jenkins RB, O'Fallon JR, et al. : Clinicopathologic study of 85 similarly treated patients with anaplastic tumors. Cancer 86 : 672-683, 1999
PubMed
15. Silvani A, Salmaggi A, Pozzi A, et al. : Effectiveness of early chemotherapy treatment in anaplastic astrocytoma patients. Tumori 81 (6) : 424-428, 1995
PubMed
16. Glioma Meta-analysis Trialists (GMT) Group : Chemotherapy in adult high-grade glioma : a systemic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359 : 1011-1018, 2002
 
17. Curran WJJr, Scott CB, Horton J, et al. : Recursive partitioning analysis of prognostic factors in three oncology group malingnant glioma trialas. J Natl cancer Inst 85 : 704-710, 1993
 
18. Levin VA, Silver P, Hannigan J, et al. : Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas : NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18 : 321-324, 1990
PubMed
19. Prados MD, Gutin PH, Phillips TL, et al. : Highly anaplastic astrocytoma : a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23 : 3-8, 1992
PubMed
20. Prados MD, Seiferheld W, Sandler HM, et al. : Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma : final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58 (4) : 1147-1152, 2004
PubMed
21. Ron IG, Gal O, Vishne TH, Kovner F : Long-term follow-up in managing anaplastic astrocytoma by multimodality approach with surgery followed by postoperative radiotherapy and PCV-chemotherapy : phase II trial. Am J Clin Oncol 25 (3) : 296-302, 2002
PubMed
22. Brandes AA, Nicolardi L, Tosoni A, et al. : Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma. Neuro Oncol 8 (3) : 253-260, 2006
PubMed
23. Combs SE, Nagy M, Edler L, et al. : Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors. Radiother Oncol 88 (2) : 177-182, 2008
PubMed
24. Shonka NA, Theeler B, Cahill D, et al. : Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy : a retrospective review within the era of temozolomide. J Neurooncol 113 (2) : 305-311, 2013
PubMed
25. Barker CA, Chang M, Beal K, Chan TA : Survival of patients treated with radiation therapy for anaplastic astrocytoma. Radiol Oncol 48 (4) : 381-386, 2014
PubMed
26. Minniti G, Scaringi C, Arcella A, et al. : IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy. J Neurooncol 118 (2) : 377-383, 2014
PubMed
27. Mayer A, Schwanbeck C, Sommer C, et al. : Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma : The Mainz experience. Strahlenther Onkol 191 (8) : 665-671, 2015
PubMed
28. Nayak L, Panageas KS, Reiner AS, et al. : Radiotherapy and temozolomide for anaplastic astrocytic gliomas. J Neurooncol 123 (1) : 129-134, 2015
PubMed
29. Wick W, Hartmann C, Engel C, et al. : NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27 : 5874-5880, 2009
PubMed
30. Reuss DE, Kratz A, Sahm F, et al. : Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130 (3) : 407-417, 2015
PubMed
P.164 掲載の参考文献
1. Schomas DA, Laack NNI, Rao RD, et al. : 30-year experience with long-term follow-up at Mayo Clinic. Neuro-Oncology 11 : 437-445, 2009
 
2. Youland RS, Brown PD, Giannini C, P et al. : Adult low-grade glioma : 19-year experience at a single institution. Am J Clin Oncol. 2012 Aug 13., 2012
 
3. Maintz D, Fiedler K, Koopmann J, et al. : Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 56 (10) : 1098-1104, 1997
PubMed
4. Sahm F, Reuss D, Koelsche C, et al. : Farewell to oligoastrocytoma : in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathol 128 (4) : 551-559, 2014
PubMed
5. Scherer HJ : The forms of growth in gliomas and their practical significance. Brain 63 : 1-35, 1940
 
6. Barnard RO, Geddes JF : The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer 60 : 1519-1531, 1987
PubMed
7. Minauf M, Jellinger K : Meningeales Wachstum von 0ligodendrogliomen. Acta Neurochir 19 : 269-280, 1968
 
8. Roldan G, Chan J, Eliasziw M, et al. : Leptomeningeal disease in oligodendroglial tumors : a population-based study. J Neurooncol 104 (3) : 811-815, 2011
PubMed
9. Mork SJ, Lindegaard K-F, Halvorsen TB, et al. : Oligodendroglioma : incidence and biological behavior in a defined population. J Neurosurg 63 : 881-889, 1985
 
10. Burger PC, Rawlings CE, Cox EB, et al. : Clinicopathologic correlations in the oligodendroglioma. Cancer 59 : 1345-1352, 1987
PubMed
11. Weir B, Elvidge AR : Oligodendrogliomas. An analysis of 63 cases. J Neurosurg 29 : 500-505, 1968
 
12. Wallner KE, Gonzales M, Sheline GE : Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68 : 684-688, 1988
PubMed
13. Reedy DP, Bay JW, Hahn JF : Role of radiation therapy in the treatment of cerebral oligodendroglioma : An analysis of 57 cases and a literature review. Neurosurg 13 : 499-503, 1983
 
14. Chin HW, Hazel JJ, Kim TH, Webster JH : Oligodendrogliomas. A clinical study of cerebral oligodendrogliomas. Cancer 45 : 1458-1466, 1980
PubMed
15. Roberts M, German WJ : A long term study of patients with oligodendrogliomas--Follow up of 50 cases, including Dr. Harvey Cushing's series. J Neurosurg 24 : 697-700, 1966
 
16. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS : The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 30 : 567-573, 1994
PubMed
17. Lee Y-Y, Tassel PV : Intracranial oligodendrogliomas : imaging findings in 35 untreated cases. AJNR 10 : 119-127, 1989
 
18. White ML, Zhang Y, Kirby P, Ryken TC : Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?. AJNR Am J Neuroradiol 26 (4) : 784-790, 2005
PubMed
19. Sankar T, Moore NZ, Johnson J, et al. : Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. Neurosurg 116 (6) : 1172-1181, 2012
PubMed
20. Megyesi JF, Kachur E, Lee DH, et al. : Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10 : 4303-4306, 2004
PubMed
21. Jenkinson MD, du Plessis DG, Smith TS, J et al. : Histological growth patterns and genotype in oligodendroglial tumours : correlation with MRI features. Brain 129 : 1884-1891, 2006
 
22. Mandonnet E, Delattre Y, Tanguy M-L, et al. : Continuous growth of mean tumor diameter in a Muller W, Afra D, Schroder R : Supratentorial recurrences of glioma. Morphological studies in relation to time intervals with oligodendrogliomas. Acta Neurochir 39 : 15-25, 1977
 
24. Olson JD, RiedelE, DeAngelis LM : Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54 : 1442-1448, 2000
 
25. Feigenberg SJ, Amdur RJ, Morris CG, et al. : Oligodendroglioma : does deferring treatment compromise outcome?. Am J Clin Oncol 26 : e60-66, 2003
PubMed
26. Weller M, Berger H, Hartmann C, et al. : Combined 1p/19q loss in oligodendroglial tumors : predictive or prognostic biomarker?. Clin Cancer Res 13 : 6933-6937, 2007
PubMed
27. Kang HC, Kim IH, Eom KY, et al. : The role of radiotherapy in the treatment of newly diagnosed supratentorial low-grade oligodendrogliomas : comparative analysis with immediate radiotherapy versus surgery alone. Cancer Res Treat 41 : 132-137, 2009
PubMed
28. van den Bent MJ, Afra D, Witte O, et al. : Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults : the EORTC 22845 randomised trial. Lancet 366 : 985-990, 2005
PubMed
29. Daumas-Duport C, Varlet P, Tucker ML, et al. : Oligodendrogliomas. Part I : Patterns of growth, histological diagnosis, clinical and imaging correlations : a study of 153 cases. J Neurooncol 34 (1) : 37-59, 1997
 
30. Pallud J, Varlet P, Devaux B, et al.: Diffuse low-grade oligodendrogliomas extend beyond MRIdefined abnormalities. Neurology 74 : 1724-1731, 2010
PubMed
31. Nijjar TS, Simpson WJ, Gadalla T, McCartney M : Oligodendroglioma. The Princess Margaret Hospital Experience (1958-1984). Cancer 71 : 4002-4006, 1993
PubMed
32. Shaw EG, Scheithauer BW, O'Fallon JR, et al. : Oligodendrogliomas : the Mayo Clinic experience. J Neurosurg 76 : 428-434, 1992
 
33. Mandonnet E, Pallud J, Fontaine D, et al. : Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev 33 : 91-96, 2010
PubMed
34. Goze C, Bezzina C, Goze E, et al. : 1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth. J Neurooncol 108 (1) : 69-75, 2012
 
35. Iwadate Y, Matsutani T, Hasegawa Y, et al. : Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy. J Neurooncol 102 : 443-449, 2011
PubMed
36. Cairncross JG, Macdonald DR, Ramsay DA : Aggressive oligodendroglioma : A chemosensitive tumor. Neurosurgery 31 : 78-82, 1992
PubMed
37. Soffietti R, Ruda R, Bradac GB, Schiffer D. : PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery. 43 (5) : 1066-1073, 1998
PubMed
38. van den Bent MJ, Kros JM, Heimans JJ, et al. : Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. Neurology 51 (4) : 1140-1145, 1998
PubMed
39. Triebels VH, Taphoorn MJ, Brandes AA, et al. : Salvage PCV chemotherapy for temozolomideresistant oligodendrogliomas. Neurology 63 : 904-906, 2004
PubMed
40. Buckner JC, Gesme D Jr, O'Fallon JR, et al. : Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma : efficacy and associations with chromosomal abnormalities. J Clin Oncol 21 (2) : 251-255, 2003
PubMed
41. Stege EMB, Kros JM, de Bruin HG, et al. : Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Cancer 103 : 802-809, 2005
PubMed
42. Lebrun C, Fontaine D, Bourg V, et al. : Treatment of newly diagnosed symptomatic pure lowgrade oligodendrogliomas with PCV chemotherapy. Eur J Neurol 14:391-398, 2007
PubMed
43. Taal W, van der Rijt CC, Dinjens WN, et al. : Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics. J Neurooncol 121 (2) : 365-372, 2015
 
44. van den Bent MJ, Taphoorn MJ, Brandes AA, et al. : Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors : the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol. 2003 Jul 1 ; 21 (13) : 2525-2528, 2003
 
45. van den Bent MJ, Chinot O, Boogerd W, et al. : Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy : EORTC Brain Tumor Group phase II study 26972. Ann Oncol 14 : 599-602, 2003
PubMed
46. Hoang-Xuan K, Capelle L, Kujas M, T et al. : emozolomide as initial treatment for adults with lowgrade oligodendrogiomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22 : 3133-3138, 2004
PubMed
47. Levin N, Lavon I, Zelikovitsh B, et al. : Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer 106 : 1759-1765, 2006
PubMed
48. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. : Temozolomide for low-grade gliomas : predictive impact of 1p/19q loss on response and outcome. Neurology 68 (21) : 1831-1836, 2007
PubMed
49. Douw L, Klein M, Fagel SS, et al. : Cognitive and radiological effects of radiotherapy in patients with low-grade glioma : long-term follow-up. Lancet Neurol 8 : 810-818, 2009
PubMed
50. 松谷雅生，高倉公朋，橋爪敬三，永井政勝，佐野圭二 : 脳腫瘍のBCNU <1,3-Bis(2-chloroethyl)-1-nitrosourea, (NSC 409962)> による治療. 脳神経 24 (6) : 757-762, 1972REFERENCES
 
51. Shibui S, Narita Y, Mizusawa J, et al. : Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer Chemother Pharmacol 71 (2) : 511-521, 2013
PubMed
52. Smith JS, Chang EF, Lamborn KR, et al. : Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26 : 1338-1345, 2008
 
53. Wilcox P, Li CC, Lee M, et al. : Oligoastrocytomas : throwing the baby out with the bathwater?. Acta Neuropathol 129 (1) : 147-149, 2015
PubMed
54. Huse JT, Diamond EL, Wang L, Rosenblum MK : Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma : a true "oligoastrocytoma"?. Acta Neuropathol 129 (1) : 151-153, 2015
PubMed
62. Swennen MHJ, Bromberg JEC, Witkamp ThD, et al. : Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma.. J Neuro-Oncol 66 : 333-339, 2004
 
P.181 掲載の参考文献
1. The Cancer Genome Atlas Research Network : Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372 (26) : 2481-2498, 2015
 
2. Wick W, Hartmann C, Engel C, et al. : NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27 : 5874-5880, 2009
PubMed
3. Giannini C, Scheithauer BW, Weaver AL, et al. : Oligodendrogliomas : reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60 (3) : 248-262, 2001
PubMed
4. Kros JM, Gorlia T, Kouwenhoven MC, et al. : Panel review of anaplastic oligodendroglioma from European Organization for Research and Treatment of Cancer Trial 26951 : assessment of con sensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol 66 : 545-551, 2007
 
5. Zlatescu MC, TehraniYazdi A, Sasaki H, et al. : Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61 (18) : 6713-6715, 2001
PubMed
6. Mueller W, Hartmann C, Hoffmann A, et al. : Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161 (1) : 313-319, 2002
PubMed
7. McDonald JM, See SJ, Tremont IW, et al. : The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer 104 : 1468-1477, 2005
PubMed
8. Khalid L, Carone M, Dumrongpisutikul N, et al. : Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol 33 (5) : 852-857, 2012
PubMed
9. Sankar T, Moore NZ, Johnson J, et al. : Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. Neurosurg 116 (6) : 1172-1181, 2012
PubMed
10. White ML, Zhang Y, Kirby P, Ryken TC : Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?. AJNR Am J Neuroradiol 26 (4) : 784-790, 2005
PubMed
11. Tsitlakidis A, Foroglou N, Venetis CA, et al. : Biopsy versus resection in the management of malignant gliomas : a systematic review and meta-analysis. J Neurosurg 112 (5) : 1020-1032, 2010
PubMed
12. Lassman AB, Iwamoto FM, Cloughesy TF, et al. : International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-Oncol 13 : 649-659, 2011
PubMed
13. Cairncross JG, Macdonald DR : Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23 (4) : 360-364, 1988
PubMed
14. Cairncross JG, Macdonald DR, Ramsay DA : Aggressive oligodendroglioma : A chemosensitive tumor. Neurosurgery 31 : 78-82, 1992
PubMed
15. Cairncross G, Berkey B, Shaw E, et al. : Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma : Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24 : 2707-2714, 2006
PubMed
16. van den Bent MJ, Carpentier AF, Brandes AA, et al. : Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas : a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24 : 2715-2722, 2006
 
17. Cairncross G, Wang M, Shaw E, et al. : Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma : long-term results of RTOG 9402. J Clin Oncol 31 (3) : 337-343, 2013
PubMed
18. van den Bent MJ, Brandes AA, Taphoorn MJ, et al. : Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma : long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31 (3) : 344-350, 2013
 
19. Taphoorn MJ, van den Bent MJ, European Organisation for Research and Treatment of Cancer : Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy : results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 25 : 5723-5730, 2007
PubMed
20. Habets EJ, Taphoorn MJ, Nederend S, et al. : Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol 116 (1) : 161-168, 2014
PubMed
21. Panageas KS, Iwamoto FM, Cloughesy TF, et al. : Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol 14 (6) : 761-767, 2012
PubMed
22. Panageas KS, Reiner AS, Iwamoto FM, et al. : Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro Oncol 16 (11) : 1541-1546, 2014
PubMed
23. Minniti G, Arcella A, Scaringi C, et al. : Chemoradiation for anaplastic oligodendrogliomas : clinical outcomes and prognostic value of molecular markers. J Neurooncol 116 (2) : 275-282, 2014
PubMed
24. Vogelbaum MA, Hu C, Peereboom DM, Macdonald DR, et al. : Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas : long term results of RTOG BR0131. J Neurooncol. 2015 Jun 19. [Epub ahead of print], 2015
 
25. Speirs CK, Simpson JR, Robinson CG, et al. : Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. Int J Radiat Oncol Biol Phys 91 (2) : 268-276, 2015
PubMed
26. Gan HK, Rosenthal MA, Dowling A, et al. : A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. Neuro Oncol 12 : 500-507, 2010
 
27. Ahluwalia MS, Xie H, Dahiya S, et al. : Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma : a phase II multicenter study. J Neurooncol 122 (1) : 111-119, 2015
PubMed
28. Iwadate Y, Matsutani T, Shinozaki N, Saeki N : Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy. Anticancer Res 31 : 4475-4479, 2011
PubMed
29. Kang HC, Yu T, Lim DH, et al. : A multicenter study of anaplastic oligodendroglioma : the Korean Radiation Oncology Group Study 13-12. J Neurooncol. 2015 Sep 4., 2015
 
30. Abrey LE, Louis DN, Oligodendroglioma Study Group : Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro Oncol 9 (3) : 314-318, 2007
 
31. Levin N, Lavon I, Zelikovitsh B, et al. : Progressive low-grade oligodendrogliomas : response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer 106 : 1759-1765, 2006
PubMed
32. Brandes AA, Tosoni A, GICNO : Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma : a prospective GICNO study. J Clin Oncol 24 (29) : 4746-4753, 2006
PubMed
33. Chamberlain MC, Johnston S : Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma. Cancer. 115 (8) : 1734-1743, 2009
PubMed
34. Taillibert S, Vincent LA, Granger B, et al. : Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Neurology 72 (18) : 1601-1606, 2009
PubMed
35. van den Bent MJ, Erridge S, Vogelbaum M, et al. : Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an intergroup trial. Neuro-Oncology 18 (Suppl. 4) : iv1, 2016 (学会抄録)
 

第3章 その他のastrocytic tumor

P.189 掲載の参考文献
1. Adriaensen ME, Schaefer-Prokop CM, Stijnen T, et al. : Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 16 (6) : 691-696, 2009
 
2. Nabbout R, Santos M, Rolland Y, et al. : Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 66 (3) : 370-375, 1999
PubMed
3. Joozwiak S, Nabbout R, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management : Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) : Clinical recommendations. Eur J Paediatr Neurol 17 (4) : 348-352, 2013
PubMed
4. Shepherd CW1, Gomez MR, Lie JT, Crowson CS : Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66 (8) : 792-796, 1991
 
5. Roth J, Roach ES, Bartels U, et al. : Subependymal giant cell astrocytoma : diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49 (6) : 439-444, 2013
PubMed
6. de Ribaupierre S, Dorfmuller G, Bulteau C, et al. : Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease : when should we operate?. Neurosurgery 60 (1) : 83-89, 2007
PubMed
7. Sun P, Krueger D, Liu J, et al. : Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions : a US national claims database study. Curr Med Res Opin 28 (4) : 651-656, 2012
PubMed
8. Sun P, Kohrman M, Liu J, et al. : Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex : a national claims database analysis. Curr Med Res Opin 28 (4) : 657-663, 2012
PubMed
9. Kotulska K, Borkowska J, Roszkowski M, et al. : Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol. 2013 Dec 10., 2013
 
10. Krueger DA, Care MM, Holland K, et al. : Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363 (19) : 1801-1811, 2010
 
11. Perek-Polnik M, Joozwiak S, Jurkiewicz E, et al. : Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex. Eur J Paediatr Neurol 16 (1) : 83-85, 2012
 
12. Franz DN, Belousova E, Sparagana S, et al. : Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1) : a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381 (9861) : 125-132, 2013
PubMed
13. Franz DN, Belousova E, Sparagana S, et al. : Long-term use of everolimus in patients with tuberous sclerosis complex : final results from the EXIST-1 study. PLoS One 11 (6) : e0158476, 2016
PubMed
P.194 掲載の参考文献
1. Perkins SM, Mitra N, Fei W, Shinohara ET : Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma : a SEER analysis. J Neurooncol 110 (1) : 99-104, 2012
PubMed
2. Kepes JJ, Kepes M, Slowik F : Fibrous xanthomas and xanthosarcomas of the meninges and the brain. Acta Neuropathol 23 (3) : 187-199, 1973
PubMed
3. Kepes JJ, Rubinstein LJ, Eng LF : Pleomorphic xanthoastrocytoma : a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 44 (5) : 1839-1852, 1979
PubMed
4. Kepes JJ, Rubinstein LJ, Ansbacher L, Schreiber DJ : Histopathological features of recurrent pleomorphic xanthoastrocytomas : further corroboration of the glial nature of this neoplasm. A study of 3 cases. Acta Neuropathol 78 (6) : 585-593, 1989
PubMed
5. Giannini C, Scheithauer BW, Burger PC, et al. : Pleomorphic xanthoastrocytoma : what do we really know about it?. Cancer 85 (9) : 2033-2045, 1999
PubMed
6. Yu S, He L, Zhuang X, Luo B : Pleomorphic xanthoastrocytoma : MR imaging findings in 19 patients. Acta Radiol 52 (2) : 223-228, 2011
 
7. Lim S1, Kim JH, Kim SA, et al. : Prognostic factors and therapeutic outcomes in 22 patients with pleomorphic xanthoastrocytoma. J Korean Neurosurg Soc 53 (5) : 281-287, 2013
 
8. Moore W, Mathis D, Gargan L, et al. : Pleomorphic xanthoastrocytoma of childhood : MR imaging and diffusion MR imaging features. AJNR Am J Neuroradiol 35 (11) : 2192-2196, 2014 5. Marton E, Feletti A, Orvieto E, Longatti P: Malignant progression in pleomorphic xanthoastrocytoma : Personal experience and review of the literature. J Neurol Sci 252 : 144-153, 2007
 
9. Gallo P, Cecchi PC, Locatelli F, et al. : Pleomorphic xanthoastrocytoma : long-term results of surgical treatment and analysis of prognostic factors. Br J Neurosurg 27 (6) : 759-764, 2013
PubMed
10. Tabouret E, Bequet C, Denicolai E, et al. : BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Eur J Surg Oncol 41 (12) : 1685-1690, 2015
PubMed
11. Dodgshun AJ, Sexton-Oates A, Saffery R, et al. : Pediatric pleomorphic xanthoastrocytoma treated with surgical resection alone : clinicopathologic features. J Pediatr Hematol Oncol 2016 Apr 27., 2016
 
12. Gaba P, Puffer RC, Hoover JM, et al. : Perioperative outcomes in intracranial pleomorphic xanthoastrocytoma. Neurosurgery. 2016 May 12. [Epub ahead of print]
 
13. Marton E, Feletti A, Orvieto E, Longatti P : Malignant progression in pleomorphic xanthoastrocytoma : Personal experience and review of the literature. J Neurol Sci 252 : 144-153, 2007
PubMed
14. Ida CM, Vrana JA, Rodriguez FJ, et al. : Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma. Acta Neuropathol Commun 30 ; 1 : 20, 2013
 
15. Ida CM, Rodriguez FJ, Burger PC, et al. : Pleomorphic xanthoastrocytoma: natural history and long-term follow-up. Brain Pathol 25 (5) : 575-586, 2015
PubMed
16. Weber RG, Hoischen A, Ehrler M, et al. : Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene 26 (7) : 1088-1097, 2007
PubMed
17. Schmidt Y, Kleinschmidt-DeMasters BK, Aisner DL, et al. : Anaplastic PXA in adults: case series with clinicopathologic and molecular features. J Neurooncol 111 (1) : 59-69, 2013
PubMed

第4章 小児のglioma

P.217 掲載の参考文献
1. Krishnatry R, Zhukova N, Guerreiro Stucklin AS, et al. : Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma : A population-based study. Cancer 122 (8) : 1261-1269, 2016
PubMed
2. Hawkins C, Walker E, Mohamed N, et al. : BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res 17 (14) : 4790-4798, 2011
PubMed
3. Jones DT, Hutter B, Jager N, et al. : Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45 (8) : 927-932, 2013
PubMed
4. Collins VP, Jones DT, Giannini C : Pilocytic astrocytoma : pathology, molecular mechanisms and markers. Acta Neuropathol 129 (6) : 775-788, 2015
PubMed
5. Horbinski C : To BRAF or not to BRAF : is that even a question anymore? J Neuropathol Exp Neurol 72 (1) : 2-7, 2013
 
6. Schwartzentruber J, Korshunov A, Liu XY, et al. : Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 (7384) : 226-231, 2012
PubMed
7. Wu G, Broniscer A, McEachron TA, et al. : Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44 (3) : 251-253, 2012
PubMed
8. Wu G, Diaz AK, Paugh BS, et al. : The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46 (5) : 444-450, 2014
PubMed
9. Diaz AK, Baker SJ : The genetic signatures of pediatric high-grade glioma : no longer a one-act play. Semin Radiat Oncol 24 (4) : 240-247, 2014
PubMed
10. Taylor KR, Mackay A, Truffaux N, et al. : Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46 (5) : 457-461, 2014
PubMed
11. Shapiro K, Shulman K : Spinal cord seeding from cerebellar astrocytoma. Child's Brain 2 : 177-186, 1976
PubMed
12. Pollack IF, Hurtt M, Pang D, Albright L : Dissemination of low grade intracranial astrocytomas in children. Cancer 73 : 2869-2878, 1994
 
13. Hukin J, Siffert J, Velasquez L, et al. : Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors. Neuro-Oncol. 4 : 253-260, 2002
PubMed
14. Chamdine O, Broniscer A, Wu S, et al. : Metastatic Low-Grade Gliomas in Children : 20 Years' Experience at St. Jude Children's Research Hospital. Pediatr Blood Cancer 63 (1) : 62-70, 2016
 
15. Broniscer A, Baker SJ, West AN, et al. : Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25 : 682-689, 2007
 
16. Parsa CF, Givrad S : Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation : grounds for designation as hamartomas. Br J Ophthalmol 92 : 40-46, 2008
PubMed
17. Dirks PB, Jay V, Becker LE, et al. : Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 34 : 68-78, 1994
PubMed
18. Mistry M, Zhukova N, Merico D, et al. : BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol 33 (9) : 1015-1022, 2015
PubMed
19. White JB, Piepgras DG, Scheithauer BW, Parisi JE : Rate of spontaneous hemorrhage in histologically proven cases of pilocytic astrocytoma. J Neurosurg 108 (2) : 223-226, 2008
PubMed
20. Binning MJ, Liu JK, Kestle JRW, et al. : Optic pathway gliomas : a review. Neurosurg Focus 23 (5) : E2, 2007
PubMed
21. Jahraus CD, Tarbell NJ : Optic Pathway Gliomas. Pediatr Blood Cancer 46 : 586-596, 2006
PubMed
22. Lazareff JA, Suwinski R, Rosa RD, Olmstead CE : Tumor volume and growth kinetics in hypothalamic-chiasmatic pediatric low grade gliomas. Pediatr Neurosurg 30 : 312-319, 1999
 
23. Packer RJ, Ater J, Allen J, et al. : Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86 : 747-754, 1997
PubMed
24. Massimino M, Spreafico F, Cefalo G, et al. : High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20 : 4209-4216, 2002
PubMed
25. Gururangan S, Cavazos CM, Ashley D, et al. : Phase II study of carboplatin in children with progressive low-grade gliomas.. J Clin Oncol 20 (13) : 2951-2958, 2002
PubMed
26. Aquino VM, Fort DW, Kamen BA : Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas : a phase II study.. J Neurooncol 41 (3) : 255-259, 1999
PubMed
27. Mahoney DH Jr, Cohen ME, Friedman HS, et al. : Carboplatin is effective therapy for young children with progressive optic pathway tumors : a Pediatric Oncology Group phase II study. Neuro Oncol 2 (4) : 213-220, 2000
PubMed
28. Silva MM, Goldman S, Keating G, et al. : Optic pathway hypothalamic gliomas in children under three years of age : the role of chemotherapy. Pediatr Neurosurg 33 (3) : 151-158, 2000
PubMed
29. Mitchell AE, Elder JE, Mackey DA, et al. : Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas. J Pediatr Hematol Oncol 23 (9) : 572-577, 2001
PubMed
30. Laithier V, Grill J, French Society of Pediatric Oncology. : Progression-free survival in children with optic pathway tumors : dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21 (24) : 4572-4578, 2003
 
31. Sawamura Y, Kamoshima Y, Kato T, et al. : Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children. Jpn J Clin Oncol 39 (5) : 277-283, 2009
PubMed
32. Rakotonjanahary J, De Carli E, Brain Tumor Committee of SFCE : Mortality in children with optic pathway glioma treated with up-front BB-SFOP chemotherapy. PLoS One 10 (6) : e0127676, 2015
PubMed
33. Ater JL, Zhou T, Holmes E, et al. : Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children : a report from the Children's Oncology Group. J Clin Oncol 30 (21) : 2641-2647, 2012
 
34. Gnekow AK, Falkenstein F, von Hornstein S, et al. : Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.. Neuro Oncol 14 (10) : 1265-1284, 2012
PubMed
35. Marcus KJ, Goumnerova L, Billett A, et al. : Stereotactic radiotherapy for localized low-grade gliomas in children : final results of a prospective trial. Int J Radiat Oncol Biol Phys 61 : 374-379, 2005
PubMed
36. Dodgshun AJ, Elder JE, Hansford JR, Sullivan MJ : Long-term visual outcome after chemotherapy for optic pathway glioma in children : Site and age are strongly predictive. Cancer 121 (23) : 4190-4196, 2015
PubMed
37. Campagna M, Opocher E, Viscardi E, et al. : Optic pathway glioma : long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer 55 (6) : 1083-1088, 2010
PubMed
38. Dalla Via P, Opocher E, Pinello ML, et al. : Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 9 (4) : 430-437, 2007
PubMed
39. Listernick R, Charrow J, Greenwald M, Mets M : Natural history of optic pathway tumours in children with neurofibromatosis type 1 : a longitudinal study. J Pediatr 125 : 63-66, 1994
PubMed
40. Cnossen MH, de Goede-Bolder A, van den Broek KM, et al. : A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child 78 : 408-412, 1998
PubMed
41. Huson SM, Compston DAS, Harper PS : A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II : guidelines for genetic counselling. J Med Genet 26 : 712-721, 1989
 
42. Prada CE, Hufnagel RB, Hummel TR, et al. : The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 167 (4) : 851-856, 2015
PubMed
43. Blanchard G, Lafforgue MP, NF France network. : Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol 20 (2) : 275-281, 2016
PubMed
44. Opocher E, Kremer LC, Da Dalt L, et al. : Prognostic factors for progression of childhood optic pathway glioma : a systematic review. Eur J Cancer 42 (12) : 1807-1816, 2006
PubMed
45. Hernaiz Driever P, von Hornstein S, Pietsch T, et al. : Natural history and management of lowgrade glioma in NF-1 children. J Neurooncol 100 (2) : 199-207, 2010
 
46. Kuenzle C, Weissert M, Roulet E, et al. : Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 25 (6) : 295-300, 1994
PubMed
47. Friedman JM, Birch P : An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1. Neuropediatrics 28 (2) : 131-132, 1997
PubMed
48. Korones DN, Padowski J, Factor BA, Constine LS : Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?. Neuro-Oncology 5 : 116-120, 2003
PubMed
49. Tihan T, Fisher PG, Kepner JL, et al. : Pediatric astrocytomas with monomorphous pilomyxoid features and a less. J Neuropathol Exp Neurol 58 : 1061-1068, 1999
 
50. Komotar RJ, Burger PC, Carson BS, et al. : Pilocytic and pilomyxoid hypotharalmic/chiasmatic astrocytomas. Neurosurgery 54 : 72-80, 2004
PubMed
51. Bhargava D, Sinha P, Chumas P, et al. : Occurrence and distribution of pilomyxoid astrocytoma. Br J Neurosurg 27 (4) : 413-418, 2013
PubMed
52. Johnson MW, Eberhart CG, Perry A, et al. : Spectrum of pilomyxoid astrocytomas : intermediate pilomyxoid tumors. Am J Surg Pathol 34 (12) : 1783-1791, 2010
PubMed
53. Hayostek CJ, Shaw EG, Scheithauer B, et al. : Astrocytoma of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 72 : 856-869, 1993
PubMed
54. Due-Tonnessen BJ, Helseth E, Scheie D, et al. : Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0-19 years) : report of 110 consecutive cases. Pediatr Neurosurg 37 : 71-80, 2002
 
55. Villarejo F, Belinchon de Diego JM, Gomez de la Riva, A : Prognosis of cerebellar astrocytomas in children. Childs Nerv Syst 24 : 203-210, 2008
 
56. Sutton LN, Cnaan A, Klatt L, et al. : Postoperative surveillance imaging in children with cerebellar astrocytomas. J Neurosurg 84 : 721-725, 1996
PubMed
57. Ogiwara H, Bowman RM, Tomita T : Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery 70 (1) : 40-47, 2012
PubMed
58. Stokland T, Liu JF, Ironside JW, et al. : A multivariate analysis of factors determining tumor progression in childhood low-grade glioma : a population-based cohort study (CCLG CNS9702). Neuro Oncol 12 (12) : 1257-1268, 2010
PubMed
59. Armstrong GT, Conklin HM, Huang S, et al. : Survival and long-term health and cognitive out comes after low-grade glioma. Neuro Oncol 13 : 223-234, 2011
 
60. Wisoff JH, Sanford RA, Heier LA, et al. : Primary neurosurgery for pediatric low-grade gliomas : a prospective multi-institutional study from the Children's Oncology Group. Neurosurgery 68 : 1548-1555, 2011
 
61. Garcia DM, Marks JE, Latifi HR, Kliefoth AB : Childhood cerebellar astrocytomas : is there a role for postoperative irradiation. Int J Radiat Oncol Biol Phys 18 : 815-818, 1990
 
62. Daszkiewicz P, Maryniak A, Roszkowski M, Barszcz S : Long-term functional outcome of surgical treatment of juvenile pilocytic astrocytoma of the cerebellum in children. Childs Nerv Syst 25 : 855-860, 2009
PubMed
63. Bernhardtsen T, Laursen H, Bojsen-Moller M, Gjerris F : Sub-classification of low-grade cerebellar astrocytoma : is it clinically meaningful?. Childs Nerv Syst 19 (10-11) : 729-773, 2003
 
64. Jones DT, Mulholland SA, Pearson DM, et al. : Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol 121 (6) : 753-761, 2011
PubMed
65. Ait Khelifa-Gallois N, Puget S, Longaud A, et al. : Clinical evidence of the role of the cerebellum in the suppression of overt articulatory movements during reading. A study of reading in children and adolescents treated for cerebellar pilocytic astrocytoma. Cerebellum 14 (2) : 97-105, 2015
 
66. Bull KS, Liossi C, Culliford D, et al. : Child-related characteristics predicting subsequent healthrelated quality of life in 8- to 14-year-old children with and without cerebellar tumors : a prospective longitudinal study. Neurooncol Pract 1 (3) : 114-122, 2014
PubMed
67. Saunders DE, Phipps KP, Wade AM, Hayward RD : Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg : 102 (2 Suppl) : 172-178, 2005
PubMed
68. Schneider JHJr, Raffel C, McComb JG : Benign cerebellar astrocytomas of childhood. Neurosurgery 30 : 58-63, 1992
 
69. Dirven CMF, Mooij JJA, Molenaar WM : Cerebellar pilocytic astrocytoma : a treatment protocol based upon analysis of 73 cases and a review of the literature. Child's Nery Syst 13 : 17-23, 1997
 
70. Smoots DW, Geyer JR, Lieberman DM, Berger MS : Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst 14 : 636-648, 1998
PubMed
71. Palma L, Celli P, Mariottini A : Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumour regression. Acta Neurochir (Wien) 146 : 581-588, 2004
PubMed
72. Davis CH, Joglekar VM : Cerebellar astrocytomas in children and young adults. J Neurol Neurosurg Psychiat 44 : 820-828, 1981
 
73. Palma L, Russo A, Mercuri S : Cystic cerebral astrocytomas in infancy and childhood : long-term results. Child's Brain 10 : 79-91, 1983
PubMed
74. Burkhard C, di Parte P-L Schuler D, et al. : A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 98 : 1170-1174, 2003
 
75. Garcia DM, Latifi HR, Simpson JR, Picker S : Astrocytomas of the cerebellum in children. J Neurosurg 71 : 661-664, 1989
 
P.233 掲載の参考文献
1. Fisher PG, Breiter SN, Carson BS, et al. : A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocytic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89 : 1569-1576, 2000
PubMed
2. Yoshimura J, Onda K, Tanaka R, Takahashi H : Clinicopathological study of diffuse type brainstem gliomas : analysis of 40 autopsy cases. Neurol Med Chir (Tokyo) 43 (8) : 375-382, 2003
PubMed
3. Khatib ZA, Heideman RL, Kovnar EH, et al. : Predominance of pilocytic histology in dorsally exophytic brain stem tumors. Pediatr Neurosurg 20 : 2-10, 1994
PubMed
4. Klimo P Jr, Pai Panandiker AS, Thompson CJ, et al. : Management and outcome of focal low-grade brainstem tumors in pediatric patients : the St. Jude experience. J Neurosurg Pediatr 11 (3) : 274-281, 2013
 
5. 松谷雅生, 佐野圭二 : Brain stem glioma の治療と予後. 小児脳神経 2 (6) : 411-416, 1978
 
6. Hoffman HJ, Becker L, Craven MA : A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 7 : 243-248, 1980
PubMed
7. Chamdine O, Gajjar A : Molecular characteristics of pediatric high-grade gliomas. CNS Oncol 3 (6) : 433-443, 2014
PubMed
8. Buckley RC : Pontine gliomas. A pathologic study and classification of twenty-five cases. Arch Pathol 9 : 779-819, 1930
 
9. Golden GS, Ghatak NR, Hirano A, French JH : Malignant glioma of the brain-stem A clinicopathological analysis of 13 cases. J Neurol Neurosurg psychiat 35 : 732-738, 1972
 
10. Packer RJ, Allen J, Nielsen S, et al. : Brain stem glioma : Clinical manifestations of meningeal gliomatosis. Ann Neurol 14 : 177-182, 1983
PubMed
11. Mantravadi RVP, Phatak R, Bellur S, et al. : Brain stem gliomas : an autopsy study of 25 cases. Cancer 49 : 1294-1296, 1982
 
12. Littman P, Jarrett P, Bilaniuk LT, et al. : Pediatric brain stem gliomas. Cancer 45 : 2787-2792, 1980
PubMed
13. Albright AL, Packer RJ, Zimmerman R, et al. : Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas : a report from the Children's Cancer Group. Neurosurgery 33 : 1026-1030, 1993
 
14. Grimm SA, Chamberlain MC : Brainstem glioma : a review. Curr Neurol Neurosci Rep 13 (5) : 346, 2013
PubMed
15. Schumacher M, Schulte-Monting J, Stoeter P, et al. : Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood : a multicenter review. J Neurosurg 106 (2 Suppl Pediatrics) : 111-119, 2007
 
16. Donahue B, Allen J, Siffert J, et al. : Patterns of redurrence in brain stem gliomas : evidence for craniospinal dissemination. Int J Radiat Oncol Biol Phys 40 : 677-680, 1998
PubMed
17. Sethi R, Allen J, Donahue B, et al. : Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. J Neurooncol 102 : 121-127, 2011
PubMed
18. Massimino M, Spreafico F, Biassoni V, et al. : Diffuse pontine gliomas in children : changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87 (3) : 355-361, 2008
PubMed
19. Wagner S, Warmuth-Metz M, Emser A, et al. : Treatment options in childhood pontine gliomas. J Neuro-Oncol 79 : 281-287, 2006
 
20. Warren K, Bent R, Wolters PL, et al. : A phase 2 study of pegylated interferon α-2b (PEG-Intron (R)) in children with diffuse intrinsic pontine glioma. Cancer 118 (14) : 3607-3613, 2012
 
21. Cohen KJ, Heideman RL, Zhou T, et al. : Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas : a report from the Children's Oncology Group. Neuro Oncol 13 (4) : 410-416, 2011
 
22. Haas-Kogan DA, Banerjee A, Poussaint TY, et al. : Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol 13 (3) : 298-306, 2011
PubMed
23. Pollack IF, Stewart CF, Kocak M, et al. : A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas : a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 13 (3) : 290-297, 2011
 
24. Epstein FJ, Farmer JP : Brain-stem glioma growth patterns. J Neurosurg 78 : 408-412, 1993
PubMed
25. Pollack IF, Hoffman HJ, Humphreys RP, Becker L : The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78 : 859-863, 1993
 
26. May LP, Blaser SI, Hoffman HJ, et al. : Benign intrinsic tectal "tumors" in children. J Neurosurg 74 : 867-871, 1991
 
27. Squires LA, Allen JC, Abbott R, Epstein FJ : Focal tectal tumors : management and prognosis. Neurology 44 (5) : 953-956, 1994
PubMed
28. Ternier J, Wray A, Puget S, et al. : Tectal plate lesions in children. J Neurosurg 104 (6 Suppl) : 369-376, 2006
 
29. Bognar L, Turjman F, Villanyi E, et al. : Tectal plate gliomas. Part II : CT scans and MR imaging of tectal gliomas. Acta Neurochir (Wien) 127 (1-2) : 48-54, 1994
 
30. Griessenauer CJ, Rizk E, Miller JH, et al. : Pediatric tectal plate gliomas : clinical and radiological progression, MR imaging characteristics, and management of hydrocephalus. J Neurosurg Pediatr 13 (1) : 13-20, 2014
PubMed
31. Lapras C, Bognar L, Turjman F, et al. : Tectal plate gliomas. Part I : Microsurgery of the tectal plate gliomas. Acta Neurochir (Wien) 126 (2-4) : 76-83, 1994
PubMed
32. Bowers DC, Georgiades C, Aronson LJ, et al. : Tectal glioma : natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 32 : 24-29, 2000
PubMed
33. Gass D, Dewire M, Chow L, et al. : Pediatric tectal plate gliomas : a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae. J Neurooncol 122 (1) : 169-177, 2015
PubMed
34. Wellons JC 3rd, Tubbs RS, Banks JT, et al. : Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas. Neurosurgery 51 (1) : 63-67, 2002
PubMed
35. Stark AM, Fritsch MJ, Claviez A, et al. : Management of tectal glioma in childhood. Pediatr Neurol 33 (1) : 33-38, 2005
PubMed
36. Cooper IS, Kernohan JW, Graig WM : Tumors of the medulla oblongata. AMA Arch Neurol Psychiat 67 : 269-282, 1952
 
37. Queiroz Lde S, da Cruz Neto JN, Lopes de Faria J. : Glioblastoma multiforme of the medulla oblangata. Acta Neuropathol 29 (4) : 355-360, 1974
PubMed
38. Guillamo JS, Monjour A, Association des Neuro-Oncologues d'Expression Francaise (ANOCEF). : Brainstem gliomas in adults : prognostic factors and classification. Brain 124 (Pt 12) : 2528-2539, 2001
 
39. Kesari S, Kim RS, Markos V, Drappatz J, Wen PY, Pruitt AA : Prognostic factors in adult brainstem gliomas : a multicenter, retrospective analysis of 101 cases. J Neurooncol 88 (2) : 175-183, 2008
 
40. Salmaggi A, Fariselli L, Associazione Italiana di Neuro-oncologia : Natural history and manage ment of brainstem gliomas in adults. A retrospective Italian study. J Neurol 255 (2) : 171-177, 2008
 
41. Reithmeier T, Kuzeawu A, Hentschel B, Loeffler M, Trippel M, Nikkhah G : Retrospective analysis of 104 histologically proven adult brainstem gliomas : clinical symptoms, therapeutic approaches and prognostic factors. BMC Cancer 14 : 115, 2014
PubMed
42. Theeler BJ, Ellezam B, Melguizo-Gavilanes I, de Groot JF, Mahajan A, Aldape KD, Bruner JM, Puduvalli VK : Adult brainstem gliomas : Correlation of clinical and molecular features. J Neurol Sci 353 (1-2) : 92-97, 2015
PubMed
P.236 掲載の参考文献
1. Puget S, Crimmins DW, Garnett MR, et al. : Thalamic tumors in children : a reappraisal. J Neurosurg 106 (5 Suppl) : 354-362, 2007
 
2. Krouwer HGJ, Prados MD : Infiltrative astrocytomas of the thalamus. J Neurosurg 82 : 548-557, 1995
 
3. Finlay JL, Boyett JM, Yates AJ, et al. : Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13 (1) : 112-123, 1995
 
4. Batra V, Sands SA, Holmes E, et al. : Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma : a report from the Children's Oncology Group. Pediatr Blood Cancer 61 (1) : 151-157, 2014
 

第5章 Ependymal tumors

P.255 掲載の参考文献
1. Taylor MD, Poppleton H, Fuller C, et al. : Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8 (4) : 323-335, 2005
PubMed
2. Poppleton H, Gilbertson RJ : Stem cells of ependymoma. Br J Cancer 96 : 6-10, 2007
PubMed
3. Wani K, Armstrong TS, Collaborative Ependymoma Research Network : A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123 (5) : 727-738, 2012
 
4. Witt H, Mack SC, Ryzhova M, et al. : Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20 (2) : 143-157, 2011
PubMed
5. Mack SC, Witt H, Piro RM, et al. : Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.. Nature 506 (7489) : 445-450, 2014
PubMed
6. Parker M, Mohankumar KM, Punchihewa C, et al. : C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506 (7489) : 451-455, 2014
 
7. Pajtler KW, Witt H, Sill M, et al. : Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27 (5) : 728-743, 2015
PubMed
8. Korshunov A, Witt H, Hielscher T, et al. : Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28 (19) : 3182-3190, 2010
 
9. Mack SC, Witt H, Wang X, et al. : Emerging insights into the ependymoma epigenome. Brain Pathol 23 (2) : 206-209, 2013
PubMed
10. Versteeg R : Tumours outside the mutation box. Nature 506 (7489) : 438-439, 2014
PubMed
11. Pajtler KW, Pfister SM, Kool M : Molecular dissection of ependymomas. Oncoscience 2 (10) : 827-828, 2015
PubMed
12. Ramaswamy V, Hielscher T, Mack SC, et al. : Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era : a retrospective multicohort analysis. J Clin Oncol 34 (21) : 2468-2477, 2016
 
13. Ikezaki K, Matsushima T, Inoue T, et al. : Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32 : 38-44, 1993
PubMed
14. van Veelen-Vincent M-L C, Perrre-Kahn A, Kalifa C Sainte-Rose C, et al. : Ependymoma in childhood : prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 97 : 827-835, 2002
 
15. Rogers L, Pueschel J, Spetzler R, et al. : Is gross-total resection sufficient treatment for posterior fossa ependymomas?. J Neurosurg 102 : 629-636, 2005
PubMed
16. Salazar OM : A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas. Int J Radiat Oncol Biol Phys 9 : 1231-1234, 1983
 
17. Nazar GB, Hoffman HJ, Becker LE, et al. : Infratentorial ependymomas in childhood : prognostic factors and treatment. J Neurosurg 72 : 408-417, 1990
PubMed
18. Lyons MK, Kelly PJ : Posterior fossa ependymomas : Report of 30 cases and review of the literature. Neurosurgery 28 : 659-665, 1991
PubMed
19. Figarella-Branger D, Civatte M, Bouvier-Labit C, et al. : Prognostic factors in intracranial ependymomas in children. J Neurosurg 93 : 605-613, 2000
 
20. Roncaroli F, Consales A, Fioravanti A, Cenacchi G : Supratentorial cortical ependymoma : report of three cases. Neurosurgery 57 (1) : E192, 2005
PubMed
21. Van Gompel JJ, Koeller KK, Meyer FB, et al. : Cortical ependymoma : an unusual epileptogenic lesion. J Neurosurg 114 : 1187-1194, 2011
PubMed
22. Snuderl M, Chi SN, De Santis SM, et al. : Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol 67 (9) : 911-920, 2008
PubMed
23. Ellison DW, Kocak M, Figarella-Branger D, et al. : reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10 : 7, 2011
 
24. Tihan T, Zhou T, Holmes E, et al. : The prognostic value of histological grading of posterior fossa ependymomas in children : a Children's Oncology Group study and a review of prognostic factors. Mod Pathol 21 : 165-177, 2008
 
25. Yuh EL, Barkovich AJ, Gupta N : Imaging of ependymomas : MRI and CT. Childs Nerv Syst 25 : 1203-1213, 2009
PubMed
26. Paulino AC, Wen BC, Buatti JM, et al. : Intracranial ependymomas : an analysis of prognostic factors and patterns of failure. Am J Clin Oncol 25 (2) : 117-122, 2002
PubMed
27. Korshunov A, Golanov A, Sycheva R, Timirgaz V : The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era. Cancer 100 : 1230-1237, 2004
PubMed
28. Mork SJ, Loken AC : Ependymoma--A follow up study of 101 cases. Cancer 40 : 907-915, 1977
PubMed
29. Massimino M, Solero CL, Garre ML, et al. : Second-look surgery for ependymoma : the Italian experience. J Neurosurg Pediatr 8 (3) : 246-250, 2011
PubMed
30. Merchant TE, Fouladi M : Ependymoma : new therapeutic approaches including radiation and chemotherapy. J Neuro-Oncol 75 : 287-299, 2005
 
31. Merchant TE, Li C, Xiong X, et al. : Conformal radiotherapy after surgery for paediatric ependymoma : a prospective study. Lancet Oncol 10 : 258-266, 2009
PubMed
32. Swanson EL, Amdur RJ, Morris CG, et al. : Intracranial ependymomas treated with radiotherapy : long-term results from a single institution. J Neurooncol 102 (3) : 451-457, 2011
PubMed
33. Paulino AC, Wen BC : The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys 47 : 585-589, 2000
PubMed
34. Shu HG, Sall WF, Maity A, et al. : Childhood intracranial ependymoma. Twenty year experience from a singl institution.. Cancer 110 : 432-441, 2007
 
35. von Hoff K, Kieffer V, Habrand J-L, et al. : Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications. BMC Cancer 8 : 15, 2008
PubMed
36. Conklin HM, Li C, Xiong X, Merchant TE, et al. : Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 26 : 3965-3970, 2008
PubMed
37. Bouffet E, Capra M, Bartels U : Salvage chemotherapy for metastatic and recurrent ependymoma of childhood. Childs Nerv Syst 25 : 1293-1301, 2009
PubMed
38. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL. : Adjuvant chemotherapy of childhood posterior fossa ependymoma : cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone : a Childrens Cancer Group study. Med Pediatr Oncol 27 (1) : 8-14, 1996
PubMed
39. Robertson PL, Zeltzer PM, Boyett JM, et al. : Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children : a report of the Children's Cancer Group. J Neurosurg 88 : 695-703, 1998
 
40. Garvin JH Jr, Selch MT, Children's Oncology Group : Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942 : a report from the Children's Oncology Group. Pediatr Blood Cancer 59 (7) : 1183-1189, 2012
 
41. Grill J, Le Deley MC, French Society of Pediatric Oncology : Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age : a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19 (5) : 1288-1296, 2001
 
42. Grundy RG, Wilne SA, Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee : Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children : the UKCCSG/SIOP prospective study. Lancet Oncol 8 (8) : 696-705, '2007
 
43. Massimino M, Gandola L, Barra S, et al. : Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Int J Radiat Oncol Biol Phys 80 (3) : 807-814, 2011
PubMed
44. Massimino M, Miceli R, Giangaspero F, et al. : Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. Neuro Oncol. 2016 May 18, 108., 2016
 
45. Venkatramani R, Ji L, Lasky J, et al. : Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. J Neurooncol 113 (2) : 285-291, 2013
PubMed
46. Koshy M, Rich S, Merchant TE, et al. : Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neurooncol 105 (3) : 583-590, 2011
PubMed
47. Ernestus RI, Wilcke O, Schroder R : Supratentorial ependymomas in childhood : clinicopathological findings and prognosis. Acta Neurochir (Wien) 111 (3-4) : 96-102, 1991
PubMed
48. Palma L, Celli P, Cantore G : Supratentorial ependymomas of the first two decades of life. Longterm follow-up of 20 cases (including two subependymomas). Neurosurgery 32 : 169-175, 1993
PubMed
49. Landau E, Boop FA, Conklin HM, et al. : Supratentorial ependymoma : disease control, complications, and functional outcomes after irradiation. Int J Radiat Oncol Biol Phys 85 (4) : e193-199, 2012
PubMed
50. Shuangshoti S, Rushing EJ, Mena H, et al. : Supratentorial extraventricular ependymal neoplasms. a clinicopathologic study of 32 patients. Cancer 103 : 2598-2605, 2005
PubMed
51. Lehman NL : Patterns of brain infiltration and secondary structure formation in supratentorial ependymal tumors. J Neuropathol Exp Neurol 67 (9) : 900-910, 2008
PubMed
52. Raghunathan A, Wani K, Collaborative Ependymoma Research Network : Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol 23 (5) : 584-594, 2013
 
53. Hollon T, Nguyen V, Smith BW, et al. : Supratentorial hemispheric ependymomas : an analysis of 109 adults for survival and prognostic factors. J Neurosurg 125 (2) : 410-418, 2016
PubMed
54. Zacharoulis S, Ji L, Pollack IF, et al. : Metastatic ependymoma : a multi-institutional retrospective analysis of prognostic factors. Pediatr Blood Cancer 50 (2) : 231-235, 2008
PubMed
55. Goldwein JW, Glauser TA, MD, et al. : Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66 : 557-563, 1990
 
56. Merchant TE, Boop FA, Kun LE, Sanford RA : A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys 71 : 87-97, 2008
PubMed
57. Messahel B, Ashley S, Children's Cancer Leukaemia Group Brain Tumour Committee : Relapsed intracranial ependymoma in children in the UK : patterns of relapse, survival and therapeutic outcome. Eur J Cancer 45 (10) : 1815-1823,2009
 
58. Bouffet E, Hawkins CE, Balloura W, et al. : Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys 83 (5) : 1541-1548, 2012
 
59. Zacharoulis S, Ashley S, Moreno L, et al. : Treatment and outcome of children with relapsed ependymoma : a multi-institutional retrospective analysis. Childs Nerv Syst 26 (7) : 905-911, 2011
 
60. Merchant TE, Haida T, Wang MH, et al. : Anaplastic ependymoma : treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 86 (6) : 943-949, 1997
PubMed
61. Timmermann G, Kortmann RD, Kuhl J, et al. : Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood : results of the german prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46 : 287-295, 2000
 
62. Iwamoto N, Murai Y, Yamamoto Y, et al. : Supratentorial extraventricular anaplastic ependymoma in an adult with repeated intratumoral hemorrhage. Brain Tumor Pathol 31 (2) : 138-143, 2014
 
63. Metellus P, Figarella-Branger D, Guyotat J, et al. : prognostic factors and outcome analysis in a retrospective series of 46 adult patients. Cancer 113 : 175-185, 2008
 
64. Shuangshoti S, Rushing EJ, Mena H, et al. : Supratentorial extraventricular ependymal neoplasms : a clinicopathologic study of 32 patients. Cancer 103 (12) : 2598-2605, 2005
PubMed
P.259 掲載の参考文献
1. Bagley CA, Wilson S, Kothbauer KF, et al. : Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev 32 : 321-334, 2009
PubMed
2. Weber DC, Wang Y, Miller R, et al. : Long-term outcome of patients with spinal myxopapillary ependymoma : treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol 17 (4) : 588-595, 2015
 
P.262 掲載の参考文献
1. Scheinker IM : Subependymoma : a newly recognized tumor of subependymal derivation. J Neurosurg 2 (3) : 232-240, 1945
 
2. Shuangshoti S, Rushing EJ, Mena H, et al. : Supratentorial extraventricular ependymal neoplasms : a clinicopathologic study of 32 patients. Cancer 103 (12) : 2598-2605, 2005
PubMed
3. Kim Y, Lee SY, Yi KS, et al. : Infratentorial and intraparenchymal subependymoma in the cerebellum : case report. Korean J Radiol 15 (1) : 151-155, 2014
 
4. Jallo GI, Zagzag D, Epstein F. : Intramedullary subependymoma of the spinal cord. Neurosurgery 38 (2) : 251-257, 1996
PubMed
5. Lombardi D, Scheithauer BW, Meyer FB, et al. : Symptomatic subependymoma : a clinicopathological and flow cytometric study. J Neurosurg 75 (4) : 583-588, 1991
PubMed
6. Scheithauer BW : Symptomatic subependymoma. Report of 21 cases with review of the literature. J Neurosurg 49 (5) : 689-696, 1978
PubMed
7. Rushing EJ, Cooper PB, Quezado M, et al. : Subependymoma revisited : clinicopathological evaluation of 83 cases. J Neurooncol 85 (3) : 297-305, 2007
 
8. Lobato RD, Cabello A, Carmena JJ, et al. : Subependymoma of the lateral ventricle. Surg Neurol 15 (2) : 144-147, 1981
PubMed
9. Cheng TM, Coffey RJ, Gelber BR, Scheithauer BW : Simultaneous presentation of symptomatic subependymomas in siblings : case reports and review. Neurosurgery 33 (1) : 145-150, 1993
PubMed
10. Ryken TC, Robinson RA, VanGilder JC : Familial occurrence of subependymoma. Report of two cases. J Neurosurg 80 (6) : 1108-1111, 1994
 
11. Stevens JM, Kendall BE, Love S : Radiological features of subependymoma with emphasis on computed tomography.. Neuroradiology 26 (3) : 223-228, 1984
PubMed
12. Ragel BT, Osborn AG, Whang K, et al. : Subependymomas : an analysis of clinical and imaging features. Neurosurgery 58 (5) : 881-890, 2006
PubMed
13. Hou Z, Wu Z, Zhang J, et al. : Lateral ventricular subependymomas : An analysis of the clinical features of 27 adult cases at a single institute. Neurol India 60 (4) : 379-384, 2012
 
14. Jain A, Amin AG, Jain P, et al. : Subependymoma : clinical features and surgical outcomes. Neurol Res 34 (7) : 677-684, 2012
PubMed
15. Lindboe CF, Stolt-Nielsen A, Dale LG : Hemorrhage in a highly vascularized subependymoma of the septum pellucidum : case report. Neurosurgery 31 (4) : 741-745, 1992
 
16. Bi Z, Ren X, Zhang J, Jia W : Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. J Neurosurg 122 (1) : 49-60, 2015
 

第6章 その他のglioma

P.264 掲載の参考文献
1. Sughrue ME, Choi J, Rutkowski MJ, et al. : Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci 18 : 750-754, 2011
PubMed
2. Bell JW, Osborn AG, Salzman KL, et al. : Neuroradiologic characteristics of astroblastoma. Neuroradiology. 49 : 203-209, 2007
PubMed
3. Brat DJ, Hirose Y, Cohen KJ, et al. : Astroblastoma : clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 10 (3) : 342-352, 2000
PubMed
4. Ahmed KA, Allen PK, Mahajan A, et al. : Astroblastomas : a Surveillance, Epidemiology, and End Results (SEER) -based patterns of care analysis. World Neurosurg 82 (1-2) : e291-297, 2014
PubMed
5. Janz C, Buhl R. : Astroblastoma : report of two cases with unexpected clinical behavior and review of the literature. Clin Neurol Neurosurg 125 : 114-124, 2014
PubMed
6. Lehman NL, Hattab EM, Mobley BC, et al. : Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. Neuro Oncol. 2016 Jul 14. pii : now 118. [Epub ahead of print], 2016
 
P.266 掲載の参考文献
1. Lellouch-Tubiana A, Boddaert N, Bourgeois M, et al. : Angiocentric neuroepithelial tumor (ANET) : a new epilepsy-related clinicopathological entity with distinctive MRI. Brain Pathol 15 (4) : 281-286, 2005
 
2. Ersen A, Canda MS, Men S, et al. : Angiocentric Glioma : The Infiltrative Glioma with Ependymal Differentiation. Turk Patoloji Derg 10 : 1-5, 2014
 
3. Shakur SF, McGirt MJ, Johnson MW, et al. : Angiocentric glioma : a case series. J Neurosurg Pediatr 3 (3) : 197-202, 2009
 
4. Covington DB, Rosenblum MK, Brathwaite CD, Sandberg DI : Angiocentric glioma-like tumor of the midbrain. Pediatr Neurosurg 45 (6) : 429-433, 2009
PubMed
5. Ampie L, Choy W, DiDomenico JD, et al. : Clinical attributes and surgical outcomes of angiocentric gliomas. J Clin Neurosci 28 : 117-122, 2016
PubMed
6. Bandopadhayay P, Ramkissoon LA, Jain P, et al. : MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48 (3) : 273-282, 2016
PubMed
7. Raghunathan A, Olar A, Vogel H, et al. : Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol 16 (4) : 255-259, 2012
 
P.268 掲載の参考文献
1. Desouza RM, Bodi I, Thomas N, et al. : Chordoid glioma : ten years of a low-grade tumor with high morbidity. Skull Base 20 (2) : 125-138, 2010
PubMed
2. Morais BA, Menendez DF, Medeiros RS, et al. : Chordoid glioma : Case report and review of the literature. Int J Surg Case Rep 7C : 168-171, 2015
PubMed
3. Kobayashi T, Tsugawa T, Hashizume C, et al. : Therapeutic approach to chordoid glioma of the third ventricle.. Neurol Med Chir (Tokyo) 53 (4) : 249-255, 2013
PubMed
4. Ampie L, Choy W, Lamano JB, et al. : Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas : A systematic review of literature. Clin Neurol Neurosurg 138 : 129-136, 2015
PubMed

第7章 Choroid plexus tumor

P.270 掲載の参考文献
1. Aicardi J : Aicardi syndrome. Brain Dev 27 (3) : 164-171, 2005
PubMed
2. Frye RE, Polling JS, Ma LC : Choroid plexus papilloma expansion over 7 years in Aicardi syndrome. J Child Neurol 22 (4) : 484-487, 2007
PubMed
P.275 掲載の参考文献
1. Wrede B, Liu P, Wolff JEA : Chemotherapy improves the survival of patients with choroids plexus carcinoma : a meta-analysis of individual cases with choroids plexus tumors. J Neuroonocol 85 : 345-351, 2007
PubMed
2. Cannon DM, Mohindra P, Gondi V, et al. : Choroid plexus tumor epidemiology and outcomes : implications for surgical and radiotherapeutic management. J Neurooncol 121 (1) : 151-157, 2015
PubMed
3. Lafay-Cousin L, Keene D, Carret AS, et al. : Choroid plexus tumors in children less than 36 months : the Canadian Pediatric Brain Tumor Consortium (CPBTC) experience. Childs Nerv Syst 27 (2) : 259-264, 2011
PubMed
4. Wolff JEA, Sajedi1 M, Brant R, et al. : Choroid plexus tumors. Br J Cancer 87 : 1086-1091, 2002
 
5. Keskin F, Erdi F, Kaya B, Toy H : Sellar-suprasellar extraventricular choroid plexus papilloma : a case report and review of the literature. J Korean Neurosurg Soc 59 (1) : 58-61, 2016
PubMed
6. Wrede B, Hasselblatt M, Peters O, et al. : Atypical choroid plexus papilloma : clinical experience in the CPT-SIOP-2000 study. J Neurooncol 95 (3) : 383-392, 2009
PubMed
7. Hawkins JC 3rd : Treatment of choroid plexus papillomas in children : a brief analysis of twenty years' experience. Neurosurgery 6 (4) : 380-384, 1980
PubMed
8. Piguet V, de Tribolet N : Choroid plexus papilloma of the cerebellopontine angle presenting as a subarachnoid hemorrhage : case report. Neurosurgery 15 : 114-116, 1984
PubMed
9. Meyers SP, Khademian ZP, Chuang SH, et al. : Choroid plexus carcinomas in children: MRI features and patient outcomes. Neuroradiology 46 (9) : 770-780, 2004
PubMed
10. Abdulkader MM, Mansour NH, Van Gompel JJ, et al. : Disseminated choroid plexus papillomas in adults : A case series and review of the literature. J Clin Neurosci. 2016 Jun 29., 2016
 
11. Lam S, Lin Y, Cherian J, Qadri U, et al. : Choroid plexus tumors in children : a population-based study. Pediatr Neurosurg 49 (6) : 331-338, 2013
 
12. Raimondi AJ, Gutierrez FA : Diagnosis and surgical treatment of choroid plexus papillomas. Childs Brain 1 (2-3) : 81-11, 1975
 
13. Jeibmann A, Hasselblatt M, Gerss J, et al. : Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropath Exp Neurol 65 : 1069-1073, 2006
PubMed
14. Passariello A, Tufano M, Spennato P, et al. : The role of chemotherapy and surgical removal in the treatment of Choroid Plexus carcinomas and atypical papillomas. Childs Nerv Syst 31 (7) : 1079-1088, 2015
PubMed
15. Gozali AE, Britt B, Shane L, et al. : Choroid plexus tumors ; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer 58 (6) : 905-909, 2014
 
16. Berger C, Thiesse P, Lellouch-Tubiana A, et al. : Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 42 (3) : 470-475, 1998
PubMed
17. Zaky W, Dhall G, Khatua S, et al. : Choroid plexus carcinoma in children : the Head Start experience. Pediatr Blood Cancer 62 (5) : 784-789, 2015
PubMed
18. Schneider C, Kamaly-Asl I, Ramaswamy V, et al. : Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas. J Neurosurg Pediatr 16 (2) : 126-133, 2015
PubMed
19. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. : A cancer family syndrome in twenty-four kindreds. Cancer Res 48 (18) : 5358-5362, 1988
PubMed
20. Tinat J, Bougeard G, Baert-Desurmont A, et al. : 2009 Version of the Chompret criteria for Li Fraumeni Syndrome. J Clin Oncol 27 (26) : e108-e109, 2009
PubMed
21. Tabori U, Shlien A, Baskin B, et al. : TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28 (12) : 1995-2001, 2013
 
22. Bahar M, Kordes U, Tekautz T, Wolff J : Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni syndrome: advantageous or detrimental? Anticancer Res 35 (5) : 3013-3017, 2015
PubMed
23. Merino DM, Shlien A, Villani A, et al. : Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups. Clin Cancer Res 21 (1) : 184-192, 2015
PubMed
24. Japp AS, Gessi M, Messing-Junger M, et al. : High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors. J Neuropathol Exp Neurol 74 (2) : 110-120, 2015
 
25. Thomas C, Sill M, Ruland V, et al. : Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups. Neuro Oncol 18 (6) : 790-796, 2016
PubMed

第8章 Neuronal and mixed neuronal - glial tumors

P.280 掲載の参考文献
1. Hassoun J, Gambarelli D, Grisoli F, et al. : Central neurocytoma. An electron-microscopic sudy of two cases. Acta Neuropathol (Berl) 56 : 151-156, 1982
 
2. von Demling A, Janzer P, Kleihues P, Wiestler OD : Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 79 : 473-479, 1990
 
3. Figarella-Branger D, Pellissier JF, Daumas-Duport C, et al. : Central neurocytomas : Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol 16 : 97-109, 1992
PubMed
4. Wichmann W, Shubiger O, von Deimling A, et al. : Neuroradiology of central neurocytoma. Neuroradiology 33 : 143-148, 1991
 
5. Yasargil MG, von Ammon K, von Deimling A, Valavanis A, Wichmann W, Wiestler OD : Central neurocytoma : histopathological variants and therapeutic approaches. J Neurosurg 76 : 32-37, 1992
PubMed
6. Lubrano V, Francois P, Loundou A, et al. : Outcomes after surgery for central neurocytoma : results of a French multicentre retrospective study. Acta Neurochir (Wien) 155 (7) : 1261-1269, 2013
PubMed
7. Kim JW, Kim DG, Kim IK, et al. : Central neurocytoma : long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single institute. Neurosurgery 72 (3) : 407-413, 2013
 
8. Chen YD, Li WB, Feng J, Qiu XG : Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma. Radiat Oncol 9 : 242, 2014
PubMed
9. Garcia RM, Ivan ME, Oh T, Barani I, Parsa AT : Intraventricular neurocytomas : a systematic review of stereotactic radiosurgery and fractionated conventional radiotherapy for residual or recurrent tumors. Clin Neurol Neurosurg 117 : 55-64, 2014
 
10. Yamanaka K, Iwai Y, Shuto T, et al. : Treatment results of gamma knife radiosurgery for central neurocytoma : report of a Japanese multi-institutional cooperative study. World Neurosurg 90 : 300-305, 2016
PubMed
11. Rades D, Schild SE, Fehlauer F : Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62 : 987-989, 2004
PubMed
12. Kaur G, Kane AJ, Sughrue ME, et al. : MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas. J Clin Neurosci 20 (1) : 89-93, 2013
PubMed
13. Nishio S, Takeshita I, Fukui M : Primary cerebral ganglioneurocytoma in adult. Cancer 66 : 358-362, 1990
PubMed
14. Liu K, Wen G, Lv XF, et al. : MR imaging of cerebral extraventricular neurocytoma : a report of 9 cases. AJNR Am J Neuroradiol 34 (3) : 541-546, 2013
PubMed
P.284 掲載の参考文献
1. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al. : A Surgically curable tumor of young patients with intractable partial seizures. Neurosurgery 23 : 545-556, 1988
PubMed
2. Ostrom QT, Gittleman H, Farah P, et al. : CBTRUS statistical report : Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 17 Suppl 4, 2015
 
3. Chassoux F, Landre E, Mellerio C, et al. : Dysembryoplastic neuroepithelial tumors : epileptogenicity related to histologic subtypes. Clin Neurophysiol 124 (6) : 1068-1078, 2013
PubMed
4. Chassoux F, Daumas-Duport C : Dysembryoplastic neuroepithelial tumors : where are we now?. Epilepsia 54 Suppl 9 : 129-134, 2013
 
5. Ranger A1, Diosy D : Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies. Childs Nerv Syst 31 (6) : 847-855, 2015
 
6. Mano Y, Kumabe T, Shibahara I, Saito R, Sonoda Y, Watanabe M, Tominaga T. Dynamic changes in magnetic resonance imaging appearance of dysembryoplastic neuroepithelial tumor with or without malignant transformation. J Neurosurg Pediatr 11 (5) : 518-525, 2013 References
PubMed
7. Heiland DH, Staszewski O, Hirsch M, Masalha W, Franco P, Grauvogel J, Capper D, Schrimpf D, Urbach H, Weyerbrock A : Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis. J Neuropathol Exp Neurol 75 (4) : 358-365, 2016
PubMed
8. Lee D, Cho YH, Kang SY, Y et al. : BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas. J Surg Oncol 111 (3) : 359-364, 2015
 
9. Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, Faury D, et al. : Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131 (6) : 847-863, 2016
PubMed
P.288 掲載の参考文献
1. Dudley RW, Torok MR, Gallegos DR, Mulcahy-Levy JM, Hoffman LM, Liu AK, Handler MH, Hankinson TC : Pediatric low-grade ganglioglioma : epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database. Neurosurgery 76 (3) : 313-319, 2015
PubMed
2. Lang FF, Epstein FJ, Ransohoff J, et al. : Central nervous system gangliogliomas. Part 2 : Clinical outcome. J Neurosurg 79 : 867-873, 1993
PubMed
3. Miller DC, Lang FF, Epstein FJ : Central nervous system gangliogliomas. Part 1 : Pathology. J Neurosurg 79 : 859-866, 1993
PubMed
4. Castillo M, Davis PC, Yoshii T, Hoffman JCJr. : Intracranial ganglioglioma: MR, CT, and clinical findings in 18 patients. AJNR 154 : 607-612, 1990
 
5. Haddad SF, Moore SA, Menezes AH, VanGilder JC : Ganglioglioma : 13 years of experience. Neurosurgery 31 : 171-178, 1992
PubMed
6. Henry JM, Heffner RR, Earle KM: Gangliogliomas of CNS : A clinico-pathological study of 50 cases. Neuropath Exp Neurol 37 : 626, 1978
 
7. Johannsson JH, Rekate HL, Roessmann U : Gangliogliomas : Pathological and clinical correlation. J Neurosurg 54 : 58-63, 1981
PubMed
8. Wolf HK, Muller MB, Spanle M, et al. : Ganglioglioma : a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol 88 : 166-173, 1994
PubMed
9. Klouwer HGJ, Davis RL, McDermott MW, et al. : Gangliogliomas : a clinicopathological study of 25 cases and review of the literature. J Neuro-Oncol 17 : 139-154, 1993
 
10. Wacker MR, Cogen PH, Etzell JE, et al. : Diffuse leptomeningeal involvement by a ganglioglioma in a child. J Neurosurg 77 : 302-306, 1992
 
11. Hall WA, Yunis EJ, Albright AL : Anaplastic ganglioglioma in an infant : Case report and review of the literature. Neurosurgery 19 : 1016-1020, 1986
 
12. Compton JJ, Laack NN, Eckel LJ, et al. : Long-term outcomes for low-grade intracranial ganglioglioma : 30-year experience from the Mayo Clinic. J Neurosurg 117 (5) : 825-830, 2010
 
13. Majores M, von Lehe M, Fassunke J, et al. : Tumor recurrence and malignant progression of gangliogliomas. Cancer 113 (12) : 3355-3363, 2008
PubMed
14. Haydon DH, Dahiya S, Smyth MD, et al. : Greater extent of resection improves ganglioglioma recurrence-free survival in children : a volumetric analysis. Neurosurgery 75 (1) : 37-42, 2014
PubMed
15. Joyon N, Tauziede-Espariat A, Alentorn A, et al. : K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. Neuropathol Appl Neurobiol. 2016 May 24. Epub ahead of print), 2016
 
16. Yust-Katz S, Anderson MD, Liu D, et al. : Clinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol 16 (3) : 409-413, 2014
PubMed
17. Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD : Outcome and prognostic features in anaplastic ganglioglioma : analysis of cases from the SEER database. J Neurooncol 105 (3) : 539-545, 2011
PubMed
18. Schindler G, Capper D, Meyer J, J et al. : Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121 (3) : 397-405, 2011
 
19. Chappe C, Padovani L, Scavarda D, et al.: Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF (V600E) mutation and expression. Brain Pathol 23 (5) : 574-583, 2013
PubMed
P.290 掲載の参考文献
1. Ebina K, Suzuki S, Takahashi T, et al. : Gangliobytoma of the pineal body. A case report and review of the literature. Acta Neurochir 74 : 134-140, 1985
PubMed
2. Bridenstine M, Kerr JM, Lillehei KO, et al. : Cushing's disease due to mixed pituitary adenomagangliocytoma of the posterior pituitary gland presenting with Aspergillus sp. sinus infection. Clin Neuropathol 32 (5) : 377-383, 2013
PubMed
3. Tanriover N, Aydin O, Kucukyuruk B, A et al. : Endoscopic approach to a collision tumor of growth hormone-secreting adenoma and gangliocytoma in the pituitary gland. J Craniofac Surg 25 (4) : 1277-1279, 2014
PubMed
4. Takahashi M, Kondo T, Morichika M, et al. : Autopsy case of undiagnosed gangliocytoma in the medulla oblongata complicated with cerebral palsy. Leg Med (Tokyo). 19 : 119-121, 2016
 
P.293 掲載の参考文献
1. Lehrmitte J, Duclos P : Sur un ganglio-neurome diffuse du cortex du cervelet. Bull Assoc Fr Etude Cancer 9 : 99-107, 1920
 
2. Milbouw G, Born JD, Martin D, et al. : Clinical and radiological aspects of dysplastic gangliocytoma (Lhermitte-Duclos disease) : a report of two cases with review of the literature. Neurosurgery 22 : 124-128, 1988.
PubMed
3. Matsumoto H, Minami H, Yoshida Y : Lhermitte-Duclos disease treated surgically in an elderly patient : case report and literature review. Turk Neurosurg 25 (5) : 783-787, 2015
 
4. Nowak DA, Trost HA : Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma) : a malformation, hamartoma or neoplasm?. Acta Neurol Scand 105 (3) : 137-145, 2002
PubMed
5. Meltzer CC, Smirniotopoulos JG, Jones RV : The striated cerebellum : an MR imaging sign in Lhermitte-Duclos disease (dysplastic gangliocytoma). Radiology 194 (3) : 699-703, 1995
 
6. Awwad EE, Levy E, Martin DS, Merenda GO : Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement. AJNR Am J Neuroradiol 16 (8) : 1719-1720, 1995
PubMed
7. Goto Y, Hashimoto N, Okita Y, et al. : A surgically treated case of Lhermitte-Duclos disease with a precise natural history and high uptake of FDG on PET. J Neurooncol 97 (3) : 445-450, 2010
 
8. Williams DW 3rd, Elster AD, Ginsberg LE, Stanton C : Recurrent Lhermitte-Duclos disease : report of two cases and association with Cowden's disease. AJNR 13 : 287-290, 1992
PubMed
9. Robinson S, Cohen AR : Cowden disease and Lhermitte-Duclos disease : characterization of a new phakomatosis. Neurosurgery 46 (2) : 371-383, 2000
PubMed
10. Lok C, Viseux V, Avril MF, et al. : Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore) 84 (2) : 129-136, 2005
PubMed
11. Zhou XP, Marsh DJ, Morrison CD, et al. : Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 73 (5) : 1191-1198, 2003
PubMed
12. Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, Boardman LA. : Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 8 (1) : 6, 2010
PubMed
P.295 掲載の参考文献
1. Taratuto AL, Monges J, Lylyk P, Leiguarda R : Superficial cerebral astrocytoma attached to dura. Report of six cases in infants. Cancer 54 (11) : 2505-2512, 1984
PubMed
2. VandenBerg SR, May EE, Rubinstein LJ, et al. : Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differntiation potential ("desmoplastic infantile gangliogliomas") Report on 11 cases of a distinct embryonak with favorable prognosis. J Neurosurg 66 : 58-71, 1987
 
3. Duffiner PK, Burger PC, Cohen ME, et al. : Desmoplastic infantile gangliogliomas : an approach to therapy. Neurosurgery 34 : 583-589, 1994
 
4. Kato M, Yano H, Okumura A, et al. : A non-infantile case of desmoplastic infantile astrocytoma. Childs Nerv Syst 20 (7) : 499-501, 2004
PubMed
5. Kuchelmeister K, Bergmann M, von Wild K, et al. : Desmoplastic ganglioglioma : report of two noninfantile cases. Acta Neuropathol 85 : 190-204, 1993
 
6. Bader A, Heran M, Dunham C, Steinbok P : Radiological features of infantile glioblastoma and desmoplastic infantile tumors : British Columbia's Children's Hospital experience. J Neurosurg Pediatr 16 (2) : 119-125, 2015
PubMed
7. Trehan G, Bruge H, Vinchon M, et al. : MR imaging in the diagnosis of desmoplastic infantile tumor : retrospective study of six cases. AJNR Am J Neuroradiol 25 (6) : 1028-1033, 2004
PubMed
8. Sugiyama K, Arita K, Shima T, et al. : Good clinical course in infants with desmoplastic cerebral neuroepithelial tumor treated by surgery alone. J Neurooncol 59 (1) : 63-69, 2002
PubMed
9. Mallucci C, Lellouch-Tubiana A, Salazar C, et al. : The management of desmoplastic neuroepithelial tumours in childhood. Childs Nerv Syst 16 (1) : 8-14, 2000
PubMed
10. Al-Kharazi K, Gillis C, Steinbok P, Dunham C : Malignant desmoplastic infantile astrocytoma- a case report and review of the literature. Clin Neuropathol 32 (2) : 100-106, 2013
PubMed
11. Komori T, Scheithauer BW, Parisi JE, et al. : Mixed conventional and desmoplastic infantile ganglioglioma : an autopsied case with 6-year follow-up. Mod Pathol 14 (7) : 720-726, 2001
PubMed
12. Phi JH, Koh EJ, Kim SK, et al. : Desmoplastic infantile astrocytoma : recurrence with malignant transformation into glioblastoma : a case report. Childs Nerv Syst 27 (12) : 2177-2181, 2011
PubMed
13. Loh JK, Lieu AS, Chai CY, Howng SL : Malignant transformation of a desmoplastic infantile ganglioglioma. Pediatr Neurol 45 (2) : 135-137, 2011
PubMed
14. Gessi M, Zur Muhlen A, Hammes J, et al. : Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas. J Neuropathol Exp Neurol 72 (9) : 807-815, 2013
PubMed
15. Koelsche C, Sahm F, Paulus W, et al. : BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma. Neuropathol Appl Neurobiol 40 (3) : 337-344, 2014
PubMed
P.298 掲載の参考文献
1. Pages M, Lacroix L, Tauziede-Espariat A, et al. : Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun 3 : 85, 2015
PubMed
2. Bridge JA, Liu XQ, Sumegi J, et al. : Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol 23 (2) : 121-128, 2013
PubMed
3. Komori T, Scheithauer BW, Anthony DC, et al. : Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm.. Am J Surg Pathol 22 (10) : 1171-1183, 1998
PubMed
4. Tanaka Y, Yokoo H, Komori T, et al. : A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors : a manifestation of the oligodendroglial phenotype?. Acta Neuropathol 110 (1) : 39-47, 2005
 
5. Schlamann A, von Bueren AO, Hagel C, Zwiener I, et al.: An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle. PLoS One 9 (7) : e101211, 2014
PubMed
6. Li D, Wang JM, Li GL, et al. : Clinical, radiological, and pathological features of 16 papillary glioneuronal tumors. Acta Neurochir (Wien) 156 (4) : 627-639, 2014
 
P.300 掲載の参考文献
1. Komori T, Scheithauer BW, Hirose T : A rosette-forming glioneuronal tumor of the fourth ventricle : infratentorial form of dysembryoplastic neuroepithelial tumor?. Am J Surg Pathol 26 (5) : 582-591, 2002
 
2. Zhang J, Babu R, McLendon RE, et al. : A comprehensive analysis of 41 patients with rosetteforming glioneuronal tumors of the fourth ventricle. J Clin Neurosci 20 (3) : 335-341, 2013
PubMed
3. Wang Y, Xiong J, Chu SG, et al. : Rosette-forming glioneuronal tumor : report of an unusual case with intraventricular dissemination. Acta Neuropathol 118 (6) : 813-839, 2009
 
4. Gessi M, Lambert SR, Lauriola L, et al. : Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT). J Neurooncol 110 (1) : 21-25, 2012
PubMed
5. Gessi M, Moneim YA, Hammes J, et al. : FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle. J Neuropathol Exp Neurol 73 (6) : 580-584, 2014
PubMed
P.302 掲載の参考文献
1. Patel N, Fallah A, Provias J, Jha NK : Cerebellar liponeurocytoma. Can J Surg 52 (4) : E117-E119, 2009
PubMed
2. Alkadhi H, Keller M, Brandner S, et al. : Neuroimaging of cerebellar liponeurocytoma. Case report. Neurosurg 95 (2) : 324-331, 2001
PubMed
3. Takami H, Mukasa A, Ikemura M, et al. : Findings from positron emission tomography and genetic analyses for cerebellar liponeurocytoma. Brain Tumor Pathol 32 (3) : 210-215, 2015
PubMed
4. Wang KE, Ni M, Wang L, et al. : Cerebellar liponeurocytoma : A case report and review of the literature. Oncol Lett 11 (2) : 1061-1064, 2016
 
5. Nishimoto T, Kaya B : Cerebellar liponeurocytoma. Arch Pathol Lab Med 136 (8) : 965-969, 2012
PubMed
6. Pikis S, Fellig Y, Margolin E : Cerebellar liponeurocytoma in two siblings suggests a possible familial predisposition. J Clin Neurosci 32 : 154-156, 2016
PubMed
7. Horstmann S, Perry A, Reifenberger G, et al. : Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathol 14 (3) : 281-289, 2004
PubMed
P.303 掲載の参考文献
1. Schniederjan MJ, Alghamdi S, Castellano-Sanchez A, et al. : Diffuse leptomeningeal neuroepithelial tumor : 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry. Am J Surg Pathol 37 (5) : 763-771, 2013
PubMed
2. Rodriguez FJ, Perry A, Rosenblum MK, et al. : Disseminated oligodendroglial-like leptomeningeal tumor of childhood : a distinctive clinicopathologic entity. Acta Neuropathol 124 (5) : 627-641, 2012
PubMed

第9章 胎児性脳腫瘍

P.309 掲載の参考文献
1. Sturm D, Orr BA, Toprak UH, et al. : New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164 (5) : 1060-1072, 2016
PubMed
2. Ostrom QT, de Blank PM, Kruchko C, et al. : Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol 16 Suppl 10 : x1-x36, 2015
 
3. Desandes E, Guissou S, Chastagner P, Lacour B : Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors. Neuro Oncol 16 (7) : 975-983, 2014
 
4. The Committee of Brain Tumor Registry of Japan : Report of Brain Tumor Registry of Japan (2001-2004), 13th Edition. Neurol Med Chir (Tokyo), vol. 54, Supplement 1, 2014
 
5. 渋井壮一郎 : 脳腫瘍疫学の変遷. No Shinkei Geka 43 (11) : 1031-1042, 2015
 
6. Tulla M, Berthold F, Graf N, et al. : Incidence, trends, and survival of children with embryonal tumors. Pediatrics 136 (3) : e623-32, 2015
PubMed
7. Woehrer A, Slavc I, Waldhoer T, et al. : Incidence of atypical teratoid/rhabdoid tumors in children : a population-based study by the Austrian Brain Tumor Registry, 1996-2006. Cancer 116 (24) : 5725-5732, 2010
PubMed
P.325 掲載の参考文献
Hori T, Tanaka S. Nishiyama M, et al. : Distribution of intrathecally administered ACNU in Mongrel dogs: pharmacokinetics and quantitative autoradiographic study. Surg Neurol 40 : 183-195, 1993
PubMed
P.366 掲載の参考文献
1. Thorne RN, Pearson ADJ, Nicoll JAR, et al. : Decline in incidence of medulloblastoma in children. Cancer 74 : 3240-3244, 1994
 
2. MRC Vitamin Study Resarch Group : Prevention of neural tube defects : Results of the Medical Research Council Vitamin Study. Lancet 338 : 131-137, 1991
 
3. Partap S, Curran EK, Propp JM, et al. : Medulloblastoma incidence has not changed over time : a CBTRUS study. J Pediatr Hematol Oncol 31 : 970-971, 2009
PubMed
4. Preston-Martin S, Yu MC, Benton B, Henderson BE : N-Nitroso compounds and childhood brain tumors : a case-control study. Cancer Res 42 : 5240-5245, 1982
PubMed
5. Bunin GR, Gallagher PR, Rorke-Adams LB, et al. : Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood : a children's oncology group study. Cancer Epidemiol Biomarkers Prev 15 : 1660-1667, 2006
 
6. Hirakawa K, Suzuki K, Ueda S, Handa J : Fetal origin of the medulloblastoma : evidence from growth analysis of two cases. Acta Neuropathol (Berl) 70 : 227-234, 1986
PubMed
7. Nagashima K, Yasui K, Kimura J, et al. : Induction of brain tumor by a nwly isolated JC virus (Tokyo-1 strain). Am J Pathol 116 : 455-463, 1984
PubMed
8. Farwell JR, Dohrmann GJ, Flannery JT : Medulloblastoma in childhood : an epidemiological study. J Neurosurg 61 : 657-664, 1984
PubMed
9. McManamy CS, Pears J, Weston CL, et al. : Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17 : 151-164, 2007
PubMed
10. Halperin EC, Friedman HS : Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?. Cancer 78 : 874-880, 1996
 
11. 古畑匡規, 藍原康雄, 江口盛一郎, 他 : 小脳出血で発症した症に髄芽腫の1例. 脳神経外科 42 (6) : 545-551, 2014
 
12. Meyers SP, Kemp SS, Tarr RW : MR imaging features of medulloblastomas. AJR 158 : 859-865, 1992
PubMed
13. Buhring U, Strayle-Batra M, Freudenstein D, et al. : MRI features of primary, secondary and metastatic medulloblastoma. Eur Radiol. 2002 Jun ; 12 (6) : 1342-1348, 2002
PubMed
14. Perreault S, Ramaswamy V, Achrol AS, et al. : MRI Surrogates for Molecular Subgroups of Medulloblastoma. AJNR Am J Neuroradiol 35 (7) : 1263-1269, 2014
PubMed
15. Okamoto K, Ito J, Ishikawa K, et al. : Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 10 (8) : 1342-1350, 2000
PubMed
16. Rumboldt Z, Camacho DL, Lake D, et al. : Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 27 (6) : 1362-1369, 2006
PubMed
17. Pillai S, Singhal A, Byrne AT, et al. : Diffusion-weighted imaging and pathological correlation in pediatric medulloblastomas- "They are not always restricted!". Childs Nerv Syst 27 (9) : 1407-1411, 2011
 
18. Wefers AK, Warmuth-Metz M, Poschl J, et al. : Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. Acta Neuropathol 127 (6) : 931-933, 2014
PubMed
19. Gibson P, Tong Y, Robinson G, et al. : Subtypes of medulloblastoma have distinct developmental origins. Nature 468 (7327) : 1095-1099, 2010
PubMed
20. Sarah ES, Leary SE, Zhou T, et al. : Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma : a report from the Children's Oncology Group. Cancer 117 : 3262-3267, 2011
 
21. Warmuth-Metz M, Blashofer S, von Bueren AO, et al. : Recurrence in childhood medulloblastoma. J Neurooncol 103 : 705-711, 2011
PubMed
22. Dhall G, Grodman H, Ji L, et al. : Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer 50 : 1169-1175, 2008
 
23. Mazloom A, Zangeneh AH, Paulino AC : Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys 78 : 72-78, 2010
PubMed
24. Kleinman GM, Hochberg FH, Richardson EP : Systemic metastases from medulloblastoma : report of two cases and review of the literature. Cancer 48 : 2296-2309, 1981
PubMed
25. Krapf H, Buhring U, Friese S, Kuker W : Medulloblastom des Kleinhirnwurms mit Liquorraumaussaat Ungewohnliche klinische und MRT-Prasentation. Klin Neuroradiol 10 (2) : 85-90, 2000
PubMed
26. Cushing H : Experiences with cerebellar medulloblastomas : critical review. Acta Path et Microbiol Scandinav 1 : 1-86, 1930
 
27. Bailey P : Further Notes on the Cerebellar Medulloblastomas : The Effect of Roentgen Radiation. Am J Pathol. 6 : 125-136, 1930
PubMed
28. Ingraham FD, Bailey OT, Barker WF : Medulloblastoma cerebelli ; diagnosis, treatment and survivals, with a report of 56 cases. N Engl J Med. 238 : 171-174, 1948
 
29. Matson DD. Neurosurgery of Infancy and Childhood, 2nd Ed. Charles C Thomas Pub., Springfield, Illinois, USA., 1969
 
30. McIntosh N : Medulloblastoma-a changing prognosis?. Arch Dis Child 54 (3) : 200-203, 1979
PubMed
31. Patterson R, Farr RF : Cerebellar medulloblastomas : Treatmentby irradiation of the whole central nervous system. Acta Radiol 39 : 323-336, 1953
 
32. Landberg TG, Lindgren ML, Cavallin-Stahl EK, et al. : Improvements in the radiotherapy of medulloblastoma, 1946-1975. Cancer 45 (4) : 670-678, 1980
PubMed
33. Hughes EN, Shillito J, Sallan SE, et al. : Medulloblastoma at the Joint Center for Radiation Therapy between 1986 and 1984. The influence of radiation dose on the pattern of failure and survival. Cancer 61 : 1992-1998, 1988
 
34. Harisiadis L, Chang CH : Medulloblastoma in children : a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 2 : 833-841, 1977
PubMed
35. Berry MP, Jenkin DT, Keen CW, Nair CW, Simpson WJ : Radiation therapy for medulloblastoma. A 21-year review. J Neurosurg 55 : 43-51, 1981
 
36. Silverman CL, Simpson JR : Cerebellar medulloblastoma : the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8 : 1869-1876, 1982
PubMed
37. Jereb B, Reid A, Ahuja RK : Patterns of failure in patients with medulloblastoma. Cancer 50 : 2941-2947, 1982
PubMed
38. Jereb B, Krishnaswami S, Reid A, Allen JC : Radiation for medulloblastoma adjusted to prevent recurrence to the cribriform plate region. Cancer 54 : 602-604, 1984
 
39. Crafts DC, Levin VA, Edwards MS, et al. : Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU and vincristine. J Neurosurg 49 : 589-592, 1978
PubMed
40. Thomas PR, Duffner PK, Cohen ME, et al. : Multimodality therapy for medulloblastoma. Cancer 45 : 666-669, 1980
PubMed
41. Allen JC, Helson L : High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55 : 749-756, 1981
 
42. Levin VA, Vestnys PS, Edwards MS, et al. : Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51 : 1364-1370, 1983
PubMed
43. Lefkowitz IB, Packer RJ, Siegel KR, et al. : Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Cancer 65 : 412-417, 1990
PubMed
44. Sexauer CL, Khan A, Burger PC, et al. : Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study. Cancer. Oct 1 ; 56 (7) : 1497-501, 1985
 
45. Pendergrass TW, Milstein JM, Geyer JR, et al. : Eight drugs in one day chemotherapy for brain tumors : experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5 : 1221-1231, 1987
PubMed
46. Garton GR, Schomberg PJ, Scheithauer BW, et al. : Medulloblastoma - prognostic factors and outcome of treatment : review of the Mayo Clinic experience. Mayo Clin Proc 65 : 1077-1086, 1990
 
47. Evans AE, Jenkin RDT, Sposto, R, et al. : The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednizolone. J Neurosurg 72 : 572-582, 1990
 
48. Tait DM, Thornton-Jones H, Bloom HJ, et al. : Adjuvant chemotherapy for medulloblastoma : the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26 (4) : 464-469, 1990
PubMed
49. Krischer JP, Ragab AH, Kun L, et al. : Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group Study. J Neurosurg 74 : 905-909, 1991
 
50. Chang CH, Housepian EM, Herbert C : An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastoma. Radiology 93 : 1351-1359, 1969
 
51. Padovani L, Sunyach MP, Perol D, et al. : Common strategy for adult and pediatric medulloblastoma : a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68 (2) : 433-440, 2007
PubMed
52. Kombogiorgas D, Puget S, Boddaert N, Peet A, et al. : Appraisal of the current staging system for residual medulloblastoma by volumetric analysis. Childs Nerv Syst 27 (12) : 1201-1206, 2011
 
53. Thomas PR, Deutsch M, Kepner JL, et al. : Low-stage medulloblastoma : final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18 : 3004-3011, 2000
PubMed
54. Packer RJ, Sutton LN, Goldwein JW, et al. : Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblatoma. J Neurosurg 74 : 433-440, 1991
 
55. Packer RJ, Sutton LN, Elterman R, et al. : Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81 : 690-698, 1994
PubMed
56. Packer RJ, Goldwein J, Nicholson HS, et al. : Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy : a children's cancer group study. J Clin Oncol 17 : 2127-2136, 1999
 
57. Packer RJ, Gajjar A, Vezina G, et al. : Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24 : 4204-4208, 2006
 
58. Packer RJ, Zhou T, Holmes E, V et al. : Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy : results of Children's Oncology Group trial A9961. Neuro Oncol 15 (1) : 97-103, 2013
 
59. Gajjar A, Chintagumpala M, Ashley D, et al. : Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96) : long-term results from a prospective, multicentre trial. Lancet Oncol 7 : 813-820, 2006
PubMed
60. Bailey CC, Gnekow A, Wellek S, et al. : Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO) : SIOP II. Med Pediatr Oncol 25 : 166-178, 1995
PubMed
61. von Hoff K, Hinkes B, Gerber NU, D et al. : Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomized multicentre trial HIT '91. Eur J Cancer 45 : 1209-1217, 2009
 
62. Gentet JC, Bouffet E, Doz F, et al. : Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma : results of the M7 French Cooperative Study. J Neurosurg 82 (4) : 608-614, 1995
PubMed
63. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. : Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy : a French Society of Pediatric Oncology Study. Clin Oncol 23 : 4726-4734, 2005
PubMed
64. Taylor RE, Bailey CC, Robinson KJ, et al. : Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 58 : 1184-1193, 2004
 
65. Lannering B, Rutkowski S, Doz F, et al. : Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma : results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 30 (26) : 3187-3193, 2012
 
66. Carrie C, Grill J, Figarella-Branger D, et al. : Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma : long-term results of MSFOP 98. J Clin Oncol 27 (11) : 1879-1883, 2009
PubMed
67. Kopelson G, Linggood RM, Kleinman GM : Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer 51 : 312-319, 1983
PubMed
68. Zeltzer PM, Boyett JM, Finlay JL, et al. : Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children : conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol.17 : 832-845, 1999
 
69. Allen J, Donahue B, Mehta M, et al. : A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor : a report from the Children's Oncology Group (CCG 9931). Int J Radiat Oncol Biol Phys. 74 : 1006-1011, 2009
 
70. Mosijczuk AD, Nigro NA, Thomas PR, et al. : Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group Study. Cancer 72 : 2755-2762, 1993
 
71. Tarbell NJ, Friedman H, Polkinghorn WR, et al. : High-risk medulloblastoma : a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). J Clin Oncol 31 (23) : 2936-2041, 2013
PubMed
72. Taylor RE, Bailey CC, Robinson KJ, et al. : Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41 : 727-734, 2005
PubMed
73. Kuhl J, Muller HL, Berthold F, et al. : Preradiation chemotherapy of children and young adults with malignant brain tumors : results of the German pilot trial HIT '88/'89. Klin Padiatr 210 : 227-233, 1998
 
74. Verlooy J, Mosseri V, Bracard S, et al. : Treatment of high risk medulloblastomas in children above the age of 3 years : a SFOP study. Eur J Cancer. 42 : 3004-3014, 2006
 
75. Pietsch T, Schmidt R, Remke M, et al. : Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol 128 (1) : 137-149, 2014
PubMed
76. Johnston DL, Keene D, Bartels U, et al : Medulloblastoma in children under the age of three years : a retrospective Canadian review. J Neurooncol 94 : 51-56, 2009
 
77. Park TS, Hoffman HJ, Hendrick EB, et al : Medulloblastoma : clinical presentation and management experience at the Hospital For Sick Children, Toronto, 1950-1980. J Neurosurg 58 : 543-552, 1983
PubMed
78. Rutkowski S, von Hoff K, Emser A, et al : Survival and prognostic factors of early childhood medulloblastoma : an international meta-analysis. J Clin Oncol 28 : 4961-4968, 2010
PubMed
79. Saran FH, Driever PH, Thilmann C, et al : Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 42 : 959-967, 1998
PubMed
80. Jakacki RI, Feldman H, Jamison C, et al : A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. Int J Radiat Oncol Biol Phys 60 (2) : 531-536, 2004
PubMed
81. Duffner PK, Horowitz ME, Krischer JP : Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Eng J Med 328 : 1725-1731, 1993
 
82. Strother DR, Lafay-Cousin L, Boyett JM, et al. : Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma : a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro Oncol 16 (3) : 457-65, 2014
PubMed
83. Geyer JR1, Zeltzer PM, Boyett JM, et al. : Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day : a report from the Childrens Cancer Group. J Clin Oncol 12 (8) : 1607-1615, 1994
 
84. Geyer JR, Sposto R, Jennings M, et al. : Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors : a report from the Children's Cancer Group. J Clin Oncol 23 : 7621-7631, 2005
 
85. Ashley DM, Merchant TE, Strother D, et al. : Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma : Children's Oncology Group study P9934. J Clin Oncol 30 (26) : 3181-3186, 2012
 
86. Mason WP, Grovas A, Halpern S, et al. : Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16 (1) : 210-221, 1998
PubMed
87. Chi SN, Gardner SL, Levy AS, et al. : Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22 (24) : 4881-4887, 2004
PubMed
88. Grundy RG, Wilne SH, Robinson KJ, et al. : Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years : results of the first UKCCSG/SIOP CNS 9204 trial. Eur J Cancer 46 : 120-133, 2010
PubMed
89. Grill J, Sainte-Rose C, Jouvet A, et al. : Treatment of medulloblastoma with postoperative chemotherapy alone : an SFOP prospective trial in young children. Lancet Oncol 6 : 573-580, 2005
PubMed
90. Rutkowski S, Gerber NU, von Hoff K, et al. : Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol 11 : 201-210, 2009
PubMed
91. Rutkowski S, Bode U, Deinlein F, et al. : Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352 : 978-986, 2005
PubMed
92. von Bueren AO, von Hoff K, Pietsch T, et al. : Treatment of young children with localized medulloblastoma by chemotherapy alone : results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 13 : 669-679, 2011
PubMed
93. Curran EK, Le GM, Sainani KL, et al. : Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol 95 (1) : 81-85, 2009
PubMed
94. Carrie C, Lasset C, Alapetite C, et al. : Multivariete analysis of prognostic factors in adult patients with medullobalstoma. Prospective study of 156 patients. Cancer 74 : 2352-2360, 1994
 
95. Sarkar C, Pramanik P, Karak AK, et al. : Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 59 (1) : 49-61, 2002
PubMed
96. Herrlinger U, Steinbrecher A, Rieger J, et al. : Adult medulloblastoma : prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 252 : 291-299, 2005
PubMed
97. Padovani L, Sunyach MP, Perol D, et al. : Common strategy for adult and pediatric medulloblastoma : a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68 (2) : 433-440, 2007
PubMed
98. Korshunov A, Remke M, Werft W, et al. : Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol 28 (18) : 3054-3060, 2010
PubMed
99. Riffaud L, Saikali S, Leray E, et al. : Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111 : 478-487, 2009
 
100. Rodriguez FJ, Eberhart C, O'Neill BP, et al. : Histopathologic grading of adult medulloblastomas. Cancer 109 : 2557-2565, 2007
PubMed
101. Malheiros SM, Carrete H Jr, Stavale JN, et al. : MRI of medulloblastoma in adults. Neuroradiology 45 : 463-467, 2003
PubMed
102. Brandes AA, Ermani M, Amista P, et al. : The treatment of adults with medulloblastoma : a prospective study. Int J Radiat Oncol Biol Phys 57 (3) : 755-761, 2003
PubMed
103. Brandes AA, Franceschi E, Tosoni A, et al. : Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110 : 2035-2041, 2007
PubMed
104. Friedrich C, von Bueren AO, von Hoff K, et al. : Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol : a prospective observational multicentre study. Eur J Cancer 49 (4) : 893-903, 2003
 
105. von Bueren AO, Friedrich C, von Hoff K, et al. : Metastatic medulloblastoma in adults : outcome of patients treated according to the HIT2000 protocol. Eur J Cancer 51 (16) : 2434-2443, 2015
 
106. Lai R : Survival of patients with adult medulloblastoma : a population-based study. Cancer 112 : 1568-1574, 2008
PubMed
107. Kocakaya S, Beier CP, Beier D : Chemotherapy increases long-term survival in patients with adult medulloblastoma-a literature-based meta-analysis. Neuro Oncol 2015 Sep 10, 2015
 
108. Sarkar C, Pramanik P, Karak AK, et al. : Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 59 (1) : 49-61, 2002.
PubMed
109. Remke M, Hielscher T, Northcott PA, et al. : Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 29 (19) : 2717-2723, 2011
 
110. Deutsch M : The impact of myelography on the treatment results for medulloblastoma. Int J Radiat Oncol Biol Phys 10 : 999-1003, 1984
PubMed
111. Levin VA, Rodriguez LA, Edwards MSB, et al. : Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68 : 383-387, 1988
 
112. Gajjar A, Mulhern RK, Heideman RL, et al. : Medulloblastoma in very young children : outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 12 (6) : 1212-1216, 1994
PubMed
113. Cefalo G, Massimino M, Ruggiero A, et al. : Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor : an Italian multi-institutional phase II trial. Neuro Oncol 16 (5) : 748-753, 2014
PubMed
114. Aguilera D, Mazewski C, Fangusaro J, MacDonald TJ, et al. : Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma : a multi-institutional experience. Childs Nerv Syst 29 (4) : 589-596, 2013
PubMed
115. Finlay JL, Goldman S, Wong MC, et al. : Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol 14 (9) : 2495-503, 1996
 
116. Gajjar A, Pizer B : Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors. Pediatr Blood Cancer 54 (4) : 649-651, 2010
PubMed
117. Muller K, Mynarek M, Zwiener I, et al. : Postponed is not canceled : role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HITREZ 1997 & 2005 studies. Int J Radiat Oncol Biol Phys 88 (5) : 1019-1024, 2014
 
118. Massimino M, Gandola L, Spreafico F, et al. : No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Int J Radiat Oncol Biol Phys 73 (5) : 1358-1363, 2009
PubMed
119. Dunkel IJ, Gardner SL, Garvin JH Jr, et al. : High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neuro Oncol 12 (3) : 297-303, 2010
PubMed
120. Kieran MW, Turner CD, Rubin JB, et al. : A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol 27 (11) : 573-581, 2005.
PubMed
121. Sterba J, Pavelka Z, Andre N, et al. : Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy. Pediatr Blood Cancer 54 (4) : 616-617, 2010.
PubMed
122. Ramaswamy V, Remke M, Bouffet E, et al. : Recurrence patterns across medulloblastoma subgroups : an integrated clinical and molecular analysis. Lancet Oncol 14 (12) : 1200-1207, 2013
PubMed
123. Wang X, Dubuc AM, Ramaswamy V, et al. : Medulloblastoma subgroups remain stable across primary and metastatic compartments. Acta Neuropathol 129 (3) : 449-457, 2015
PubMed
124. Morrissy AS, Garzia L, Shih DJ, et al. : Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529 (7586) : 351-357, 2016
PubMed
125. Gurney JG, Krull KR, Kadan-Lottick N, et al. : Social outcomes in the Childhood Cancer Survivor Study cohort. J Clin Oncol 27 (14) : 2390-2395, 2009
PubMed
126. Peylan-Ramu N, Poplack DG, Pizzo PA, et al. : Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298 (15) : 815-818, 1978
PubMed
127. Cumberlin RL, Luk KH, Wara et al. : Medulloblastoma - Treatment results and effect on normal tissues. Cancer 43 : 1014-1020, 1979
PubMed
128. Sheline GE : Irradiation injury of the human brain : a review of clinical experience. Radiation damage to the nervous system. Gilbert HA, Kagan AR (eds),, Raven Press, New York, 39-58, 1980
 
129. Gudrunardottir T, Lannering B, Remke M, et al. : Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma : a review. Childs Nerv Syst. 2014 Feb 26., 2014
 
130. Nishiyama K, Funakoshi S, Izumoto S, et al. : Long-term effects of radiation for medulloblastoma on intellectual and physical development. A case report of monozygotic twins. Cancer 73 : 2450-2455, 1994
PubMed
131. Edelstein K, Spiegler BJ, Fung S, et al. : Early aging in adult survivors of childhood medulloblastoma : long-term neurocognitive, functional, and physical outcomes. Neuro Oncol 13 (5) : 536-45, 2011
PubMed
132. Mulhern RK, Palmer SL, Merchant TE, et al. : Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23 : 5511-5519, 2005
PubMed
133. Moxon-Emre I, Bouffet E, Taylor MD, et al. : Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 32 (17) : 1760-1768, 2014
PubMed
134. Fukunaga-Johnson N, Lee JH, Sandler HM, et al. : Patterns of failure following treatment for medulloblastoma : is it necessary to treat the entire posterior fossa?. Int J Radiat Oncol Biol Phys 42 : 143-146, 1998
PubMed
135. Ris MD, Walsh K, Wallace D, et al. : Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma : COG A9961. Pediatr Blood Cancer 60 (8) : 1350-1357, 2013
PubMed
136. Saha A, Salley CG, Saigal P, et al. : Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols. Pediatr Blood Cancer 61 (9) : 1644-1652, 2014
 
137. Riva D, Giorgi C, Nichelli F, et al. : Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology 59 : 48-53, 2002
PubMed
138. Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hyder D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T : Growth hormone replacement therapy in children with medulloblastoma : use and effect on tumor control. J Clin Oncol 19 : 480-487, 2001
 
139. Raman S, Grimberg A, Waguespack SG, et al. : Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee. J Clin Endocrinol Metab 100 (6) : 2192-2203, 2015
PubMed
140. Tsui K, Gajjar A, Li C, et al. : Subsequent neoplasms in survivors of childhood central nervous system tumors : risk after modern multimodal therapy. Neuro Oncol 17 (3) : 448-456, 2015
PubMed
141. Tabori U, Sung L, Canadian Pediatric Brain Tumor Consortium : Medulloblastoma in the second decade of life : a specific group with respect to toxicity and management : a Canadian Pediatric Brain Tumor Consortium Study. Cancer 103 : 1874-1880, 2005
PubMed
142. Northcott PA, Shih DJ, Peacock J, et al. : Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488 (7409) : 49-56, 2012
PubMed
143. Shih DJ, Northcott PA, Remke M, et al. : Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol 32 (9) : 886-896, 2014
PubMed
144. Kool M, Korshunov A, Remke M, et al. : Molecular subgroups of medulloblastoma : an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123 : 473-484, 2012
PubMed
145. Gajjar A, Bowers DC, Karajannis MA, et al. : Pediatric brain tumors : innovative genomic information is transforming the diagnostic and clinical landscape.. J Clin Oncol 33 (27) : 2986-2998, 2015
PubMed
146. Ramaswamy V, Remke M, Adamski J, et al. : Medulloblastoma subgroup-specific outcomes in irradiated children : who are the true high-risk patients? Neuro Oncol 18 (2) : 291-297, 2016
PubMed
147. Hamilton SR, Liu B, Parsons RE, P et al. : The molecular basis of Turcot's syndrome. N Engl J Med 332 (13) : 839-847, 1995
PubMed
148. Zurawel RH, Chiappa SA, Allen C, Raffel C : Sporadic medulloblastomas contain oncogenic betacatenin mutations. Cancer Res 58 (5) : 896-899, 1998
PubMed
149. Clifford SC, Lusher ME, Lindsey JC, et al. : Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5 (22) : 2666-2670, 2006
PubMed
150. Hahn H, Wicking C, Zaphiropoulous PG, et al. : Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85 (6) : 841-851, 1996
PubMed
151. Wolter M, Reifenberger J, Sommer C, et al. : Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57 (13) : 2581-2585, 1997
PubMed
152. Zurawel RH, Allen C, Chiappa S, et al. : Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 27 (1) : 44-51, 2000
PubMed
153. Taylor MD, Liu L, Raffel C, et al. : Mutations in SUFU predispose to medulloblastoma. Nat Genet 31 (3) : 306-310, 2002
PubMed
154. Thompson MC, Fuller C, Hogg TL, et al. : Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24 (12) : 1924-1931, 2006
PubMed
155. Taylor MD, Northcott PA, Korshunov A, et al. : Molecular subgroups of medulloblastoma : the current consensus. Acta Neuropathol 123 : 465-472, 2012
PubMed
156. Schwalbe EC, Williamson D, Lindsey JC, et al. : DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125 (3) : 359-371, 2013
PubMed
157. Hovestadt V, Remke M, Kool M, et al. : Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125 (6) : 913-916, 2013
PubMed
158. Ellison DW, Onilude OE, United Kingdom Children's Cancer Study Group Brain Tumour Committee : β-Catenin status predicts a favorable outcome in childhood medulloblastoma : the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23 (31) : 7951-7957, 2005
 
159. Gottardo NG, Hansford JR, McGlade JP, et al. : Medulloblastoma Down Under 2013 : a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol 127 (2) : 189-201, 2014
 
160. Roussel MF, Robinson GW : Role of MYC in Medulloblastoma. Cold Spring Harb Perspect Med Nov 1 ; 3 (11), 2013
 
161. Gibson P, Tong Y, Robinson G, et al. : Subtypes of medulloblastoma have distinct developmental origins. Nature 468 (7327) : 1095-1099, 2010
PubMed
162. Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ : Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 20 (22) : 5630-5640, 2014
PubMed
163. Zhukova N, Ramaswamy V, Remke M, et al. : Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 31 (23) : 2927-2935, 2013
PubMed
164. Kool M, Jones DT, Jager N, et al. : Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25 (3) : 393-405, 2014
PubMed
165. Gessi M, von Bueren AO, Rutkowski S, Pietsch T : p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. J Neurooncol 106 (1) : 135-141, 2012
PubMed
166. Wu X, Northcott PA, Croul S, Taylor MD : Mouse models of medulloblastoma. Chin J Cancer 30 (7) : 442-449, 2011
PubMed
167. Yang ZJ, Ellis T, Markant SL, et al. : Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell 14 (2) : 135-145, 2008
 
168. Grammel D, Warmuth-Metz M, von Bueren AO, et al. : Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol 123 (4) : 601-614, 2012
PubMed
169. Robinson GW, Orr BA, Wu G, et al. : Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma : Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.. J Clin Oncol 33 (24) : 2646-2654, 2015
PubMed
170. Pei Y, Moore CE, Wang J, T et al. : An animal model of MYC-driven medulloblastoma. Cancer Cell 21 (2) : 155-167, 2012
 
171. Kawauchi D, Robinson G, Uziel T, et al. : A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21 (2) : 168-180, 2012
PubMed
172. Northcott PA, Lee C, Zichner T, et al. : Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511 (7510) : 428-434, 2014
PubMed
173. Lin CY, Erkek S, Tong Y, et al. : Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530 (7588) : 57-62, 2016 References
 
174. Ramaswamy V, Remke M, Bouffet E, et al. : Risk stratification of childhood medulloblastoma in the molecular era : the current consensus. Acta Neuropathol 131 (6) : 821-831, 2016
PubMed
175. 金村米博, 市村幸一, 正札智子, 他 : 髄芽腫の分子遺伝学的診断とその標準化. 脳外誌 24 (7) : 436-444, 2015
 
P.379 掲載の参考文献
1. Wippold FJ II, Perry A : Neuropathology for the neuroradiologist : rosettes and pseudorosettes. AJNR Am J Neuroradiol 27 (3) : 488-492,2006
 
2. 竹内浩明 : 脳腫瘍病理診断 第11回 髄芽腫 : ロゼット構造の鑑別. 脳神経外科速報 23 (8) : 872-878,2013
 
P.394 掲載の参考文献
1. Hart MN, Earle KM : Primitive neuroectodermal tumors of the brain in children. Cancer 32 : 890-897, 1973
PubMed
2. Kosnic EJ, Boesel CP, Bay J, Sayers MP : Primitive neuroectodermal tumors of the central nervous system in children. J Neurosurg 48 : 741-746, 1978
 
3. Markesbery WR, Challa VR : Electron microscopic findings in primitive neuroectodermal tumors of the cerebrum. Cancer 44 (1) : 141-147, 1979
PubMed
4. Rorke LB : The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42 : 1-15, 1983
PubMed
5. Tomita S, McLone DG, Yasue M : Cerebral primitive neuroectodermal tumors in childhood. J Neurooncol 6 : 233-243, 1988
 
6. Pfister S, Remke M, Toedt G, et al. : Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosomes Cancer 46 (9) : 839-851, 2007
PubMed
7. Eberhart CG, Brat DJ, Cohen KJ, Burger PC : Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3 (4) : 346-352, 2000
PubMed
8. Gessi M, Giangaspero F, Lauriola L, et al. : Embryonal tumors with abundant neuropil and true rosettes : a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 33 (2) : 211-217, 2009
PubMed
9. Pfister S, Remke M, Castoldi M, et al. : Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. Acta Neuropathol 117 (4) : 457-464, 2009
 
10. Korshunov A, Remke M, Gessi M, R et al. : Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 120 (2) : 253-260, 2010
 
11. Paulus W, Kleihues P : Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol 120:269-270, 2010
PubMed
12. Nobusawa S, Yokoo H, Hirato J, et al. : Analysis of chromosome 19q13.42 amplification in embryonal brain tumors with ependymoblastic multilayered rosettes. Brain Pathol 22 (5) : 689-697, 2012
PubMed
13. Korshunov A, Sturm D, Ryzhova M, et al. : Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128 (2) : 279-289, 2014
PubMed
14. Picard D, Miller S, Hawkins CE, et al. : Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours : an integrative genomic analysis. Lancet Oncol 13 (8) : 838-848, 2012
PubMed
15. Sturm D, Orr BA, Toprak UH, et al. : New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164 (5) : 1060-1072, 2016
PubMed
16. Gajjar A, Bowers DC, Karajannis MA, et al. : Pediatric Brain Tumors : Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. J Clin Oncol 33 (27) : 2986-2998, 2015
PubMed
17. Paulino AC, Cha DT, Barker JL Jr, et al. : Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys 58 (4) : 1171-1176, 2004
PubMed
18. Reddy AT, Janss AJ, Phillips PC, et al. : Outcome for children with supratentorial primitive neu roectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88 (9) : 2189-2193, 2000
 
19. Timmermann B, Kortmann RD, Kuhl J, et al. : Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children : results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24 (10) : 1554-1560, 2006
PubMed
20. Timmermann B, Kortmann RD, Kuhl J, et al. : Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood : results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20 (3) : 842-849, 2002
PubMed
21. Fangusaro J, Finlay J, Sposto R, J et al.: Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs) : report of the Head Start I and II experience. Pediatr Blood Cancer 50(2) : 312-318, 2008
 
22. Pizer BL, Weston CL, Robinson KJ, et al. : Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 42 (8) : 1120-1128, 2006
PubMed
23. Chintagumpala M, Hassall T, Palmer S, et al. : A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol 11 (1) : 33-40, 2009
 
24. Gerber NU, von Hoff K, Resch A, et al. : Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. Int J Radiat Oncol Biol Phys 89 (4) : 863-871, 2014
PubMed
25. Friedrich C, von Bueren AO, von Hoff K, et al. : Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 15 (2) : 224-234, 2013
PubMed
26. Massimino M, Gandola L, Biassoni V, et al. : Evolving of therapeutic strategies for CNS-PNET. Pediatr Blood Cancer 60 (12) : 2031-2035, 2013
PubMed
27. Duffner PK, Cohen ME, Heffner RR, Freeman AI : Primitive neuroectodermal tumors of childhood. An approach to therapy. J Neurosurg 55 : 376-381, 1981
PubMed
28. 山本良裕，国塩勝三，須賀正和，他: V-Pシャントによる腹膜転移をきたしたPrimitive Neuroectodermal Tumorの1剖検例. Neurol Med Chir (Tokyo) 29 (12) : 1137-1143, 1989
 
29. Dai AI, Backstrom JW, Burger PC, Duffner PK : Supratentorial primitive neuroectodermal tumors of infancy : clinical and radiologic findings. Pediatr Neurol 430-434, 2003
PubMed
30. Nowak J, Seidel C, Pietsch T, et al. : Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro Oncol 17 (8) : 1157-1165, 2015
 
31. Robles HA, Smirniotopoulos JG, Figueroa RE : Understanding the radiology of intracranial primitive neuroectodermal tumors from a pathological perspective : a review. Semin Ultrasound CT MR 13 (3) : 170-181, 1992
PubMed
32. Erdem E, Zimmerman RA, Haselgrove JC, et al. : Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology 43 (11) : 927-933, 2001
PubMed
33. Chawla A, Emmanuel JV, Seow WT, et al. : Paediatric PNET : pre-surgical MRI features. Clin Radiol 62 (1) : 43-52, 2007
PubMed
34. 村田純一, 阿部弘, 田代邦雄, 他 : Primitive neuroectodermal tumorの2例. 小児脳神経 12 : 101-106, 1987
 
35. Zagzag D, Miller DC, Knopp E, et al. : Primitive neuroectodermal tumors of the brainstem: investigation of seven cases. Pediatrics 106 : 1045-1053, 2000
PubMed
36. Friedrich C, Warmuth-Metz M, von Bueren AO, et al. : Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials : clinical findings of a rare disease. J Neurosurg Pediatr 15 (3) : 227-235, 2015
 
37. Benesch M, Sperl D, von Bueren AO, et al. : Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children : four cases from the German HIT database with a critical review of the literature. J Neurooncol 104 (1) : 279-286, 2011
PubMed
38. Ellis JA, Rothrock RJ, Moise G, et al. : Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases. Neurosurg Focus 30 (1) : E1, 2011
PubMed
39. Kim DG, Lee DY, Paek SH, et al. : Supratentorial primitive neuroectodermal tumors in adults. J Neurooncol 60 (1) : 43-52, 2002
PubMed
40. Papadopoulos EK, Fountas KN, Brotis AG, Paterakis KN : A supratentorial primitive neuroectodermal tumor presenting with intracranial hemorrhage in a 42-year-old man : a case report and review of the literature. J Med Case Rep 7 :86, 2013
 
41. Friedrich C, Muller K, von Hoff K, et al. : Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol. J Neurooncol 116 (3) : 567-575, 2014
 
42. Chan M, Herrera SR, Neckrysh S, et al. : Primitive neuroectodermal tumor after radiation therapy for craniopharyngioma. Neurosurg Focus 30 (1) : E3, 2011
PubMed
43. 佐藤裕之, 澁谷航兵, 小泉孝幸, 他 : 小脳虫部髄芽腫に対する放射線療法25年後に発生した前頭葉CNS primitive neuroectodermal tumorの1例. 脳神経外科 42 (7) : 641-650, 2014
 
44. Gerber NU, von Hoff K, von Bueren AO, et al. : Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. J Neurooncol 102 (3) : 459-469, 2011
PubMed
45. Nowak J, Seidel C, Berg F, et al. : MRI characteristics of ependymoblastoma : results from 22 centrally reviewed cases. AJNR Am J Neuroradiol 35 (10) : 1996-2001, 2014
PubMed
46. Nowak J, Seidel C, Pietsch T, et al. : Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro Oncol 17 (8) : 1157-1165, 2015
 
47. Nowak J, Seidel C, Pietsch T, et al. : Ependymoblastoma of the brainstem : MRI findings and differential diagnosis. Pediatr Blood Cancer 61 (6) : 1132-1134, 2014
PubMed
48. Adamek D, Sofowora KD, Cwiklinska M, et al. : Embryonal tumor with abundant neuropil and true rosettes : an autopsy case-based update and review of the literature. Childs Nerv Syst 29 (5) : 849-854, 2013
PubMed
P.409 掲載の参考文献
1. Beckwith JB, Palmer NF : Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 41 (5) : 1937-1948, 1978
PubMed
2. Haas JE, Palmer NF, Weinberg AG, Beckwith JB : Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 12 (7) : 646-657, 1981
PubMed
3. Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB : The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases. Cancer 54 (10) : 2137-2146, 1984.
 
4. Rorke LB, Packer R, Biegel J : Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol. 1995 ; 24 (1) : 21-28, 1995
PubMed
5. Russell DS: The Pinealoma : its relationship to teratoma. J Path Bact 56 : 145-150, 1944, 1944
 
6. Rorke LB, Packer RJ, Biegel JA : Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood : definition of an entity. J Neurosurg 85 (1) : 56-65, 1996
PubMed
7. Douglass EC, Valentine M, Rowe ST, et al. : Malignant rhabdoid tumor : a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosomes Cancer 2 (3) : 210-216, 1990
PubMed
8. Versteege I, Sevenet N, Lange J, et al. : Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 (6689) : 203-206, 1998
PubMed
9. Biegel JA, Tan L, Zhang F, et al. : Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8 (11) : 3461-3467, 2002
PubMed
10. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA : Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28 (5) : 644-650, 2004
PubMed
11. Kraus JA1, Oster C, Sorensen N, et al. : Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene. Neuropathol Appl Neurobiol 28 (2) : 136-141, 2002
 
12. Judkins AR, Burger PC, Hamilton RL, et al. : INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 64 (5) : 391-397, 2005
PubMed
13. Haberler C, Laggner U, Slavc I, et al. : Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors : Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 30 (11) : 1462-1468, 2006
 
14. Hasselblatt M, Gesk S, Oyen F, et al. : Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35 (6) : 933-935, 2011
 
15. Proust F, Laquerriere A, Constantin B, et al. : Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neurooncol 43 (1) : 63-70, 1999
PubMed
16. Biegel JA, Zhou JY, Rorke LB, et al. : Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59 (1) : 74-79, 1999
PubMed
17. Sevenet N, Sheridan E, Amram D, et al. : Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65 (5) : 1342-1348, 1999
PubMed
18. Janson K, Nedzi LA, David O, et al. : Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 47 (3) : 279-284, 2006.
 
19. Bruggers CS, Bleyl SB, Pysher T, et al. : Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 56 (7) : 1026-1031, 2011
PubMed
20. Bourdeaut F, Lequin D, Brugieres L, et al. : Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 17 (1) : 31-38, 2011
PubMed
21. Dufour C, Beaugrand A, Le Deley MC, et al. : Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 118 (15) : 3812-3821, 2012
PubMed
22. Meyers SP1, Khademian ZP, Biegel JA, et al. : Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood : MRI features and patient outcomes. AJNR Am J Neuroradiol 27 (5) : 962-971, 2006
 
23. Jin B, Feng XY: MRI features of atypical teratoid/rhabdoid tumors in children. Pediatr Radiol 43 (8) : 1001-1008, 2013
PubMed
24. Arslanoglu A, Aygun N, Tekhtani D, et al. : Imaging findings of CNS atypical teratoid/rhabdoid tumors. AJNR Am J Neuroradiol 25 (3) : 476-480, 2004
PubMed
25. Bruggers CS, Moore K : Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain. J Pediatr Hematol Oncol 36 (6) : e341-345, 2014
 
26. Hilden JM, Meerbaum S, Burger P, et al. : Central nervous system atypical teratoid/rhabdoid tumor : results of therapy in children enrolled in a registry. J Clin Oncol 22 (14) : 2877-2884, 2004
 
27. Tekautz TM, Fuller CE, Blaney S, et al. : Atypical teratoid/rhabdoid tumors (ATRT) : improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23 (7) : 1491-1499, 2005
PubMed
28. von Hoff K, Hinkes B, Dannenmann-Stern E, et al. : Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57 (6) : 978-985, 2011
 
29. Athale UH, Duckworth J, Odame I, Barr R : Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. J Pediatr Hematol Oncol 31 (9) : 651-663, 2009
PubMed
30. Gardner SL, Asgharzadeh S, Green A, et al. : Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 51 (2) : 235-240, 20086.
 
31. Chi SN, Zimmerman MA, Yao X, et al. : Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27 (3) : 385-389, 2009
PubMed
32. Slavc I, Chocholous M, Leiss U, et al. : Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Med 3 (1) : 91-100, 2014
PubMed
33. Zaky W, Dhall G, Ji L, et al. : Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors : the Head Start III experience. Pediatr Blood Cancer 61 (1) : 95-101, 2014
PubMed
34. Benesch M, Bartelheim K, Fleischhack G, et al. : High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT) : a report from the European Rhab doid Registry (EU-RHAB). Bone Marrow Transplant 49 (3) : 370-375, 2014
 
35. Park ES, Sung KW, Baek HJ, et al. : Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 27 (2) : 135-140, 2012
PubMed
36. Schrey D, Carceller Lechon F, Malietzis G, et al. : Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor : individual pooled data analysis and review of the literature. J Neurooncol 126 (1) : 81-90, 2016
PubMed
37. Olson TA, Bayar E, Kosnik E, et al. : Successful treatment of disseminated central nervous system malignant rhabdoid tumor. J Pediatr Hematol Oncol 17 (1) : 71-75, 1995
PubMed
38. Zimmerman MA, Goumnerova LC, Proctor M, S et al. : Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol 72 (1) : 77-84, 2005
 
39. Sredni ST, Huang CC, Pundy T, Patel K, et al. : A gene signature for a long-term survivor of an atypical teratoid/rhabdoid tumor. Cancer Genet 207 (9) : 420-424, 2014
 
40. Torchia J, Picard D, Lafay-Cousin L, et al. : Molecular subgroups of atypical teratoid rhabdoid tumours in children : an integrated genomic and clinicopathological analysis. Lancet Oncol 16 (5) : 569-582, 2015
PubMed
41. Johann PD, Erkek S, Zapatka M, et al. : Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29 (3) : 379-93, 2016
PubMed
42. Lafay-Cousin L, Fay-McClymont T, Johnston D, F et al. : Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience. Pediatr Blood Cancer 62 (7) : 1265-1269, 2015
 
43. Shonka NA, Armstrong TS, Prabhu SS, et al. : Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. J Clin Med Res 3 (2) : 85-92, 2011
PubMed
44. Park HG, Yoon JH, Kim SH, et al. : Adult-onset sellar and suprasellar atypical teratoid rhabdoid tumor treated with a multimodal approach : a case report. Brain Tumor Res Treat 2 (2) : 108-113, 2014
PubMed
45. Kanoto M, Toyoguchi Y, Hosoya T, et al. : Radiological image features of the atypical teratoid/rhabdoid tumor in adults: a systematic review. Clin Neuroradiol 25 (1) : 55-60, 2015
PubMed
46. Kuge A, Sato S, Sakurada K, et al. : Atypical teratoid rhabdoid tumor located in the pineal region following prophylactic irradiation for acute lymphoblastic leukemia. Brain Tumor Pathol 29 (3) : 177-181, 2012
PubMed
47. Gorayski P, Boros S, Ong B, et al. : Radiation-induced primary cerebral atypical teratoid/rhabdoid tumour in an adult. J Clin Neurosci 20 (10) : 1466-1468, 2013
 
P.413 掲載の参考文献
1. Molloy PT, Yachnis AT, Rorke LB, et al. : Central nervous system medulloepithelioma : a series of eight cases including two arising in the pons. J Neurosurg 84 (3) : 430-436, 1996
 
2. Davies RP, Lee CS : Medulloepithelioma : MRI appearances. Australas Radiol 32 (4) : 503-505, 1988
PubMed
3. Pang LM, Roebuck DJ, Ng HK, Chan YL : Sellar and suprasellar medulloepithelioma. Pediatr Radiol 31 (8) : 594-596, 2001
PubMed
4. Korshunov A, Sturm D, Ryzhova M, et al. : Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128 (2) : 279-289, 2014
PubMed
5. Horten BC, Rubinstein LJ : Primary cerebral neuroblastoma. A clinicopathological study of 35 cases. Brain 99 (4) : 735-756, 1976
PubMed
6. Berger MS, Edwards MS, Wara WM, Levin VA, Wilson CB : Primary cerebral neuroblastoma. Long-term follow-up review and therapeutic guidelines. J Neurosurg 59 (3) : 418-423, 1983
PubMed
7. Dastur DK : Cerebral ganglioglio-neuroblastoma : an unusual brain tumour of the neuron series. J Neurol Neurosurg Psychiatry 45 (2) : 139-142, 1982
 
8. 中島麓, 桑原武夫, 柳下三郎 : 原発性cerebral ganglioneuroblastomaの1例. Neurol Med Chir (Tiokyo) 23 : 301-304, 1983
 
9. Gasparetto EL1, Rosemberg S, Matushita H, Leite Cda C : Ganglioneuroblastoma of the cerebellum : neuroimaging and pathological features of a case. Arq Neuropsiquiatr 65 (2A) : 338-340, 2007
 

第10章 Cancer predisposition syndrome

P.442 掲載の参考文献
1. 国立研究開発法人国立がん研究センターがん対策情報センター刊行「がんの統計'14」2015 (http://ganjoho.jp/reg_stat/statistics/brochure/backnumber/2014_jp.html)
 
2. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP : A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323 (6089) : 643-646, 1986
PubMed
3. Knudson AG Jr : Mutation and cancer : statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (4) : 820-823, 1971
PubMed
4. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A : Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (6366) : 215-221, 1992
PubMed
5. Ko LJ, Prives C : p53 : puzzle and paradigm. Genes Dev 10 (9) : 1054-1072, 1996
PubMed
6. International Agency for Research on Cancer, WHO. IARC TP53 Database. http://p53.iarc.fr
 
7. Kleihues P, Ohgaki H : Genetics of glioma progression and the definition of primary and secouncary glioblastoma. Brain Pathol 7 : 1131-1136, 1997
 
8. http://www.cancer.net/cancer-types/li-fraumeni-syndrome
 
9. Tinat J, Bougeard G, Baert-Desurmont A, et al. : 2009 Version of the Chompret criteria for Li Fraumeni Syndrome. J Clin Oncol 27 (26) : e108-e109, 2009
PubMed
10. Varley JM, McGown G, Thorncroft M, et al. : Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. Am J Hum Genet 65 (4) : 995-1006, 1999
PubMed
11. Gonzalez KD, Noltner KA, Buzin CH, et l. : Beyond Li Fraumeni Syndrome : clinical characteristics of families with p53 germline mutations. J Clin Oncol 27 (8) : 1250-1256, 2009
 
12. Li FP, Fraumeni JF Jr : Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Ann Intern Med 71 (4) : 747-752, 1969
PubMed
13. Bougeard G, Renaux-Petel M, Flaman JM, et al. : Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33 (21) : 2345-2352, 2015
PubMed
14. Robertson LB, Armstrong GN, Olver BD, et al. : Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Fam Cancer 9 (3) : 413-421, 2010
PubMed
15. Enciso-Mora V, Hosking FJ, Di Stefano AL, et al. : Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer 108 (10) : 2178-2185, 2013
PubMed
16. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. : A cancer family syndrome in twenty-four kindreds. Cancer Res 48 (18) : 5358-5362, 1988
PubMed
17. Tabori U, Shlien A, Baskin B, et al. : TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28 (12) : 1995-2001, 2013
 
18. Zhukova N, Ramaswamy V, Remke M, et al. : Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 31 (23) : 2927-2935, 2013
PubMed
19. Gorlin RJ, Goltz RW : Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 262 : 908-912, 1960
PubMed
20. Gururangan S, Robinson G, Ellison DW, et al. : Gorlin syndrome and desmoplastic medulloblastoma : Report of 3 cases with unfavorable clinical course and novel mutations. Pediatr Blood Cancer 62 (10) : 1855-1858, 2015
PubMed
21. Gorlin RJ : Nevoid Basal-Cell Carcinoma Syndrome. Medicine 66 (2) : 98-113, 1987
PubMed
22. Herzberg JJ, Wiskemann A : Die funfte Phakomatose, Basalzellnaevus mit familiarer Belastung und Medulloblastom. Dermatologica 126 : 106-123, 1963
 
23. Evans DG, Farndon PA, Burnell LD, et al.M : The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64 (5) : 959-961, 1991
 
24. Cowan R, Hoban P, Kelsey A, et al. : The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 76 (2) : 141-145, 1997
PubMed
25. Amlashi SF, Riffaud L, Brassier G, Morandi X : Nevoid basal cell carcinoma syndrome : relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 98 (3) : 618-624, 2003
PubMed
26. Garre ML, Cama A, Bagnasco F, et al. : Medulloblastoma variants : age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. Clin Cancer Res 15 (7) : 2463-2471, 2009
PubMed
27. Fukushima Y, Oka H, Utsuki S, et al. : Nevoid Basal cell carcinoma syndrome with medulloblastoma and meningioma--case report. Neurol Med Chir (Tokyo) 44 (12) : 665-668, 2004
PubMed
28. Rushing EJ, Olsen C, Mena H, et al. : Central nervous system meningiomas in the first two decades of life : a clinicopathological analysis of 87 patients. J Neurosurg 103 (6 Suppl) : 489-495, 2005
 
29. Tamoney HJ Jr : Basal cell nevoid syndrome. Am Surg 35 (4) : 279-283, 1969
PubMed
30. Therkildsen C, Ladelund S, Rambech E, et al. : Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome. Eur J Neurol 22 (4) : 717-724, 2015
PubMed
31. Attard TM, Giglio P, Koppula S, et al. : Brain tumors in individuals with familial adenomatous polyposis : a cancer registry experience and pooled case report analysis. Cancer 109 (4) : 761-766, 2007
 
32. Ikeda J1, Sawamura Y, van Meir EG : Pineoblastoma presenting in familial adenomatous polyposis (FAP) : random association, FAP variant or Turcot syndrome?. Br J Neurosurg 12 (6) : 576-578, 1988
 
33. Lynch HT, Shaw MW, Magnuson CW, et al. : Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 117 (2) : 206-212, 1966
PubMed
34. Rodriguez-Hernandez I, Garcia JL, Santos-Briz A, Hernandez-Lain A, Gonzalez-Valero JM, Gomez-Moreta JA, Toldos-Gonzalez O, et al. : Integrated analysis of mismatch repair system in malignant astrocytomas. PLoS One 8 (9) : e76401, 2013
 
35. Turcot J, Despres JP, St Pierre F : Malignant tumors of the central nervous system associated with familial polyposis of the colon : report of two cases. Dis Colon Rectum 2 : 465-468, 1959
PubMed
36. Hamilton SR, Liu B, Parsons RE, et al. : The molecular basis of Turcot's syndrome. N Engl J Med. 332 (13) : 839-847, 1995
PubMed
37. Paraf F, Jothy S, Van Meir EG : Brain tumor-polyposis syndrome : two genetic diseases?. J Clin Oncol 15 (7) : 2744-2758, 1997
PubMed
38. South CD, Hampel H, Comeras I, et al. : The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 100 (4) : 277-281, 2008
PubMed
39. Park DM, Yeaney GA, Hamilton RL, et al. : Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme. Neuro Oncol 11 (4) : 452-455, 2009
 
40. Binder ZA, Johnson MW, Joshi A, et al. : Glioblastoma multiforme in the Muir-Torre syndrome. Clin Neurol Neurosurg 113 (5) : 411-415, 2011
PubMed
41. Lehrer MD, Lynch H, Glembocki DJ, Patel NB : Glioblastoma multiforme as initial internal malignancy in Muir-Torre syndrome (MTS). JAAD Case Rep 1 (6) : 381-383, 2015
PubMed
42. Ricciardone MD, Ozcelik T, Cevher B, et al. : Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59 (2) : 290-293, 1999
PubMed
43. Wang Q, Lasset C, Desseigne F, et al. : Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 59 (2) : 294-297, 1999
PubMed
44. Wimmer K, Kratz CP : Constitutional mismatch repair-deficiency syndrome. Haematologica 95 (5) : 699-701, 2010
PubMed
45. Wimmer K, Kratz CP, EU-Consortium Care for CMMRD (C4CMMRD) : Diagnostic criteria for constitutional mismatch repair deficiency syndrome : suggestions of the European consortium 'care for CMMRD' (C4CMMRD). J Med Genet 51 (6) : 355-365, 2014
 
46. Bakry D, Aronson M, Durno C, et al. : Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome : report from the constitutional mismatch repair deficiency consortium. Eur J Cancer 50 (5) : 987-996, 2014
PubMed
47. Shlien A, Campbell BB, Biallelic Mismatch Repair Deficiency Consortium : Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 47 (3) : 257-262, 2015
PubMed
48. Hill DA, Ivanovich J, Priest JR, et al. : DICER1 mutations in familial pleuropulmonary blastoma. Science 325 (5943) : 965, 2009
PubMed
49. Priest JR, Watterson J, Strong L, et al. : Pleuropulmonary blastoma : a marker for familial disease. J Pediatr 128 (2) : 220-224, 1996
 
50. Priest JR, McDermott MB, Bhatia S, et al. : Pleuropulmonary blastoma : a clinicopathologic study of 50 cases. Cancer 80 (1) : 147-161, 1997
PubMed
51. Scheithauer BW, Kovacs K, Horvath E, et al. : Pituitary blastoma. Acta Neuropathol 116 (6) : 657-666, 2008
 
51. Scheithauer BW, Horvath E, Abel TW, et al. : Pituitary blastoma : a unique embryonal tumor. Pituitary 15 (3) : 365-373, 2012
PubMed
52. Sahakitrungruang T, Srichomthong C, Pornkunwilai S, et al. : Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease. J Clin Endocrinol Metab 99 (8) : E1487-1492, 2014
 
53. de Kock L, Sabbaghian N, Plourde F, et al. : Pituitary blastoma : a pathognomonic feature of germline DICER1 mutations. Acta Neuropathol 128 (1) : 111-122, 2014
PubMed
54. Sabbaghian N, Hamel N, Srivastava A, et al. : Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49 (7) : 417-419, 2012
 
55. de Kock L, Sabbaghian N, Druker H, et al. : Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128 (4) : 583-595, 2014
PubMed
56. Sevenet N, Sheridan E, Amram D, et al. : Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65 (5) : 1342-1348, 1999
PubMed
57. Taylor MD, Liu L, Raffel C, et al. : Mutations in SUFU predispose to medulloblastoma. Nat Genet 31 (3) : 306-310, 2002
PubMed
58. Brugieres L, Remenieras A, Pierron G, et al. : High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol 30 (17) : 2087-2093, 2012
 
59. Rubinstein JH, Taybi H : Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105 : 588-608, 1963
PubMed
60. Miller RW, Rubinstein JH : Tumors in Rubinstein-Taybi syndrome. Am J Med Genet 56 (1) : 112-115, 1995
PubMed
61. Bourdeaut F, Miquel C, Richer W, et al. : Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma. Pediatr Blood Cancer 61 (2) : 383-386, 2014
PubMed
62. Swift M, Morrell D, Massey RB, Chase CL : Incidence of cancer in 161 families affected by ataxiatelangiectasia. N Engl J Med 325 (26) : 1831-1836, 1991
PubMed
63. Miyagi K, Mukawa J, Kinjo N, et al. : Astrocytoma linked to familial ataxia-telangiectasia. Acta Neurochir (Wien) 135 (1-2) : 87-92, 1995
 
64. Masri AT, Bakri FG, Al-Hadidy AM, et al. : Ataxia-telangiectasia complicated by craniopharyngioma--a new observation. Pediatr Neurol 35 (4) : 287-288, 2006
PubMed
65. Amariglio N, Hirshberg A, Scheithauer BW, et al. : Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6 (2) : e1000029, 2009
 
66. DeWire MD, Beltran C, Boop FA, et al. : Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia : a case report and review of the literature. J Clin Oncol 31 (1) : e12-14, 2013
 
67. Liberzon E, Avigad S, Cohen IJ, et al. : ATM gene mutations are not involved in medulloblastoma in children. Cancer Genet Cytogenet 146 (2) : 167-169, 2003
PubMed
68. Hart RM, Kimler BF, Evans RG, Park CH : Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys 13 (8) : 1237-1240, 1987
 
69. Ramasubramanian A, Kytasty C, Meadows AT, et al. : Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. Am J Ophthalmol 156 (4) : 825-829, 2013
PubMed
70. Derrey S, Proust F, Debono B, et al. : Association between Cowden syndrome and Lhermitte-Duclos disease : report of two cases and review of the literature. Surg Neurol 61 (5) : 447-454, 2004
PubMed
71. Tan TC, Ho LC. : Lhermitte-Duclos disease associated with Cowden syndrome. J Clin Neurosci 14 (8) : 801-805, 2007
PubMed
72. Lauge A, Lefebvre C, Laurent-Puig P, et al. : No evidence for germline PTEN mutations in families with breast and brain tumours. Int J Cancer. Jun 21 ; 84 (3) : 216-219, 1999
 
73. Shepherd CW, Gomez MR, Lie JT, Crowson CS : Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66 (8) : 792-796, 1991
PubMed
74. 厚生労働省難治性疾患政策研究事業 (http://www.nanbyou.or.jp/entry/3626#01)
 
75. Hipple Ev : Vorstellung eines Patienten mit einer sehr ungewohnlichen Netzhaut. Ber Detsch Ophthal Ges.24 : 269, 1895
 
76. Lindau A : Studien uiber Kleinhirncyten. Bau, Pathogeneseud. Beziehungen fur angiomatosis retinae. Acta Pathol Microbiol Scand.3 (Suppl 1) : 1-128, 1926
 
77. 執印太郎編 : フォン・ヒッペル・リンドウ (VHL) 病 診療ガイドライン, 46頁, 中外医学社, 東京, 2011年
 
78. National Institutes of Health Consensus Development Conference Statement : neurofibromatosis. : National Institutes of Health Consensus Development Conference Statement : neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1 (3) : 172-178, 1988
PubMed
79. Evans DG : Neurofibromatosis 2. In : GeneReviews(R), Pagon RA, Adam MP, Ardinger HH, et al., editors, Seattle (WA), http://www.ncbi.nlm.nih.gov/books/NBK1201/
 
80. Lekanne Deprez RH, Bianchi AB, Groen NA, et al. : Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54 (6) : 1022-1029, 1994
PubMed
81. Goudet P, Dalac A, Le Bras M, et al. : MEN1 disease occurring before 21 years old : a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines. J Clin Endocrinol Metab 100 (4) : 1568-1577, 2015
 
82. de Laat JM, Dekkers OM, Pieterman CR, et al. : Long-term natural course of pituitary tumors in patients with MEN1 : Results from the DutchMEN1 Study Group (DMSG). J Clin Endocrinol Metab 100 (9) : 3288-3296, 2015
 
83. Lee M, Pellegata NS : Multiple endocrine neoplasia type 4. Front Horm Res 41 : 63-78, 2013
PubMed
84. Vierimaa O, Georgitsi M, Lehtonen R, et al. : Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 (5777) : 1228-1230, 2006
PubMed
85. Cazabat L, Bouligand J, Salenave S, et al. : Germline AIP mutations in apparently sporadic pituitary adenomas : prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 97 (4) : E663-670, 2012
 
86. Hasle H, Mellemgaard A, Nielsen J, Hansen J : Cancer incidence in men with Klinefelter syndrome. Br J Cancer 71 (2) : 416-420, 1995
PubMed
87. Nakata Y, Yagishita A, Arai N : Two patients with intraspinal germinoma associated with Klinefelter syndrome : case report ana review of the literature. Am J Neuroradiol 27 : 1204-1210, 2006
 
88. Liang R, Woo E, Ho F, C, et al. : Klinefelter's syndrome and primary central nervous system lymphoma. Med Pediatr Oncol 18 (3) : 236-239, 1990
 
89. Sasayama T, Mizukawa K, Sakagami Y, et al. : Glioblastoma multiforme associated with Klinefelter syndrome. Neurol Med Chir (Tokyo) 49 (11) : 532-535, 2009
PubMed
90. Satge D, Sasco AJ, Lacour B. : Are solid tumours different in children with Down's syndrome?. Int J Cancer 106 (2) : 297-298, 2003
PubMed
91. Satge D, Monteil P, Sasco AJ, et al. : Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma. Cancer 91 (8) : 1458-1466, 2001
PubMed
92. Satge D, Stiller CA, Rutkowski S, et al. : A very rare cancer in Down syndrome : medulloblastoma. Epidemiological data from 13 countries. J Neurooncol 112 (1) : 107-114, 2013
PubMed

第11章 Germ cell tumor

P.481 掲載の参考文献
1. Naganuma H : J Neurosurg 61 (5) : 931, 1984
PubMed
1. Soejima T : Neuroradiology 29 : 366, 1987
PubMed
1. Bjornsson J : Clin Neuropathol 5 (6) : 242, 1986
PubMed
1. Shirato H : Int J Radiat Oncol Biol Phys 37 : 511, 1997
PubMed
1. Arita N : Surg Neurol 9 : 198, 1978
PubMed
1. Logothetis CJ, Samuels ML, Trindade A, Johnson DE : The growing teratoma syndrome. Cancer 50 : 1629-1635, 1982
PubMed
1. The Committee of Brain Tumor Registry of Japan : Report of Brain Tumor Registry of Japan (2001-2004), 13th Edition. Neurol Med Chir (Tokyo). 2014 ; 54 (Suppl.)
 
2. Bestle J : Acta path microbiol scand 74 (2) : 214, 1968
PubMed
2. Jeffery GM, Theaker JM, Lee AH, et al. : The growing teratoma syndrome. Br J Urol 67 : 195-202, 1991
PubMed
2. Cho K-T, Wang K-C, Kim S-K, et al. : Pediatric brain tumors : statistics of SNUH, Korea (1959-2000). Child's Nerv Syst. 2002 ; 18 (1-2) : 30-37
 
2. Aoyama H : Radiother. Oncol. 47 : 201, 1998
PubMed
2. Chan HSL : Neurosurgery 14 : 540, 1984
 
2. Shibamoto Y : Int J Radiat Oncol Biol Phys 37 : 505, 1997
PubMed
2. Jellinger K : Acta Neuropathol 15 : 176, 1970
PubMed
3. Fujii T : J Neurosurg 55 (3) : 484, 1981
PubMed
3. Nakamura H : Acta Oncol 45 (4) : 476, 2006
PubMed
3. Wong T-T, Ho DM, Chang K-P, et al. : Primary pediatric brain tumors. Statistics of Taipei VGH, Taiwan (1975-2004). Cancer. 2005 ; 104 (10) : 2156-2167
 
3. Ho KL : Cancer 44 (3) : 1081, 1979
PubMed
3. Osuka S : J Neurooncol 83 (1) : 71, 2007
PubMed
3. Packer RJ : Cancer 54 : 520, 1984
PubMed
4. Sonoda T : J Neurosurg Pediatrics 2 : 118, 2008
 
4. Ogawa K : Int J Radiat Oncol Biol Phys 72 : 1347, 2008
PubMed
4. 三宅清雄 : 京府医大誌 65 : 1025, 1959
 
4. Sakata K : Surg Neurol 3 : 49, 1975
PubMed
4. Zhu J, Gao Y, Zheng W, Yang J. : Intramedullary spinal cord germinoma : a case report. Chin Med J (Engl). 2002 ; 115 (9) : 1418-1419
 
4. Tavcar D : Cancer 45 (10) : 2646, 1980
PubMed
5. Naganuma H : J Neurosurg 61 (5) : 931, 1984
PubMed
5. Itoyama Y : Neurosurgery 27 (3) : 454, 1990
PubMed
5. Ostrom QT, de Blank PM, Kruchko C, et al. : Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol. 2015 ; 17 (Suppl.1) : x1-x36
 
5. Kawabata Y : J Neurooncol 88 : 161, 2008
PubMed
5. Samii M : Neurosurgery 16 : 696, 1985
PubMed
5. Kawabata Y : J Neurooncol 88 : 161, 2008
PubMed
6. Cuccia V, Alderete D. : Suprasellar/pineal bifocal germ cell tumors. Childs Nerv Syst. 2010 ; 26 (8) : 1043-1049
 
6. Jinguji S : J Neurosurg Pediatr 11 (4) : 454, 2013
PubMed
6. Hirano T : Acta Path Jap 26 : 97, 1976
PubMed
6. Naganuma H : J Neurosurg 61 (5) : 931, 1984
PubMed
6. Tsuchiyama M : Acta Pathol Jpn 31 : 521, 1981
PubMed
6. Jinguji S : J Neurosurg Pediatr 11 (4) : 454, 2013
PubMed
7. Matsutani : 未発表データ
 
7. Ogawa K : Cancer 98 : 369, 2003
PubMed
7. Bruyland M : Eur Neurol 25 (3) : 172, 1986
PubMed
7. Kawakami Y : J Neurosurg 53 : 369, 1980
PubMed
7. Keene D, Johnston D, Strother D, et al. : Epidemiological survey of central nervous system germ cell tumors in Canadian children. J Neuro-Oncol 82 (3) : 289-295, 2007
 
8. Tabuchi K : Acta Med Okayama 27 : 125, 1973
PubMed
8. Fujisawa I, Asato R, Okumura R, et al. : Magnetic resonance imaging of neurohypophyseal germinomas. Cancer. 1991 ; 68 (5) : 1009-1014
 
8. Wong T-T : Childs Nerv Syst 24 : 71, 2008
 
8. Chang CG : Neurosurgery 8 : 656, 1981
PubMed
8. 村田高穂 : 脳外 12 (1) : 83, 1984
 
9. Saitoh M : Child's Nerv Syst 7 : 246, 1991
 
9. 中村信之 : 医学のあゆみ 116 (2) : 161, 1981
 
9. Kageyama N : Ectopic pinealoma in tha region of the optic chiasma. Report of five cases. J Neurosurg. 1971 ; 35 (6) : 755-759
 
9. Tominaga I : No to Shinkei 30 : 165, 1978
PubMed
9. Phi JH : J Neurooncol 99 (2) : 227, 2010
PubMed
10. Wilson ER : Neurosurgery 5 (3) : 356, 1979
PubMed
10. Chen YW : Cancer 118 (10) : 2752, 2010
 
10. Matsutani M : J Neurosurg 86 : 446, 1997
PubMed
10. Fukushima K : Tumors of the diencephalon and precocious puberty. Arch F Jap Chir 27 : 553-578, 1958
 
10. Page R : J Neurol Neurosurg Psychiat 49 : 93, 1986
 
11. Sklar CA, Grumbach MM, Kaplan SL, Conte FA : Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy : report of 10 patients. J Clin Endocrinol Metab. 1981 ; 52 (1) : 9-16
 
11. 阿部弘昌 : 医療 26 (1) : 49, 1972
 
11. Bamberg M : Cancer 54 (5) : 903, 1984
PubMed
11. Sonoda T : J Neurosurg Pediatrics 2 : 118, 2008
 
12. Arita N : J Neurosurg 53 (2) : 244, 1980
PubMed
12. 木村伯子 : 癌の臨床 28 (1) : 34, 1981
 
12. Wong T-T : Cancer 104 : 2156, 2005
PubMed
12. Aida T, Abe H, Fujieda K, Matsuura N : Endocrine functions in children with suprasellar germinoma. Neurol Med Chir (Tokyo). 1993 ; 33 (3) : 152-157
 
13. Asano N : Neurol Med Chir (Tokyo) 30 (7) : 483, 1990
PubMed
13. Tang J : Childs Nerv Syst 24 (3) : 303, 2008
PubMed
13. Shinoda J : J Neuro-Oncol 66 (1-2) : 225, 2004
 
13. Saeki N, Takami K, Murai H, et al. : Long-term outocome of endocrine function in patients with neurohypophyseal germinomas. Endocr. 2000 ; 47 (1) : 83-89
 
14. Yoshiki T : Cancer 37 (5) : 2343, 1978
 
14. Furukawa F : Acta Pathol Jpn 36 : 773, 1986
PubMed
14. Phi JH : J Neurooncol 99 (2) : 227, 2010
PubMed
14. Aizer AA, Sethi RV, Hedley-Whyte ET, et al. : Bifocal intracranial tumors of nongerminomatous germ cell etiology : diagnostic and therapeutic implications. Neuro Oncol. 2013 Jul ; 15 (7) : 955-960, 2013
PubMed
15. Haddock M : Int J Radiat Oncol Biol Phys 38 : 915, 1997
PubMed
15. Jennings MT, Gelman R, Hochberg F : Intracranial germ-cell tumors : natural history and pathogenesis. J Neurosurg 63 : 155-167, 1985
PubMed
15. 木村伯子 : 癌の臨床 28 (1) : 34, 1981
 
15. Giuffre R : J Neurosurg 42 (5) : 602, 1975
PubMed
16. Bjornsson J, Scheithauer BW, Okazaki H, Leech RW : Intracranial germ cell tumors : Pathological and immunohistochemical aspects of 70 cases. J Neuropath Exp Neurol 44 : 32-46, 1985
 
16. Jennings CD : Neurosurgery 16 (1) : 9, 1985
PubMed
16. Sutton LN : Neurosurgery 45 (6) : 1292, 1999
PubMed
17. Hoffman HJ, Otsubo H, Hendrick B, et al. : Intracranial germ cell tumors in children. J Neurosurg 74 : 545-551, 1991
 
17. Nguyen Q-N : Cancer 107 : 2228, 2006
PubMed
17. Yamagami T : Surg Neurol 19 : 469, 1983
 
18. Bruton OC : J Pediat 59 (5) : 719, 1961
 
18. Ho DM, Liu H-C : Primary intracranial germ cell tumor. Pathologic study of 51 patients. Cancer 70 : 1577-1584, 1992
PubMed
18. Kretschmar C : Pediatr Blood Cancer 48 : 285, 2007
PubMed
19. Hasegawa H : Med J Osaka Univ 25 (1-2) : 63, 1974
 
19. Khatua S : Pediatr Blood Cancer 55 : 42, 2010
PubMed
19. Matsutani M, Sano K, Takakura K, et al. : Primary intracranial germ cell tumors : A clinical analysis of 153 histologically verified cases. J Neurosurg 86 : 446-455, 1997
 
20. 岩田金次郎 : 脳神経 14 (9) : 815, 1962
 
20. Hoffman HJ : J Neurosurg 74 : 545, 1991
PubMed
20. Mostofi FK, Price EB : Tumors of the male genital system. AFIP, Washington D.C., 1973
 
21. 増田俊和 : 埼玉医大誌 10 (5) : 293, 1983
 
21. Bamberg M : J Clin Oncol 17 (8) : 2585, 1999
PubMed
21. Rubinstein LJ : Tumors of the central nervous system. AFIP, Washington D.C., 1972
 
22. 新村富士夫 : 癌の臨床 29 (7) : 832, 1983
 
22. Shinoda J, Miwa Y, Sakai N, et al. : Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ cell tumors. J Neurosurg 63 : 733-739, 1985
PubMed
22. Alapetite C : Neuro-Oncology 12 : 1318, 2010
PubMed
23. McKay DG, Hertig AT, Adams EC, et al. : Histochemical observations on the germ cells of human embryos. Anat Rec 117 : 201-219, 1953
PubMed
23. Calaminus G : Klin Padiatr 216 : 141, 2004
PubMed
24. Nakamura H, Takeshima H, Makino K, Kuratsu J : C-kit expression in germinoma : an immunohistochemistry-based study. J Neurooncol 75 : 163-167, 2005
PubMed
25. Jallu A, Rahm B, Kanaan I, Banna M : Pituitary tooth : case report of a suprasellar teratoma. Child's Nerv Syst 6 : 368-369, 1990
 
26. 小林憲夫, 坂本敬三, 伊東宏 : 斜台上方に歯牙と骨片がみられた奇形腫の1例. 小児脳神経 5 : 53-59, 1980
 
27. Drapkin AJ Rose WS, Pellmar MB : Mature teratoma in the fourth ventricle of an adult : case report and review of the literature. Neurosurgery 21 : 404-410, 1987
PubMed
28. Waters DC, Venes JL, Zis K : Case report : childhood cerebellopontine angle teratoma associated with congenital hydrocephalus. Neurosurgery 18 : 784-786, 1986
PubMed
29. Nishigaya K, Ueno T, Satou E, et al. : Mature teratoma incidentally found in the sylvian fissure : A report of antopsy case. Brain Tumor Pathol 11 : 131-134, 1994
 
30. Nakamura Y, Sato Y, Nishimura G, T et al. : Malignant teratoma in the brain. An immunohistochemical study. Cancer 55 : 103-107, 1985
 
31. 勇木清, 児玉安紀, 恩田純, 他 : トルコ鞍内原発malignat germ cell tumorの1例-PVB療法と放射線併用例. 癌の臨床 34 : 2091-2095, 1988
 
32. Watterson J, Priest JR : Control of extraneural metastasis of a primary intracranial nongernimonatous germ cell tumor. J Neurosurg 71 : 601-604, 1989
PubMed
33. 宮町敬吉, 阿部弘, 田代邦雄, 会田敏光 : Embryonal carcfinomaを伴う多発性奇形腫の1例. 脳外 14 : 1161-1165, 1986
 
34. Reger SN : Selected hearing impairment associated with pinealoma. Ann Otol 87 : 834-836, 1978
PubMed
35. Sugiyama K, Uozumi T, Arita K, et al. : Clinical evaluation of 33 patients with histologically verified germinoma. Surg Neurol 42 : 200-210, 1994
PubMed
36. Sano K, Matsutani M : Pinealoma (germinoma) treated by direct surgery and postoperative irradiation. A long-term follow-up. Child's Brain 8 (2) : 81-97, 1981
PubMed
37. 田中秀樹, 松谷雅生, 前田達浩, 他 : 頭蓋内 choriocarcinoma とgerminoma with syncytiotrophoblastic giant cell - HCG産生2症例の報告. 小児脳神経 14 : 251-257, 1989
 
38. 武内重二 : 松果体腫瘍と思春期早発症. Neurosurgeon 4 : 89-98, 1985
 
39. Kitanaka C, Matsutani M, Sora S, et al. : Precocious puberty in a girl with an hCG-secreting suprasellar immature teratoma. J Neurosurg 81 : 601-604, 1994
 
40. Douglas-Akinwande AC, Ying J, Momin Z, et al. : Diffusion-weighted imaging characteristics of primary central nervous system germinoma with histopathologic correlation : a retrospective study. Acad Radiol 16 (11) : 1356-1365, 2009
PubMed
41. Korogi Y, Takahashi M, Ushio Y : MRI of pineal region tumors. J Neuro-Oncol 54 : 251-261, 2001
 
42. Javadpour N, McIntire KR, Waldmann TA : Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma. A prospective study. Cancer 42 : 2768-2772, 1978
PubMed
43. Zaloudek CJ, Tavassoli FA, Norris HJ : Dysgerminoma with syncytiotrophoblastic giant cells. A histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol 5 : 361-367, 1981
PubMed
44. 小松清秀, 平塚秀雄, 稲葉穰 : 松果体部腫瘍4剖検例の病理学的検討. 脳神経 23 : 917-926, 1971
 
45. DeGirolami U, Schmidek H : Clinicopathological study of 53 tumors of the pineal region. J Neurosurg 39 : 455-462, 1973
PubMed
46. Lewis I, Baxter DW : Atypical teratoma of the pineal. Can Med Assoc J 89 : 103-110, 1963
PubMed
47. Ghatak NR, Hirano A, Zimmerman HM : Intrasellar germinomas. A form of ectopic pinealoma. J Neurosurg 31 : 670-675, 1969
PubMed
48. Jellinger K : Primary intracranial germ cell tumors. Acta Neuropathol (Berl) 25 : 291-306, 1973
PubMed
49. 沼部敏夫, 神岡芳雄 : 異所性松果体腫の1例. 脳神経 15 (8) : 73-80, 1963
 
50. 郭隆, 笹生俊一, 鈴木二郎, 他 : 同側大脳半球萎縮を来した異所性松果体腫瘍の1剖検例. 臨床神経 14 : 623-630, 1974
 
51. 樺島啓吉, 原田正純, 丸林徹 : 異所性松果体腫瘍の1例-経過・剖検所見-. 脳と神経 29 (4) : 453-458, 1977
 
52. Higano S, Takahashi S, Ishii K, et al. : Germinoma originating in the basal ganglia and thalamus : MR and CT evaluation. AJNR 15 : 1433-1441, 1994
 
53. Wong T-T, Chen YW, Guo W-Y, et al. : Germinoma involving the basal ganglia in children. Childs Nerv Syst 24 : 71-78, 2008
PubMed
54. Moon WK, Chang KH, Kim IO, et al. : Germinomas of the basal ganglia and thalamus : MR findings and a comparison between MR and CT. AJR Am J Roentgenol 162 (6) : 1413-1417, 1994
 
55. Phi JH, Cho BK, Kim SK, et al. : Germinomas in the basal ganglia : magnetic resonance imaging classification and the prognosis. J Neurooncol 99 (2) : 227-236, 2010
PubMed
56. 松本圭蔵, 大田浩石, 松本 : 不随意運動を呈した視床部松果体腫瘍, 臨床神経 11 : 373-379, 1971
 
57. Kobayashi T, Yoshida J, Kida Y : Bilateral germ cell tumors involving the basal ganglia and thalamus. Neurosurgery 24 : 579-583, 1989
PubMed
58. Nakasu Y, Takeuchi S, Takayama S, et al. : Poikilothermia in a female patient with a germinoma in the basal ganglia. Acta Neurochir (Wien) 120 : 190-192, 1993
 
59. Tsuchida Y, Tsuboi K, Yanaka K, Nose T : Basal ganglia germinoma with crossed cerebellar diaschisis. Case report. Neurol Med Chir (Tokyo) 33 : 779-782, 1993
PubMed
60. Liang SY, Yang TF, Chen YW, L et al. : Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. Neuro Oncol 15 (11) : 1543-1551, 2013
 
61. Sonoda T, Kumabe T, Sugiyama S, et al. : Germ cell tumors in the basal ganglia : problems of early diagnosis and treatment. J Neurosurg Pediatrics 2 : 118-124, 2008
 
62. Sadamura Y, Sugiyama K, Uchida H, et al. : Intracranial germinoma presenting with hemiatrophy - Follow-up results and literature review. Two case reports. Neurol Med Chir (Tokyo) 51 : 148-152, 2011
PubMed
63. Sudo A, Shiga T, Okajima M, et al. : High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral atrophy. AJNR Am J Neuroradiol 24 : 1909-1911, 2003
PubMed
64. Fujii Y, Saito Y, Ogawa T, et al. : Basal ganglia germinoma : diagnostic value of MR spectroscopy and 11C-methionine positron emission tomography. J Neurol Sci 270 : 189-193, 2008
 
65. Hao S, Li D, Feng J, et al. : Primary medulla oblongata germinomas : Two case reports and review of the literature. World J Surg Oncol 11 : 274, 2013
PubMed
66. Yip CM, Tseng HH, Hsu SS, et al. : Dyspnea and choking as presenting symptoms in primary medulla oblongata germinoma. Surg Neurol Int 5 (Suppl 4) : S170-174, 2014
 
67. Kinoshita Y, Akatsuka K, Ohtake M, et al. : Primary intramedullary spinal cord germinoma -case report-. Neurol Med Chir (Tokyo) 50 : 592-594, 2010
PubMed
68. Yamagata T, Takami T, Tsuyuguchi N, et al. : Primary intramedullary spinal cord germinoma : diagnostic challenge and treatment strategy. Neurol Med Chir (Tokyo) 49 : 128-133, 2009
PubMed
69. Madhukar M, Maller VG, Choudhary AK, et al. : Primary intramedullary spinal cord germinoma. J Neurosurg Pediatr. 2013 May ; 11 (5) : 605-609, 2013
PubMed
70. Yamamoto J, Takahashi M, Nakano Y, et al. : Intratumoral hemorrhage because of primary spinal mixed germ cell tumor presenting with atypical radiological features in an adult. Spine J 13 (10) : e31-38, 2013
 
71. Takahashi M, Koyama H, Matsubara T, et al. : Mixed germinoma and choriocarcinoma in the intramedullary spinal cord : case report and review of the literature. J Neuro-Oncol 76 : 71-75, 2006
 
72. Wang R, Fan X, Zhang B : A rare case of multifocal intramedullary germinoma in cervical spinal cord. Spinal Cord 52 Suppl 1 : S19-22, 2014
 
73. Hengstman GJD, Gons RAR, Lenssen PPA, Kappelle AC : Intracranial germinoma presenting as polyradiculopathy due to widespread spina dissemination. J Neuro-Oncol 80 : 105-106, 2006
 
74. Rabo CS, Hashimoto N, Kagawa N, et al. : A rare case of a simultaneously detected suprasellar and intramedullary spinal cord germinoma. Brain Tumor Pathol 27 (2) : 117-120, 2010
PubMed
75. Nagaishi M, Suzuki R, Tanaka Y, et al. : Pure germinoma of the pineal gland with synchronous spinal dissemination -case report-. Neurol Med chir (Tokyo) 50 : 505-508, 2010
PubMed
76. Ide M, Jimbo M, Yamamoto M, et al. : Spontaneous regression of primary intracrania germinoma. A case report. Cancer 79 : 558-563, 1997
 
77. Fujimaki T, Mishima K, Asai A, et al. : Spontaneous regression of a residual pineal tumor after resection of a cerebellar vermian germinoma. J Neuro-Oncol 41 : 65-70, 1999
 
78. Murai Y, Kobayashi S, Mizunari T, et al. : Spontaneous regression of a germinoma in the pineal body after placememt of a ventriculoperitoneal shunt. J Neurosurg 93 : 884-886, 2000
PubMed
79. Mizoguchi M, Inamura T, Shono T, et al. : A comparative study of apoptosis and proliferation in germinoma and glioblastoma. Neuro-Oncology 2 : 96-102, 2000
PubMed
80. Haw C, Steinbok P : Ventriculoscope tract recurrence after endoscopic biopsy of pineal germinoma. Pediatric Neurosurg 34 : 215-217, 2001
PubMed
81. Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S : Chemotherapy without irradiation-a novel approach for newly diagnosed CNS germ cell tumors : results of an international cooperative trial. J Clin Oncol 14 : 2908-2915, 1996
 
82. Kellie SJ, Boyce H, Dunkel IJ, Rosenblum M, Brualdi L Finlay JL : Primary Chemotherapy for intracranial nongerminomatous germ cell tumors : results of the second international CNS germ cell study group protocol. J Clin Oncol 22 : 846-853, 2004
 
83. Ohno M, Narita Y, Miyakita Y, Shibui S : The necessity of long-term follow-up including spinal examination after successful initial treatment of intracranial germinoma : case reports. Childs Nerv Syst 32 (3) : 547-551, 2016
PubMed
84. Shikama N, Ogawa K, Tanaka S, et al. : Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma. A multiinstitutional, retrospective review of 180 patients. Cancer 104 (1) : 126-134, 2005
PubMed
85. Fujikawa K, Kawahara Y, Hirano H, et al. : Germinoma with syncytiotrophoblastic giant cells recurring 13 years after radiotherapy for a pineal germinoma. Case report. Neurol Med Chir (Tokyo) 43 : 146-149, 2003
PubMed
86. Kahn L, Fridley J, Patel AJ, et al. : Disseminated germinoma in the brain and cervical spinal cord 10 years after radiographic resolution of pineal germinoma. J Clin Neurosci 19 (7) : 1055-1057, 2012
 
87. Hanakita S, Takenobu A, Kambe A, et al. : Intramedullary recurrence of germinoma in the spinal cord 15 years after complete remission of a pineal lesion. J Neurosurg Spine 16 (5) : 513-515, 2012
PubMed
88. 元持雅男, 牧田康正, 鍋島祥男, 他 : 全身転移を示した頭蓋内Germinomaの1例. 脳外 8 : 563-570, 1980
 
89. Pena CE, Smith WI Jr : Metastasizing cerebral germinoma. Ann Neurol 16 (1) : 94-95, 1984
PubMed
90. Kon H, Kumabe T, Jokura H, Shirane R : Recurrent intracranial germinoma outside the initial radiation field with progressive malignant transformation. Acta Neurochir 144 : 611-616, 2002
PubMed
91. Kamitani H, Miyata H, Ishibashi M, et al. : Mixed germ cell tumors with abundant sarcomatous component in the temporal lobe after radiochemotherapy of neurohypophyseal germinoma : a case report. Brain Tumor Pathol 23 : 83-89, 2006
PubMed
92. Tsunoda S, Sasoka Y, Sakaki T, et al. : Suprasellar embryonal carcinoma which developed ten years after local radiation therapy for pineal germinoma. Surg Neurol 40 : 146-150, 1993
 
93. Rogers SJ, Mosleh-Shirazi MA, Saran FH : Radiotherapy of localised intracranial germinoma : time to sever historical ties?. Lncet Oncol 6 (7) : 509-519, 2005
PubMed
94. Shirato H, Nishio M, Sawamura Y, Myohjin M, Kitahara T, Nishioka T, Mizutani Y, Abe H, Miyasaka K : Analysis of long-term treatment of intracranial germinoa. Int J Radiat Oncol Biol Phys 37 : 511-515, 1997
PubMed
95. Shinoda J, SakaiN, Yano H, et al. : Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG. A review with the description of three new patients. J Neuro-Oncol 66 : 225-240 ,2004
 
96. Chan HSL, Humphreys RP, Hendrick EB, et al. : Primary intracranial choriocarcinoma : a report of two cases and a review of the literature. Neurosurgery 14 : 540-545, 1984
 
97. Ho KL, Rassekh ZS : Endodermal sinus tumor of the pineal region. Case report and review of literature. Cancer 44 : 1081-1086, 1979
PubMed
98. 井原達夫, 小柳泉, 杉本信志, 他 : 頭蓋内原発endodermal sinus tumorの頭蓋内・脊髄転移例. 自験例および文献例の検討. Neurol Med Chir (Tokyo) 26 : 501-509, 1986
 
99. 中村信之, 佐藤智彦, 和田徳男, 他 : 多発性転移をきたした松果体部AFP 産生 Endodermal Sinus Tumor. 医学のあゆみ116 : 161-167, 1981
 
100. Bamberg M, Metz K, Alberti W, et al. : Endodermal sinus tumor of the pineal region--Metastases through a ventriculoperitoneal shunt. Cancer 54 (5) : 903-906, 1984
PubMed
101. Asano N, Oka H, Takase K, et al. : Intracranial and intraspinal dissemination from pineal yolk sac tumor treated by PVB therapy. Case report. Neurol Med Chir (Tokyo) 30 : 483-488, 1990
PubMed
102. Takeda Z, Maeda H, Itoh H, et al. : Yolk sac tumor in the cerebellum - a case report -. Kobe J Med Sci 31 : 63-72, 1985
PubMed
103. 田鹿妙子, 青木信彦, 水谷弘, 他 : 小脳半球endodermal sinus tumorの1例. 小児脳神経 13 : 225-228, 1988
 
104. Everts TJ, Ransburg RC : Primary intracranial endodermal sinus siums tumor. J Neurosurg 50 : 246-252, 1979
 
105. Itoyama Y, Kochi M, Yamamoto H, et al. : Clinical study of intracranial nongerminomatous germ cell tumors producing α-fetoprotein. Neurosurgery 27 : 454-460, 1990
 
106. Packer RJ, Sutton LN, Rorke LB, et al. : Intracranial embryonal cell carcinoma. Cancer 54 : 520-524, 1984
PubMed
107. Sakata K, Yamada H, Sakai N, et al. : Extraneural metastasis of pineal tumor. Surg Neurol 3 : 49-54, 1975
PubMed
108. Tsuchiyama M, Miyamoto M, Sakurai M, Kitamura H : Intracranial germ cell tumor indicating a high level of alphafetoprotein (AFP). Acta Pathol Jpn 31 : 521-526, 1981
PubMed
109. 松角康彦, 阿倍 弘, 田中隆一, 他 : 頭蓋内germ cell tumorに対するcisplatin-vinblastine-bleomycin 3者併用療法. 癌の臨床 32 : 1387-1393, 1986
 
110. 阿部弘昌, 阿部啓一, 津金沢政治 : 肺に転移をおこした脳Teratoid Tumorの1剖検例. 医療 26 : 49-52, 1972
 
111. Nishizuka Y, Morii S, Ojima A, et al. : Three autopsy case of testicular and intracranial choriocarcinoma in the male. Acta Pathol Jpn 6 Supple : 841-849, 1956
 
112. 岩田金次郎, 中島典英, 中島正光, 佐藤秩子 : 肺転移を起こした松果体部腫瘍の症例. 脳神経 14 : 815-818, 1962
 
113. Giuffre R, Lorenzo ND : Evolution of a primary intrasellar germinomatous teratoma into a choriocarcinoma. Case report. J Neurosurg 42 : 602-604, 1975
 
114. Nakasu S, Handa J, Hazama F, Hirakawa K : Suprasellar yolk-sac tumor in two sisters. Surg Neurol 20 : 147-151, 1983
PubMed
115. Naganuma H, Inoue H, Misumi S, et al. : Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases. J Neurosurg 61 : 931-937, 1984
 
116. Wang LC, Yang LH, Lee EJ, et al. : Primary embryonal cell carcinoma of cerebellopontine angle. Acta Neurochir (Wien) 139 (5) : 476-477, 1997
PubMed
117. Ikura Y, Sasaki M, Ohgami M, et al. : Mixed germ-cell tumor of the brain. Pathologic study of six autopsy cases. Pathol Res Pract 192 (6) : 595-603, 1996
PubMed
118. Sano K : Pathogenesis of intracranial germ cell tumors reconsidered. J Neurosurg 90 : 258-264, 1999
PubMed
119. Sawamura Y, Ikeda J, Shirato H, et al. : Germ cell tumours of the central nervous system : treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 34 : 104-110, 1998
PubMed
120. Ogawa K, Toita T, Nakamura K, et al. : Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors. A multiinstitutional retrospective analysis of 41 patients. Cancer 98 : 369-376, 2003
PubMed
121. Ogawa K, Shikama N, Toita T, et al. : Long-term results of radiotherapy for intracranial germinoma : A multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 58 : 705-713, 2004
PubMed
122. Shono T, Natori Y, Morioka T, et al. : Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas. J Neurosurg 107 (3 Suppl) : 193-198, 2007
 
123. Luther N, Stetler WR Jr, Dunkel IJ, et al. : Subarachnoid dissemination of intraventricular tumors following simultaneous endoscopic biopsy and third ventriculostomy. J Neurosurg Pediatr 5 (1) : 61-67, 2010
PubMed
124. Jenkin RDT, Simpson WJK, Keen CW : Pineal and suprasellar germinomas--results of radiation treatment. J Neurosurg 48 : 99-107, 1978
 
125. Salazar OM, Gastro-Vita H, Bakos RS, et al. : Radiation therapy for tumors of the pineal region. Int J Radiat Oncol Biol Phys 5 : 491-499, 1979
 
126. Linstadt D, Wara W, Edwards M, et al. : Radiotherapy of primary intracranial germinomas : the case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys 15 : 291-297, 1988
PubMed
127. Haddock M, Schild SE, Scheithauer BW, et al. : Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys 38 : 915-923, 1997
PubMed
128. Aoyama H, Shirato H, Kakuto Y, et al. : Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother. Oncol. 47 : 201-205, 1998
PubMed
129. Shibamoto Y, Sasai K, Oya N, et al. : Intracranial germinoma : radiation therapy with tumor volume-based dose selection. Radiology 218 : 452-456, 2001
PubMed
130. Matsutani M, Sano K, Takakura K, et al. : Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors. Child's Nerv Syst 14 : 59-62, 1998
 
131. Yoshida J, Sugita K, Kobayashi K, et al. : Prognosis of intracranial germ cell tumours : effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 120 : 111-117, 1993
 
132. Matsutani M, Ushio Y, Japanese Pediatric Brain Tumor Study Group : Combined chemotherapy and radiation therapy for central nervous system germ cell tumors : preliminary results of a Phase II study of the Japanese Pediatric Brain Tumor Study Group. Neurosurg Focus 15 ; 5 (1) : e7, 1998
 
133. Matsutani M, The Japanese Pediatric Brain Tumor Study Group : Combined chemotherapy and radiation therapy for CNS germ cell tumors - the Japanese experience. J Neuor-Oncol 54 : 311-316, 2001
 
134. Matsutani M, The Japanese CNS Germ Cell Study Group : Natural history of intracranial germ cell tumors and its implications for treatment. Br J Neurosurg 27 (4) : e1 [Abstract], 2013
 
135. 片上秀喜, 橋田誠一, 山口秀樹, 他 : 超高感度HCG-β測定法によるCNS胚細胞腫の診断と治療経過. ホルモンと臨床, vol.51, 増刊号, 196-206, 2003
 
136. Takami H, Fukushima S, Fukuoka K, et al. : Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors. J Neurooncol 124 (1) : 23-32, 2015
PubMed
137. Fukuoka K, Yanagisawa T, Suzuki T, et al. : Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance : assessment by using a highly sensitive enzyme immunoassay. J Neurosurg Pediatr. 2016 Jul 8 : 1-5 [Epub ahead of print]
 
138. Rappaport R, Brauner R : Growth and endocrine disorders secondary to cranial irradiation. Pediat Res 25 : 561-567, 1989
PubMed
139. Sano K, Matsutani M, Seto T : So-called intracranial germ cell tumors : personal experiences and a theory of their pathogenesis. Neurol Res 11 : 118-126, 1989
 
141. Calaminus G, Kortmann R, Worch J, et al. : SIOP CNS GCT 96 : final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 15 (6) : 788-796, 2013
PubMed
142. Murray MJ, Bartels, Nishikawa R, et al. : A multi-disciplinary Delphi method to identify consensus in the management of intracranial germ cell tumours. Lancet Oncol, in press, 2015
 
143. Sakuma Y, Sakurai S, Oguni S, et al. : c-kit gene mutations in intracranial germinomas. Cancer Sci 95 (9) : 716-720, 2004
PubMed
144. Wang L, Yamaguchi S, Burstein MD, Lau CC, et al. : Novel somatic and germline mutations in intracranial germ cell tumours. Nature 511 (7508) : 241-245, 2014
PubMed
145. Fukushima S, Otsuka A, Suzuki T, et al. : Mutually exclusive mutations of KIT and RAS are as sociated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas. Acta Neuropathol. 2014 Jan 23., 2014
 
146. Ichimura K, Fukushima S, Totoki Y, et al. : Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol 131 (6) : 889-901, 2016
PubMed
147. Tamaki N, Lin T, Shirataki K, Hosoda K, Kurata H, matsumoto S, Ito H : Germ cell tumors of the thalamus and the basal ganglia. Child's Nerv Syst 6 : 3-7, 1990
 

第12章 松果体部腫瘍

P.496 掲載の参考文献
1. Mottolese C, Szathmari A, Beuriat PA : Incidence of pineal tumours. A review of the literature. Neurochirurgie 61 (2-3) : 65-69, 2015
 
2. Ostrom QT, Gittleman H, Farah P, et al. : CBTRUS statistical report : Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 17 Suppl 4, 2015
 
3. Fauchon F, Jouvet A, Paquis P, et al. : Parenchymal pineal tumors : a clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys 46 : 959-968, 2000
PubMed
4. Jouvet A, Saint-Pierre G, Fauchon F, et al. : Pineal parenchymal tumors : a correlation of histological features with prognosis in 66 cases. Brain Pathol 10 : 49-60, 2000
PubMed
5. Villa S, Miller RC, Krengli M, et al. : Primary pineal tumors : outcome and prognostic factors--a study from the Rare Cancer Network (RCN). Clin Transl Oncol 14 (11) : 827-34, 2012
PubMed
6. Schild SE, Scheithauer BW, Schomberg PJ, et al. : Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer 72 : 870-880, 1993
PubMed
7. Chang SM, Lillis-Hearme PK, Larson DA, et al. : Pineoblastoma in adults. Neurosurgery 37 : 383-391, 1995
 
8. Gilheeney SW, Saad A, Chi S, et al. : Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol 89 (1) : 89-95, 2008
PubMed
9. Mandera M, Marcol W, Kotulska K, et al. : Childhood pineal parenchymal tumors : clinical and therapeutic aspects. Neurosurg Rev 34 (2) : 191-196, 2010
PubMed
10. Fain JS, Tomlinson FH, Scheithauer Bw, et al. : Symptomatic glial cysts of the pineal gland. J Neurosurg 80 : 454-460, 1994
PubMed
11. Ganti SR, Hilal SK, Stein Bm, et al. : CT of pineal region tumors. AJNR 7 : 97-104, 1986
 
12. Nakamura M, Saeki N, Iwadate Y, et al. : Neuroradiological characteristics of pineocytoma and pineoblastoma. Neuroradiology 42 : 509-514, 2000
PubMed
13. Kakigi T, Okada T, Kanagaki M, et al. : Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas : are they useful?. Neuroradiology. 2014 Feb 98 (Epub ahead of print), 2014
 
14. Komakula S, Warmuth-Metz M, Hildenbrand P, et al. : Pineal parenchymal tumor of intermediate differentiation : imaging spectrum of an unusual tumor in 11 cases. Neuroradiology. 2011 Aug ; 53 (8) : 577-584, 2011
PubMed
15. Gener MA, Conger AR, Van Gompel J, et al. : Clinical, pathological, and surgical outcomes for adult pineoblastomas. World Neurosurg 84 (6) : 1816-1824, 2015
PubMed
16. D'Andrea AD, Packer RJ, Rorke LB, et al. : Pineocytomas of childhood A reappraisal of natural history and response to therapy. Cancer 59 : 1353-1357, 1987
PubMed
17. Clark AJ, Sughrue ME, Ivan ME, et al. : Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol 100 (2) : 255-260, 2010
PubMed
18. Clark AJ, Ivan ME, Sughrue ME, et al. : Tumor control after surgery and radiotherapy for pineocytoma. J Neurosurg 113 (2) : 319-324, 2010
PubMed
19. Stoiber EM, Schaible B, Herfarth K, et al. : Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003 asingle institution's experience. Radiat Oncol 5 : 122, 2012
 
20. Park JH, Kim JH, Kwon DH, et al. : Upfront Stereotactic Radiosurgery for Pineal Parenchymal Tumors in Adults. J Korean Neurosurg Soc 58 (4) : 334-340, 2015
PubMed
21. Ito T, Kanno H, Sato KI, et al. : Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation (PPTID). World Neurosurg 81 (5-6) : 783-789, 2014
 
22. Yi JW, Kim HJ, Choi YJ, et al. : Successful treatment by chemotherapy of pineal parenchymal tumor with intermediate differentiation : a case report. Cancer Res Treat 45 (3) : 244-249, 2013
PubMed
23. Friedrich C, von Bueren AO, von Hoff K, et al. : Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 15 (2) : 224-234, 2013
PubMed
24. Borit, A., Blackwood, W., Mair, W.G.P. : The separation of pineocytoma from pineoblastoma. Cancer 45 : 1408-1418, 1980
 
25. Selvanathan SK, Hammouche S, Smethurst W, et al. : Outcome and prognostic features in adult pineoblastomas : analysis of cases from the SEER database. Acta Neurochir (Wien) 154 (5) : 863-869, 2012
PubMed
26. Farnia B, Allen PK, Brown PD, et al. : Clinical outcomes and patterns of failure in pineoblastoma : a 30-year, single-institution retrospective review. World Neurosurg 82 (6) : 1232-1241, 2014
PubMed
27. Gururangan S, McLaughlin C, Quinn J, et al. : High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 21 (11) : 2187-2191, 2003
PubMed
28. Hinkes BG, von Hoff K, Deinlein F, et al. : Childhood pineoblastoma : experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol 81 (2) : 217-23, 2007
PubMed
29. Bohrnsen F, Enders C, Ludwig HC, et al. : Common molecularcytogenetic alterations in tumors originating from the pineal region. Oncol Lett 10 (3) : 1853-1857, 2015
PubMed
30. De Ioris MA, Valente P, Randisi F, et al. : Baseline central nervous system magnetic resonance imaging in early detection of trilateral retinoblastoma : pitfalls in the diagnosis of pineal gland lesions. Anticancer Res 34 (12) : 7449-7454, 2014
PubMed
31. de Kock L, Sabbaghian N, Druker H, et al. : Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128 (4) : 583-595, 2014
PubMed
32. Gempt J, Ringel F, Oexle K, et al. : Familial pineocytoma. Acta Neurochir (Wien) 154 (8) : 1413-1416, 2012
PubMed
P.501 掲載の参考文献
1. Mottolese C, Szathmari A, Beuriat PA : Incidence of pineal tumours. A review of the literature. Neurochirurgie 61 (2-3) : 65-69, 2015
 
2. Poulgrain K, Gurgo R, Winter C, et al. : Papillary tumour of the pineal region. J Clin Neurosci 18 (8) : 1007-1017, 2011
PubMed
3. Abela L, Rushing EJ, Ares C, et al. : Pediatric papillary tumors of the pineal region : to observe or to treat following gross total resection?. Childs Nerv Syst 29 (2) : 307-310, 2013
PubMed
4. Fauchon F, Hasselblatt M, Jouvet A, et al. : Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region : a multicenter study. J Neurooncol 112 (2) : 223-231, 2013
PubMed
5. Chang AH, Fuller GN, Debnam JM, et al. : MR imaging of papillary tumor of the pineal region. AJNR Am J Neuroradiol 29 (1) : 187-189, 2008
PubMed
6. Rosa Junior M, da Rocha AJ, Zanon da Silva A, Rosemberg S : Papillary Tumor of the Pineal Region : MR Signal Intensity Correlated to Histopathology. Case Rep Neurol Med 2015 : 315095, 2015
PubMed
7. Rodriguez EM, Oksche A, Montecinos H : Human subcommissural organ, with particular emphasis on its secretory activity during the fetal life. Microsc Res Tech 52 (5) : 573-590, 2001
PubMed
8. Jouvet A, Fauchon F, Liberski P, et al. : Papillary tumor of the pineal region. Am J Surg Pathol 27 (4) : 505-512, 2003
PubMed
9. Edson MA, Fuller GN, Allen PK, et al. : Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. World Neurosurg 84 (1) : 76-81, 2015
PubMed
10. Heim S, Beschorner R, Mittelbronn M, et al. : Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region. Am J Surg Pathol 38 (1) : 106-110, 2014
PubMed
11. Gutenberg A, Brandis A, Hong B, et al. : Common molecular cytogenetic pathway in papillary tumors of the pineal region (PTPR). Brain Pathol 21 (6) : 672-677, 2011
PubMed
12. Cimino PJ, Gonzalez-Cuyar LF, Perry A, Dahiya S : Lack of BRAF-V600E mutation in papillary tumor of the pineal region. Neurosurgery 77 (4) : 621-628, 2015
PubMed
13. Goschzik T, Gessi M, Denkhaus D, Pietsch T : PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region. J Neuropathol Exp Neurol 73 (8) : 747-751, 2014
PubMed
14. Heim S, Sill M, Jones DT, et al. : Papillary tumor of the pineal region : a distinct molecular entity. Brain Pathol 26 (2) : 199-205, 2016
PubMed

第13章 脳の悪性リンパ腫

P.551 掲載の参考文献
1. Hodgkin T : On some morbid appearances of the absorbent glands and spleen. READ Jan, 10th & 24th, 1932
 
2. Reed, DM : On the pathological changes in Hodgkin's disease with special reference to its relation to tuberculosis. Johns Hopkins Hosp. Rep. so.' 133-196, 1902
 
3. Swerdlow SH, Campo E, Harris NL, et al., eds. : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. IARC, Lyon, pp439, 2008
 
4. Aoki R, Karube K, Sugita Y, et al. : Distribution of malignant lymphoma in Japan : analysis of 2260 cases, 2001-2006. Pathol Int 58 (3) : 174-182, 2008
PubMed
5. Clarke CA, Morton LM, Lynch C, et al. : Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 109 (1) : 280-288, 2013
PubMed
6. Gibson TM, Engels EA, Clarke CA, et al. : Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol 89 (7) : 714-720, 2014
PubMed
7. Gopal S, Martin KE, Richards KL, Eron JJ : Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010. AIDS Res Hum Retroviruses 28 (8) : 798-805, 2012
PubMed
8. Gopal S, Patel MR, Yanik EL, et al. : Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst 105 (16) : 1221-1229, 2013
PubMed
9. Alizadeh AA, Eisen MB, Davis RE, et al. : Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (6769) : 503-511, 2000
PubMed
10. Rosenwald A, Wright G, Chan WC, et al. : The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (25) : 1937-1947, 2002
PubMed
11. Hans CP, Weisenburger DD, Greiner TC, et al. : Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (1) : 275-282, 2004
PubMed
12. Choi WW, Weisenburger DD, Greiner TC, et al. : A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15 (17) : 5494-5502, 2009
PubMed
13. Lymphoma Study Group of Japanese Pathologists : The World Health Organization classification of malignant lymphomas in Japan : Incidence of recently recognized entities. Pathol Int 50 (9) : 679-764, 2000
 
14. Chihara D, Ito H, Matsuda T, Shibata A, et al. : Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164 (4) : 536-545, 2014
PubMed
15. The International Non-Hodgkin's Lymphoma Prognostic Factors Project : A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329 (14) : 987-994, 1993
 
16. Feugier P1, Van Hoof A, Sebban C, et al : Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma : a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23 (18) : 4117-4126, 2005
 
17. Persky DO, Unger JM, Spier CM, et al : Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma : Southwest Oncology Group study 0014. J Clin Oncol 26 (14) : 2258-2263, 2008
 
18. Wang Y, Li ZM, Huang JJ, et al. : Three prognostic factors influence clinical outcomes of primary testicular lymphoma. Tumour Biol 34 (1) : 55-63, 2013
 
19. Kim SJ, Kang HJ, Kim JS, et al : Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma : surgical resection followed by chemotherapy versus chemotherapy alone. Blood 117 (6) : 1958-1965, 2011
PubMed
20. Tanaka T, Shimada K, Yamamoto K, et al. : Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era : a multicenter study of 95 patients in Japan. Ann Hematol 91 (3) : 383-390, 2012
 
21. Onal C, Li YX, Miller RC, et al. : Treatment results and prognostic factors in primary thyroid lymphoma patients : a rare cancer network study. Ann Oncol 22 (1) : 156-164, 2011
PubMed
22. Yhim HY, Kim JS, Kang HJ, et al. : Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy. Int J Cancer 131 (1) : 235-243, 2012
PubMed
23. Schaumburg HH, Plank CR, Adams RD : The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain 95 (2) : 199-212, 1972
PubMed
24. Jellinger K, Radiaszkiewicz T : Involvement of the central nervous system in malignant lymphomas. Virchows Arch A Pathol Anat Histol 370 (4) : 345-362, 1976
PubMed
25. Nakhleh RE, Manivel JC, Hurd D, Sung JH : Central nervous system lymphomas. Immunohisto chemical and clinicopathologic study of 26 autopsy cases. Arch Pathol Lab Med 113 (9) : 1050-1056, 1989
 
26. Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC : CNS involvement in the non-Hodgkin's lymphomas. Cancer 45 : 545-552, 1980
PubMed
27. Bunn PA Jr, Schein PS, Banks PM, DeVita VT Jr. : Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma : leukemia revisited. Blood 47 (1) : 3-10, 1976
PubMed
28. Hollender A, Kvaloy S, Nome O, et al. : Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma : a risk model. Ann Oncol 13 (7) : 1099-1107, 2002
PubMed
29. Hollender A, Kvaloy S, Lote K, et al : Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur J Cancer 36 (14) : 1762-1768, 2000
PubMed
30. Bernstein SH, Unger JM, Leblanc M, et al. : Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma : a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group. J Clin Oncol 27 (1) : 114-119, 2009
 
31. Feugier P, Virion JM, Tilly H, et al. : Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma : influence of rituximab. Ann Oncol 15 (1) : 129-133, 2004
PubMed
32. Villa D, Connors JM, Shenkier TN, et al. : Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma : the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol 21 (5) : 1046-1052, 2010
PubMed
33. Shibamoto Y, Sumi M, Onodera S, et al. : Primary CNS lymphoma treated with radiotherapy in Japan : a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol 19 (5) : 963-971, 2014
 
34. Gregory G, Arumugaswamy A, Leung T, et al. : Rituximab is associated with improved survival for aggressive B cell CNS lymphoma. Neuro Oncol 15 (8) : 1068-1073, 2013
PubMed
35. Ferreri AJ, Reni M, International Extranodal Lymphoma Study Group (IELSG) : High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma : a randomised phase 2 trial. Lancet 374 (9700) : 1512-1520, 2009
 
36. Bataille B, Delwail V, Menet E, et al. : Primary intracerebral malignant lymphoma : report of 248 cases. J Neurosurg 92 (2) : 261-266, 2000
 
37. Kiewe P, Fischer L, Martus P, et al. : Meningeal dissemination in primary CNS lymphoma : diagnosis, treatment, and survival in a large monocenter cohort. Neuro Oncol 12 (4) : 409-417, 2010
 
38. Thiel E, Korfel A, Martus P, et al. : High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1) : a phase 3, randomised, non-inferiority trial. Lancet Oncol 11 (11) : 1036-1047, 2010
 
39. Hayabuchi N, Shibamoto Y, Onizuka Y : Primary central nervous system lymphoma in Japan : a nationwide survey. Int J Radiat Oncol Biol Phys 44 (2) : 265-272, 1999
PubMed
40. Choi JS, Nam DH, Ko YH, et al. : Primary central nervous system lymphoma in Korea : comparison of B- and T-cell lymphomas. Am J Surg Pathol 27 (7) : 919-928, 2003
 
41. Kuker W, Nagele T, Korfel A, et al. : MRI features at presentation in 100 patients. J Neurooncol 72 (2) : 169-177, 2005
PubMed
42. Haldorsen IS, Krakenes J, Krossnes BK, et al. : CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 30 (4) : 744-751, 2009
 
43. Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA : MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 14 (1) : 22, 2014
 
44. Watanabe M, Tanaka R, Takeda N, et al. : Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain. Neuroradiology 34 : 36-42, 1992
PubMed
45. Sakata A, Okada T, Yamamoto A, et al. : Primary central nervous system lymphoma : is absence of intratumoral hemorrhage a characteristic finding on MRI?. Radiol Oncol 49 (2) : 128-134, 2015
PubMed
46. Kim EY, Kim SS : Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol 46 (2) : 187-192, 2005
PubMed
47. Kinoshita M, Sasayama T, Narita Y, et al. : Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysis. Neuro Oncol 16 (5) : 728-734, 2014
PubMed
48. Schaumburg HH, Plank CR, Adams RD : The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain 95 (2) : 199-212, 1972
PubMed
49. Nakhleh RE, Manivel JC, Hurd D, Sung JH : Central nervous system lymphomas. Immunohistochemical and clinicopathologic study of 26 autopsy cases. Arch Pathol Lab Med 113 (9) : 1050-1056, 1989
PubMed
50. Henry JM, Hgeeffner RRJr., Dillard SH, et al. : Primary malignant lymphomas of the central nervous system. Cancer 34 : 1293-1302, 1974
PubMed
51. Lai R, Abrey LE, Rosenblum MK, DeAngelis LM : Treatment-induced leukoencephalopathy in primary CNS lymphoma : a clinical and autopsy study. Neurology 62 (3) : 451-456, 2004
PubMed
52. Kiewe P, Fischer L, Martus P, et al. : Meningeal dissemination in primary CNS lymphoma : diagnosis, treatment, and survival in a large monocenter cohort. Neuro Oncol 12 (4) : 409-417, 2010
 
53. Taylor JW, Flanagan EP, O'Neill BP, et al. : Primary leptomeningeal lymphoma : International Primary CNS Lymphoma Collaborative Group report. Neurology 81 (19) : 1690-1696, 2013
 
54. Kawasaki K, Wakabayashi K, Koizumi T, et al. : Spinal cord involvement of primary central nervous system lymphomas : histopathological examination of 14 autopsy cases. Neuropathology 22 (1) : 13-18, 2002
PubMed
55. Onda K, Wakabayashi K, Tanaka R, Takahashi H : Intracranial malignant lymphomas : clinicopathological study of 26 autopsy cases. Brain Tumor Pathol 16 (1) : 29-35, 1999
PubMed
56. DeAngelis LM, Yahalom J, Heinemann MH, et al. : Primary CNS lymphoma : combined treatment with chemotherapy and radiotherapy. Neurology 40 (1) : 80-86, 1990
PubMed
57. Weller M, Martus P, Roth P, et al. : Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14 (12) : 1481-1484, 2012
PubMed
58. Nelson DF, Martz KL, Bonner H, et al. : Non-Hodgikin's lymphoma of the brain : can high dose, large volume radiation therapy improve survival? Report of a prospective trial by the Radiation Therapy Oncology Group (RTOG) : RTOG 8315. Int J Radiat Oncol Biol Phys 23 : 9-17, 1992
 
59. Shibamoto Y, Ogino H, Hasegawa M, et al. : Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Int J Radiat Oncol Biol Phys. 2005 Jul 1 ; 62 (3) : 809-813, 2005
 
60. Merchut MP, Haberland C, Naheedy MH, Rubino FA : Long survival of primary cerebral lymphoma with progressive radiation necrosis. Neurology 35 (4) : 552-556, 1985
PubMed
61. Filley CM, Kleinschmidt-DeMasters BK : Toxic leukoencephalopathy. N Engl J Med 345 (6) : 425-432, 2001
PubMed
62. Omuro AM, Ben-Porat LS, Panageas KS, et al. : Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neuro 62 (10) : 1595-1600, 2005
PubMed
63. Doolittle ND, Korfel A, Lubow MA, et al. : Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology 81 (1) : 84-92, 2013
PubMed
64. O'Neill BP, O'Fallon JR, Earle JD, et al. : Primary central nervous system non-Hodgkin's lymphoma : survival advantages with combined initial therapy?. Int J Radiat Oncol Biol Phys 33 (3) : 663-673, 1995
PubMed
65. Schultz C, Scott C, Sherman W, et al. : Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas : initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 14 (2) : 556-564, 1996
 
66. Skarin AT, Zuckerman KS, Pitman SW, et al. : High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement. Blood 50 (6) : 1039-1047, 1977
PubMed
67. Glass J, Gurber ML, Cher L, Hochberg FH : Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma : long-term outcome. J Neurosurg 81 : 188-195, 1994
 
68. O'Brien P, Roos D, Pratt G, et al. : Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18 (3) : 519-526, 2000
PubMed
69. Hiraga S, Arita N, Ohnishi T, et al. : Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 91 (2) : 221-230, 1999
PubMed
70. Herrlinger U, Kuker W, Uhl M, et al. : NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma : final report. Ann Neurol 57 (6) : 843-847, 2005
PubMed
71. Holdhoff M, Ambady P, Abdelaziz A, et al. : High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology 83 (3) : 235-239, 2014
PubMed
72. Joerger M, Huitema AD, Illerhaus G, Ferreri AJ : Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma. Leuk Lymphoma 53 (10) : 1867-1875, 2012
PubMed
73. Reni M, Ferreri AJ, Guha-Thakurta N, et al. : Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int J Radiat Oncol Biol Phys 51 (2) : 419-425, 2001
PubMed
74. Correa DD, Shi W, Abrey LE, et al. : Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol 14 : 101-108, 2012
PubMed
75. Abrey LE, DeAngelis LM, Yahalom J : Long-term survival in primary CNS lymphoma. J Clin Oncol 16 (3) : 859-863, 1998
PubMed
76. Omuro AM, DeAngelis LM, Yahalom J, Abrey LE : Chemoradiotherapy for primary CNS lymphoma : an intent-to-treat analysis with complete follow-up. Neurology 64 (1) : 69-74, 2005
PubMed
77. DeAngelis LM, Seiferheld W, Schold SC, et al. : Combination chemotherapy and radiotherapy for primary central nervous system lymphoma : Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20 (24) : 4643-4648, 2002
 
78. Abrey LE, Yahalom J, DeAngelis LM : Treatment for primary CNS lymphoma : the next step. J Clin Oncol 18 (17) : 3144-3150, 2000
PubMed
79. Kasenda B, Schorb E, Fritsch K, et al. : Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. Ann Oncol 26 (3) : 608-611, 2015
PubMed
80. Ferreri AJ, Ciceri F, Brandes AA, et al. : MATILDE chemotherapy regimen for primary CNS lymphoma : results at a median follow-up of 12 years. Neurology 82 (15) : 1370-1373, 2014
 
81. Morris PG, Correa DD, Yahalom J, et al. : Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma : final results and long-term outcome. J Clin Oncol 31 (31) : 3971-3979, 2013
PubMed
82. Ferreri AJ, Reni M, Foppoli M, et al. : International Extranodal Lymphoma Study Group (IELSG) : High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma : a randomised phase 2 trial. Lancet 374 (9700) : 1512-1520, 2009
 
83. Ekenel M, Iwamoto FM, Ben-Porat LS, et al. : Primary central nervous system lymphoma : the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 113 (5) : 1025-1031, 2008
PubMed
84. Gerstner ER, Carson KA, Grossman SA, Batchelor TT : Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology 70 (5) : 401-402, 2008
PubMed
85. Zhu JJ, Gerstner ER, Engler DA, et al. : High-dose methotrexate for elderly patients with primary CNS lymphoma. Neuro Oncol 11 : 211-215, 2009
PubMed
86. Juergens A, Pels H, Rogowski S, et al. : Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67 (2) : 182-189, 2010
PubMed
87. Hoang-Xuan K, Taillandier L, Chinot O, et al. : Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years : a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 21 (14) : 2726-2731, 2003
 
88. Gerard LM, Imrie KR, Mangel J, et al. : High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma. Leuk Lymphoma. 2011 Jun 12., 2011
 
89. Chamberlain MC, Johnston SK : High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma. Neuro-Oncology 12 (7) : 736-744, 2010
PubMed
90. Omuro AM, Taillandier L, Chinot O, et al. : Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly. J Neurooncol 85 (2) : 207-211, 2007
PubMed
91. Rubenstein JL, Hsi ED, Johnson JL, et al. : Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma : CALGB 50202 (Alliance 50202). J Clin Oncol 31 (25) : 3061-3068, 2013
PubMed
92. Kiewe P, Fischer L, Martus P, et al. : Primary central nervous system lymphoma : monocenter, long-term, intent-to-treat analysis. Cancer 112 (8) : 1812-1820, 2008
PubMed
93. Omuro A, Taillandier L, Chinot O, et al. : Primary CNS lymphoma in patients younger than 60 : can whole-brain radiotherapy be deferred?. J Neurooncol 104 (1) : 323-330, 2011
PubMed
94. Omuro A, Correa DD, DeAngelis LM, et al. : R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Jan 7 [Epub ahead of print], 2015
 
95. Thiel E, Korfel A, Martus P, et al. : High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1) : a phase 3, randomised, non-inferiority trial. Lancet Oncol 11 (11) : 1036-1047, 2010
 
96. Korfel A, Thiel E, Martus P, et al. : Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84 (12) : 1242-1248, 2015
PubMed
97. Jahnke K, Korfel A, German Primary Central Nervous System Lymphoma Study Group (GPCNSL-SG) : High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol 16 (3) : 445-449, 2005
 
98. Roth P, Martus P, Kiewe P, et al. : Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial. Neurology 79 (9) : 890-896, 2012
 
99. Korfel A, Weller M, Martus P, et al. : Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL) : experience from the G-PCNSL-SG1 trial. Ann Oncol 23 (9) : 2374-2380, 2012
 
100. Kreher S, Strehlow F, Martus P, et al. : Prognostic impact of intraocular involvement in primary CNS lymphoma : experience from the G-PCNSL-SG1 trial. Ann Hematol. 2014 Sep 13. [Epub ahead of print], 2014
 
101. Kasenda B, Ferreri AJ, Marturano E, et al. : First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL) --a systematic review and individual patient data meta-analysis. Ann Oncol 26 (7) : 1305-1313, 2015
PubMed
102. Pulczynski EJ, Kuittinen O, Erlanson M, et al. : Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance : results from a phase II study by the Nordic Lymphoma Group. Haematologica 100 (4) : 534-540, 2015
 
103. DeAngelis LM, Yahalom J, Heinemann MH, et al. : C Primary CNS lymphoma : combined treatment with chemotherapy and radiotherapy. Neurology 40 (1) : 80-86, 1990
 
104. Singh A, Strobos RJ, Singh BM, et al. : Steroid-induced remissions in CNS lymphoma. Neurology 32 : 1267-1271, 1982
PubMed
105. Onder E, Arikok AT, Onder S, et al. : Corticosteroid pre-treated primary CNS lymphoma : a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability. Int J Clin Exp Pathol 8 (7) : 7798-808, 2015
PubMed
106. Schorb E, Kasenda B, Atta J, et al. : Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica 98 (5) : 765-770, 2013
PubMed
107. Jahnke K, Thiel E, Martus P, German Primary Central Nervous System Lymphoma Study Group : Relapse of primary central nervous system lymphoma : clinical features, outcome and prognostic factors. J Neurooncol 80 (2) : 159-165, 2006
 
108. Nayak L, Hedvat C, Rosenblum MK, et al. : Late relapse in primary central nervous system lymphoma : clonal persistence. Neuro Oncol 13 (5) : 525-529, 2011
PubMed
109. Nguyen PL, Chakravarti A, Finkelstein DM, et al. : Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 23 (7) : 1507-1513, 2005
PubMed
110. Hottinger AF, DeAngelis LM, Yahalom J, Abrey LE : Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology 69 (11) : 1178-1182, 2007
PubMed
111. Reni M, Zaja F, Mason W, et al. : Temozolomide as salvage treatment in primary brain lymphomas. Br J Cancer 96 (6) : 864-867, 2007
PubMed
112. Batchelor TT, Grossman SA, Mikkelsen T, et al. : Rituximab monotherapy for patients with recurrent primary CNS lymphoma. Neurology 76 (10) : 929-930, 2011
PubMed
113. Enting RH, Demopoulos A, DeAngelis LM, Abrey LE : Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 63 (5) : 901-903, 2003
 
114. Nayak L, Abrey LE, Drappatz J, et al. : Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leuk Lymphoma 54 (1) : 58-61, 2013
PubMed
115. Plotkin SR, Betensky RA, Hochberg FH, et al. : Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res 10 (17) : 5643-5646, 2004
PubMed
116. Pentsova E, Deangelis LM, Omuro A : Methotrexate re-challenge for recurrent primary central nervous system lymphoma. J Neurooncol 117 (1) : 161-165, 2014
PubMed
117. Soussain C, Choquet S, Fourme E, et al. : Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma : a retrospective study of 79 cases. Haematologica 97 (11) : 1751-1756, 2012
 
118. Korfel A, Elter T, Thiel E, et al. : Phase II study of central nervous system (CNS) -directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas. Haematologica 98 (3) : 364-370, 2013
PubMed
119. Bakshi R, Mazziotta JC, Mischel PS, et al. : Lymphomatosis cerebri presenting as a rapidly progressive dementia : clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord 10 (2) : 152-157, 1999
PubMed
120. Rollins KE, Kleinschmidt-DeMasters BK, et al. : Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol 36 (3) : 282-290, 2005
PubMed
121. Carlson BA : Rapidly progressive dementia caused by nonenhancing primary lymphoma of the central nervous system. AJNR Am J Neuroradiol 17 (9) : 1695-1697, 1996
PubMed
122. Izquierdo C, Velasco R, Vidal N, S et al. : Lymphomatosis cerebri : a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. Neuro Oncol. 2015 Sep 27. pii : nov197., 2015
 
123. Taylor JW, Flanagan EP, O'Neill BP, et al. : Primary leptomeningeal lymphoma : International Primary CNS Lymphoma Collaborative Group report. Neurology 81 (19) : 1690-1696, 2013
 
124. Fischer L, Martus P, Weller M, et al. : Meningeal dissemination in primary CNS lymphoma : prospective evaluation of 282 patients. Neurology 71 (14) : 1102-1108, 2008
PubMed
125. Kiewe P, Fischer L, Martus P, et al. : Meningeal dissemination in primary CNS lymphoma : diagnosis, treatment, and survival in a large monocenter cohort. Neuro Oncol 12 (4) : 409-417, 2010
 
126. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM : The clinical spectrum of ocular lymphoma. Cancer 72 (3) : 843-849, 1993
PubMed
127. Chan CC, Rubenstein JL, Coupland SE, et al. : Primary vitreoretinal lymphoma : a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. On cologist 16 (11) : 1589-1599, 2011
 
128. Vogel MH, Font RL, Zimmerman LE, Levine RA : Reticulum cell sarcoma of the retina and uvea. Report of six cases and review of the literature. Am J Ophthalmol 66 (2) : 205-215, 1968
PubMed
129. Char DH, Ljung BM, Miller T, Phillips T : Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 95 (5) : 625-630, 1988
PubMed
130. Coupland SE, Chan CC, Smith J : Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 17 (4) : 227-237, 2009
PubMed
131. Chan CC, Sen HN : Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. Discov Med 15 (81) : 93-100, 2013
PubMed
132. Grimm SA, McCannel CA, Omuro AM, et al. : Primary CNS lymphoma with intraocular involvement : International PCNSL Collaborative Group Report. Neurology 71 (17) : 1355-1360, 2008
 
133. Kim EY, Kim SS : Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol 46 (2) : 187-192, 2005
PubMed
134. Shenkier TN, Blay JY, O'Neill BP, et al. : Primary CNS lymphoma of T-cell origin : a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23 (10) : 2233-2239, 2005
 
135. Lymphoma Study Group : New Lecture 4. 中枢神経系悪性リンパ腫, 篠原出版, 東京, 1994
 
136. Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology 77 (8) : 784-791, 2011
PubMed
137. Kawai N, Okada M, Haba R, et al. : Insufficiency of positron emission tomography and magnetic resonance spectroscopy in the diagnosis of intravascular lymphoma of the central nervous system. Case Rep Oncol 5 (2) : 339-346, 2012
PubMed
138. Glass J, Hochberg FH, Miller DC : Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer 71 (10) : 3156-3164, 1993
PubMed
139. Fonkem E, Lok E, Robison D, et al. : The natural history of intravascular lymphomatosis. Cancer Med 3 (4) : 1010-1024, 2014
PubMed
140. Kebir S, Kuchelmeister K, Niehusmann P, et al. : Intravascular CNS lymphoma : Successful therapy using high-dose methotrexate-based polychemotherapy. Exp Hematol Oncol 1 (1) : 37,
PubMed
141. Iwamoto FM, DeAngelis LM, Abrey LE : Primary dural lymphomas : a clinicopathologic study of treatment and outcome in eight patients. Neurology 66 (11) : 1763-1765, 2006
PubMed
142. Tu PH, Giannini C, Judkins AR, et al. : Clinicopathologic and genetic profile of intracranial marginal zone lymphoma : a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol 23 (24) : 5718-5727, 2005
PubMed
143. Iwamoto FM, Abrey LE : Primary dural lymphomas : a review. Neurosurg Focus 21 (5) : E5, 2005
 
144. Levy RM, Bredesen DE, Rosenblum ML : Neurological manifestations of the acquired immunodeficiency syndrome (AIDS) : experience at UCSF and review of the literature. J Neurosurg 62 (4) : 475-495, 1985
PubMed
145. Helweg-Larsen S, Jakobsen J, Boesen F, Arlien-Soborg P : Neurological complications and concomitants of AIDS. Acta Neurol Scand 74 (6) : 467-474, 1986
PubMed
146. Matthiessen L, Marche C, Labrousse F, et al. : [Neuropathology of the brain in 174 patients who died of AIDS in a Paris hospital 1982-1988]. [Article in French]. Ann Med Interne (Paris) 143 (1) : 43-49, 1992
 
147. Chimelli L, Rosemberg S, Hahn MD, et al. : Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV) : a report of 252 autopsy cases from Brazil. Neuropathol Appl Neurobiol 18 (5) : 478-488, 1992
PubMed
148. Nishijima T, Gatanaga H, Teruya K, et al. : Brain magnetic resonance imaging screening is not useful for HIV-1-infected patients without neurological symptoms. AIDS Res Hum Retroviruses 30 (10) : 970-974, 2014
PubMed
149. Uldrick TS, Pipkin S, Scheer S, Hessol NA : Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS 28 (3) : 397-405, 2014
PubMed
150. Thurnher MM, Rieger A, Kleibl-Popov C, et al. : Primary central nervous system lymphoma in AIDS : a wider spectrum of CT and MRI findings. Neuroradiology 43 (1) : 29-35, 2001
PubMed
151. Loureiro C, Gill PS, Meyer PR, et al. : Autopsy findings in AIDS-related lymphoma. Cancer 62 (4) : 735-739, 1988
PubMed
152. Haldorsen IS, Krakenes J, Goplen AK, et al. : AIDS-related primary central nervous system lymphoma : a Norwegian national survey 1989-2003. BMC Cancer 8 : 225, 2008
PubMed
153. DeAngelis LM, Wong E, Rosenblum M, Furneaux H : Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer 70 (6) : 1607-1611, 1992
PubMed
154. Licho R, Litofsky NS, Senitko M, George M : Inaccuracy of Tl-201 brain SPECT in distinguishing cerebral infections from lymphoma in patients with AIDS. Clin Nucl Med 27 (2) : 81-86, 2002
PubMed
155. Westwood TD, Hogan C, Julyan PJ, et al. : Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIVinfected patients. Eur J Radiol 82 (8) : e374-379, 2013
PubMed
156. Camacho DL, Smith JK, Castillo M : Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 24 (4) : 633-637, 2003
PubMed
157. Schroeder PC, Post MJ, Oschatz E, et al. : Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 48 (10) : 715-720, 2006
PubMed
158. Baumgartner JE, Rachlin JR, Beckstead JH, et al. : natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73 (2) : 206-211, 1990 9. Nagai H, Odawara T, Ajisawa A, et al. : Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era. Eur J Haematol 84 (6) : 499-505, 2010
 
159. Reyes CV, Huang M : Radiation-induced primary malignant lymphoma of the brain. Consultant 360 Clinical Geriatrics 14 (9) : September, 2006 (http://www.consultant360.com/archive-cg)
 
160. 特定非営利活動法人 日本脳腫瘍学会編集 : 脳腫瘍診療ガイドライン 1. 金原出版株式会社, pp.133, 東京, 2016
 

第14章 髄膜腫

P.600 掲載の参考文献
1. Kepes JJ : Meningiomas. Biology, Pathology, and Differntial Diagnosis. Masson Publishing USA, 1982
 
2. Dolecek TA, Dressler EV, Thakkar JP, et al. : Epidemiology of meningiomas post-Public Law 107-206 : The Benign Brain Tumor Cancer Registries Amendment Act. Cancer 121 (14) : 2400-2410, 2015
PubMed
3. MacCarty CS, Taylor WF : Intracranial meningiomas : experiences at the Mayo Clinic. Neurol Med Chir (Tokyo) 19 : 569-574, 1979
 
4. Jellinger K : Histological subtypes and prognostic problems in meningiomas. J Neurol 208 : 279-298, 1975
PubMed
5. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J : Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31 : 2-12, 1992
PubMed
6. Locatelli D, Bottoni A, Uggetti C, Gozzoli L : Multiple meningiomas evaluated by computed tomography. Neurochirurgia (Stuttg) 30 (1) : 8-10, 1987
PubMed
7. Domenicucci M, Santoro A, D'Osvaldo DH, et al. : Multiple intracranial meningiomas. J Neurosurg 70 (1) : 41-44, 1989
PubMed
8. Larson JJ, Tew JM Jr, Simon M, Menon AG : Evidence for clonal spread in the development of multiple meningiomas. J Neurosurg 83 (4) : 705-709, 1995
PubMed
9. Herz DA, Shapiro K, SChulamn K : Intracranial meningiomas of infancy, childhood and adolescence. Review of the literature and addition of 9 case reports. Child's Brain 7 : 43-56, 1980
 
10. Menon G, Nair S, Sudhir J, et al.: Childhood and adolescent meningiomas : a report of 38 cases and review of literature. Acta Neurochir (Wien) 151 (3) : 239-244, 2009
PubMed
11. Kotecha RS, Pascoe EM, Rushing EJ, et al. : Meningiomas in children and adolescents : a metaanalysis of individual patient data. Lancet Oncol 12 (13) : 1229-1239, 2011
PubMed
12. Drake JM, Hendrick EB, Becker LE, et al. : Intracranial meningiomas in children. Pediat Neurosci 12 : 134-139, 1985
 
13. Deen HGJr, Scheithauer BW, Ebersold MJ : Clinical & pathological study of meningiomas of the first two decades of life. J Neurosurg 56 : 317-322, 1982
 
14. Germano IM, Edwards MSB, Davis RL, Schiffer D : Intracranial meningiomas of the first two decades of life. J Neurosurg 80 : 447-453, 1994
 
15. Wofford JL, Moran WP, Wilson TA, Velez R. : Clinical presentation of meningioma in the elderly. J Am Geriatr Soc 41 (2) : 122-126, 1993
PubMed
16. Brokinkel B, Holling M, Spille DC, et al. : Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients. J Neurosurg Jun 3 : 1-11, 2016 [Epub ahead of print], 2016
 
17. Nishizaki T, Kamiryo T, Fujisawa H, et al. : Prognostic implicatins of meningiomas in the elderly (over 70 years old) in the era of magnetic resonance imaging. Acta Neurochir 126 : 59-62, 1994
PubMed
18. Cornu P, Chatellier G, Dagreou F, et al. : Intracranial meningiomas in elderly patients. Postoperative morbidity and mortality. Factors predictive of outcome. Acta Neurochir (Wien) 102 (3-4) : 98-102, 1990
 
19. Poon MT, Fung LH, Pu JK, Leung GK : Outcome of elderly patients undergoing intracranial meningioma resection--a systematic review and meta-analysis. Br J Neurosurg 28 (3) : 303-309, 2014
PubMed
20. Poon MT, Fung LH, Pu JK, Leung GK : Outcome comparison between younger and older patients undergoing intracranial meningioma resections. J Neurooncol 114 (2) : 219-227, 2013
PubMed
21. Patil CG, Veeravagu A, Lad SP, Boakye M : Craniotomy for resection of meningioma in the elderly : a multicentre, prospective analysis from the National Surgical Quality Improvement Program. J Neurol Neurosurg Psychiatry 81 (5) : 502-505, 2010
 
22. Cohen-Inbar O, Sviri GE, Soustiel JF, Zaaroor M : The Geriatric Scoring System (GSS) in meningioma patients--validation. Acta Neurochir (Wien) 153 (7) : 1501-1508, 2011
PubMed
23. Giombini S, Solero CL, Morello G : Late outcome of operations for supratentorial convexity meningiomas. Report on 207 cases. Surg Neurol 22 : 588-594, 1984
PubMed
24. Alvernia JE, Dang ND, Sindou MP : Convexity meningiomas : study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients. J Neurosurg 115 (3) : 491-498, 2011
 
25. Hasseleid BF, Meling TR, Ronning P, et al. : Surgery for convexity meningioma: Simpson Grade I resection as the goal : clinical article. J Neurosurg 117 (6) : 999-1006, 2012
 
26. Sanai N, Sughrue ME, Shangari G, et al. : Risk profile associated with convexity meningioma resection in the modern neurosurgical era. J Neurosurg 112 (5) : 913-919, 2019
 
27. Sughrue ME, Rutkowski MJ, Shangari G, et al. : Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article. J Neurosurg 114 (3) : 731-737, 2011
PubMed
28. Sindou MP, Alvernia JE : Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses. J Neurosurg 105 (4) : 514-525, 2006
PubMed
29. Raza SM, Gallia GL, Brem H, et al. : Perioperative and long-term outcomes from the management of parasagittal meningiomas invading the superior sagittal sinus. Neurosurgery 67 (4) : 885-893, 2010
PubMed
30. Giombini S, Soleno CL, Lasio G, Morello G : Immediate and late outcome of operations for parasagittal and falx meningiomas. Report of 342 cases. Surg Neurol 21 : 427-435, 1984
 
31. Chung SB, Kim CY, Park CK, et al. : Falx meningiomas: surgical results and lessons learned from 68 cases. J Korean Neurosurg Soc 42 (4) : 276-280, 2007
 
32. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J : Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31 : 2-12, 1992
PubMed
33. Bonnal J, Thibaut A, Brotchi J, Born J : Invading meningiomas of the sphenoid ridge. J Neurosurg 53 : 587-599, 1980
 
34. Mirone G, Chibbaro S, Schiabello L, et al. : En plaque sphenoid wing meningiomas: recurrence factors and surgical strategy in a series of 71 patients. Neurosurgery 65 (6 Suppl) : 100-1008, 2009
 
35. Kotapka M, Kalia KK, Martinez AJ, Sekhar LN : Infiltratin of the carotid artery by cavernous sinus meningioma. J Neurosurg 81 : 252-255, 1994
 
36. Sughrue ME, Rutkowski MJ, Chen CJ, et al. : Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg 119 (1) : 86-93, 2013
PubMed
37. Rubin G, David UB, Gornish M, Rappaport ZH : Meningiomas of the anterior cranial fossa floor. Review of 67 cases. Acta Neurochir (Wien) 129 : 26-30, 1994
 
38. Fahlbusch R, Schott W : Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale : surgical results with special consideration of ophthalmological and endocrinological outcomes. J Neurosurg 96 (2) : 235-243, 2002
PubMed
39. Hentschel SJ, DeMonte F : Olfactory groove meningiomas. Neurosurg Focus 14 (6) : e4, 2003
PubMed
40. Solero CL, Giombini S, Morello G : Suprasellar and olfactory meningiomas. Report on a series of 153 personal cases. Acta Neurochir 67 : 181-194, 1983
PubMed
41. Pallini R, Fernandez E, Lauretti L, et al. : Olfactory groove meningioma: report of 99 cases surgically treated at the Catholic University School of Medicine, Rome. World Neurosurg 83 (2) : 219-231. e1-3, 2015
 
42. Mirimanoff RO, Dosoretz DE, Linggood RM, et al. : Meningioma : analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62 : 18-24, 1985
PubMed
43. Pepper JP, Hecht SL, Gebarski SS, et al. : Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach. Laryngoscope 121 (11) : 2282-2289, 2011
PubMed
44. Mukherjee S, Thakur B, Corns R, et al. : Resection of olfactory groove meningioma - a review of complications and prognostic factors. Br J Neurosurg 29 (5) : 685-692, 2015
PubMed
45. Sekhar LN, Jannetta PJ, Maroon JC : Tentorial meningiomas : surgical management and results. Neurosurgery 14 : 268-275, 1984
PubMed
46. Gokalp HZ, Arasil E, Erdogan A, et al. : Tentrorial meninigomas. Neurosurgery 36 : 46-51, 1995
 
47. Guidetti B, Ciappetta P, Domenicucci M : Tentorial meningiomas : surgical experience with 61 cases and long-term results. J Neurosurg 69 (2) : 183-187, 1988
PubMed
48. Bassiouni H, Hunold A, Asgari S, Stolke D : Tentorial meningiomas: clinical results in 81 patients treated microsurgically. Neurosurgery 55 (1) : 108-116, 2004
PubMed
49. Samii M, Klekamp J, Carvalho G : Surgical results for meningiomas of the craniocervical junction. Neurosurgery 39 (6) : 1086-1094, 1996
PubMed
50. Kane AJ, Sughrue ME, Rutkowski MJ, et al. : Clinical and surgical considerations for cerebellopontine angle meningiomas. J Clin Neurosci 18 (6) : 755-759, 2011
PubMed
51. Sekhar LN, Jannetta PJ : Cerebellopontine angle meningiomas. Microsurgical excision and followup results. J Neurosurg 60 (3) : 500-505, 1984
 
52. Martuza RL, Parker SW, Ojemann RG, Montgomery WW : Cerebellopontine angle meningiomas : clinical manifestations and diagnosis. Ann Otol Rhinol Laryngol 94 : 34-38, 1985
PubMed
53. Peyre M, Bozorg-Grayeli A, Rey A, et al. : Posterior petrous bone meningiomas : surgical experience in 53 patients and literature review. Neurosurg Rev 35 (1) : 53-66, 2012
PubMed
54. Agarwal V, Babu R, Grier J, et al. : Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort. Neurosurg Focus 35 (6) : E10, 2013
 
55. Menon G, Nair S, Sudhir J, et al. : Meningiomas of the lateral ventricle - a report of 15 cases. Br J Neurosurg 23 (3) : 297-303, 2009
PubMed
56. Fornari M, Savoiardo M, Morello G, Solero CL : Meningiomas of the lateral ventricles. Neuroradiological and surgical considerations in 18 cases. J Neurosurg 54 : 64-74, 1981
 
57. Guidetti B, Delfini R, Gagliardi FM, Vagnozzi R: Meningiomas of the lateral ventricles Clinical, Neuroradiologic, and surgical considerations in 19 cases. Surg Neurol 24 : 364-370, 1985
 
58. Cabezudo JM, Vaquero J, Garcia-de-Sola R, et al. : Meningioma of the anterior part of the third ventricle. Acta Neurochir (Wien) 56 (3-4) : 219-231, 1981
 
59. Lozier AP, Bruce JN: Meningiomas of the velum interpositum : surgical considerations. Neurosurg Focus 15 (1) : E11, 2003
PubMed
60. Kasliwal MK, Srinivas M, Vaishya S, et al. : Posterior third ventricular meningioma masquerading a pineal tumour. J Neurooncol 78 (1) : 103-104, 2006
PubMed
61. Almefty R, Dunn IF, Pravdenkova S, et al. : True petroclival meningiomas: results of surgical management. J Neurosurg 120 (1) : 40-51, 2014
PubMed
62. Li D, Hao SY, Wang L, et al. : Surgical management and outcomes of petroclival meningiomas : a single-center case series of 259 patients. Acta Neurochir (Wien) 155 (8) : 1367-1383, 2013
 
63. Nanda A, Javalkar V, Banerjee AD : Petroclival meningiomas : study on outcomes, complications and recurrence rates. J Neurosurg 114 (5) : 1268-1277, 2011
 
64. Yasuoka S, Okazaki H, Daube JR, MacCarty CS : Foramen magnum tumors : analysis of 57 cases of benign extramedullary tumors. J Neurosurg 49 : 828-838, 1978
PubMed
65. Knosp E, Perneczky A, Koos WT, et al. : Meningiomas of the space of the cavernous sinus. Neurosurgery 38 (3) : 434-442, 1996
PubMed
66. Demonte F, Smith HK, Al-Mefty O : Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81 : 245-251, 1994
PubMed
67. Sindou MP, Alvernia JE : Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses. J Neurosurg 105 (4) : 514-525, 2006
PubMed
68. Sughrue ME, Rutkowski MJ, Aranda D, et al. : Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 113 (5) : 1087-1092, 2010
PubMed
69. Clark WC, Theofilos CS, Fleming JC : Primary optic nerve sheath meningiomas. Report of nine cases. J Neurosurg 70 : 37-40, 1989
 
70. Hendrix LE, Kneeland JB, Haughton VM, et al. : MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique. AJR Am J Roentgenol 155 (4) : 849-854, 1990
PubMed
71. Turbin RE, Thompson CR, Kennerdell JS, et al. : A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 109(5) : 890-899, 2002
PubMed
72. Berman D, Miller NR : New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore 35 (3) : 168-174, 2006
PubMed
73. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J : Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31 : 2-12, 1992
PubMed
74. Schorner W, Schubeus P, Henkes H, et al. : "Meningeal sign" : a characteristic findings of meningioma on contrast-enhancement. Neuroradiology 32 : 90-93, 1990
PubMed
75. Schubeus P, Schorner W, Rottacker C, Sander B : Intracranial meningiomas: How frequent are indicative findings in CT and MRI?. Neuroradiolgy 32 : 467-473, 1990
 
76. Nakasu S, Nakasu Y, Matsumura K, et al. : Interface between the meningioma and the brain on magnetic resonance imaging. Surg Neurol 33 (2) : 105-116, 1990
PubMed
77. Nakasu S, Hirano A, Shimura T, Llena J : Incidental meningioma in autopsy study. Surg Neurol 27 : 319-322, 1987
PubMed
78. Hashiba T, Hashimoto N, Izumoto S, et al. : Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110 (4) : 675-684, 2009
PubMed
79. Nakasu S, Nakasu Y, Fukami T, et al. : Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol. 102 (2) : 303-310, 2011
PubMed
80. Jaaskelainen J, Haltia M, Laasonen E, et al. : The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24 : 165-172, 1985
PubMed
81. Ide M, Jimbo M, Yamamoto M, et al. : Growth rate of intracranial meningioma : tumor doubling time and proliferating cell nuclear antigen staining index. Neurol Med Chir (Tokyo) 35 (5) : 289-293, 1995
PubMed
82. Nakasu S, Nakasu Y, Nakajima M, Y et al. : Potential doubling time and tumour doubling time in meningiomas and neurinomas. Acta Neurochir (Wien) 138 (6) : 763-770, 1996
 
83. Nakaguchi H, Fujimaki T, Matsuno A, et al. : Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85 (10) : 2249-2254, 1999
PubMed
84. Kakinuma K, Tanaka R, Onda K, Takahashi H : Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time. Acta Neurochir (Wien) 140 (1) : 26-31 1998
PubMed
85. Nakamura M, Roser F, Michel J, et al. : The natural history of incidental meningiomas. Neurosurgery 53 (1) : 62-70, 2003
PubMed
86. Go RS, Taylor BV, Kimmel DW : The natural history of asymptomatic meningiomas in Olmsted Country, Ninnesota. Neurology 51 : 1718-1720, 1998
 
87. Kuratsu J, Kochi M, Ushio Y : Incidence and clinical features of asymptomatic meningioma. J Neurosurg 92 : 766-770, 2000
PubMed
88. Hashimoto N, Rabo CS, Okita Y, et al. : Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 116 (3) : 574-580, 2012
PubMed
89. Olivero WC, Lister JR, Elwood PW : The natural history and growth rate of asymptomatic meningiomas : a review of 60 patients. J Neurosurg 83 : 222-224, 1995
PubMed
90. Yoneoka Y, Fuii Y, Tanaka R : Growth of incidental meningioma. Acta Neurochir (Wien) 142 : 507-511, 2000
 
91. Niiro M, Yatsushiro K, Nakamura K, et al. : Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiat 68 : 25-28, 2000
PubMed
92. Black P, Kathiresan S, Chung W : Meningioma surgery in the elderly: a case-control study assessing morbidity and mortality. Acta Neurochir (Wien) 140 : 1013-1017, 1998
PubMed
93. Sughrue ME, Rutkowski MJ, Shangari G, et al. : Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients. J Clin Neurosci 18 (5) : 628-632, 2011
PubMed
94. Simpson D : The recurrence of intracranial meningiomas atter surgical treatment. J Neurol Neurosurg Psychiat 20 : 22-39, 1957
 
95. Oya S, Kawai K, Nakatomi H, Saito N : Significance of Simpson grading system in modern meningioma surgery : integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 117 (1) : 121-128, 2012
 
96. Heald JB, Carroll TA, Mair RJ : Simpson grade: an opportunity to reassess the need for complete resection of meningiomas. Acta Neurochir (Wien). 2014 Feb ; 156 (2) : 383-388, 2014
PubMed
97. Sughrue ME, Kane AJ, Shangari G, et al. : The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg. 2010 Nov ; 113 (5) : 1029-1035, 2010
 
98. Skullerud K, Loken AC : The prognosis in meningioma. Acta Neuropatho (Berl) 29 : 337-344, 1974
 
99. Jaaskelainen J : Seemingly complete removal of histologically benign intracranial meningioma : late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26 : 461-469, 1986
PubMed
100. Borovich B, Doron Y: Recurrence of intracranial meningiomas : the role played by regional multicentricity. J Neurosurg 64 : 58-63, 1986
PubMed
101. Borovich B, Doron Y, Braun J, et al. : Recurrence of intracranial meningiomas: the role played by regional multicentricity Part 2 : Clinical and radiological aspects. J Neurosurg 65 : 168-171, 1986
PubMed
102. Mahmood A, Qureshi NH, Malik GM : Intracranial meningiomas : analysis of recurrence after surgical treatment. Acta Neurochir (Wien) 126 : 53-58, 1994
PubMed
103. Jaaskelainen J, Haltia M, Servo A : Atypical and anaplastic meningiomas : radiology, surgery, radiotherapy, and outcome. Surg Neurol 25 : 233-242, 1986
PubMed
104. Randle JM, Salcman M, Corradino G, et al. : Histological and clinical characteristics of recurrent meningiomas. Neurosurgery 21 : 121, 1987
 
105. Nakasu S, Hirano A, Llena JF, et al. : Interface between the meningioma and the brain. Surg Neurol 32 : 206-212, 1989
PubMed
106. Sindou M, Alaywan M : Role of pia matter vascularization of the tumor in the surgical outcome of intracranial meningiomas. Acta Neurochir (Wien) 130 : 90-93, 1994
 
107. Salpietro FM, Alafaci C, Lucerna S, et al. : Peritumoral edema in meningiomas : Microsurgical observations of different brain tumor interfaces related to computed tomography. Neurosurgery 35 : 638-642, 1994
PubMed
108. Sindou MP, Alaywan M : Most intracranial meningiomas are not cleavable tumors: anatomicsurgical evidence and angiographic predictibility. Neurosurgery 42 (3) : 476-480, 1998
 
109. Spille DC, Hes K, Sauerland C, et al. : Brain Invasion in meningiomas : Incidence and correlations with clinical variables and prognosis. World Neurosurg S1878-8750 (16) 30440-30445, 2016
 
110. Barbaro NM, Gutin PH, Wilson CB, et al. : Radiation therapy in the treatment of partially tesected meningiomas. Neurosurgery 20 : 525-528, 1987
PubMed
111. Goldsmith BJ, Wara WM, Wilson CB, Larson DA : Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80 : 195-201, 1994
PubMed
112. Miralbell R, Linggood RM, dela Monte S, et al. : The role of radiotherapy in the treatment of subtotally resected benign meningiomas. M Neuro-Oncol 13 : 157-164, 1992
 
113. Rosenberg LA, Prayson RA, Lee J, et al. : Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74 (2) : 427-432, 2009
 
114. Simon M, Bostrom J, Koch P, Schramm J : Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany : impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77 (6) : 767-773, 2006
PubMed
115. Choy W, Ampie L, Lamano JB, et al. : Predictors of recurrence in the management of chordoid meningioma. J Neurooncol 126 (1) : 107-116, 2016
PubMed
116. Yang Y, Li D, Cao XY, et al. : Clinical features, treatment, and prognostic factors of chordoid meningioma : radiological and pathological features in 60 cases of chordoid meningioma. World Neurosurg 93 : 198-207, 2016
 
117. Jee TK, Jo KI, Seol HJ, et al. : Clinical features and treatment outcome of chordoid meningiomas in a single institute. J Korean Neurosurg Soc 56 (3) : 194-199, 2014
 
118. Li P, Yang Z, Wang Z, et al. : Clinical features of clear cell meningioma: a retrospective study of Smith MJ, Wallace AJ, Bennett C, et al. : Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol 234 (4) : 436-440, 2014
 
120. Sun SQ, Hawasli AH, Huang J, Chicoine MR, Kim AH : An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus 38 (3) : E3, 2015
PubMed
121. Yang SY, Park CK, Park SH, et al. : Atypical and anaplastic meningiomas : prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79 (5) : 574-580, 2008
PubMed
122. Mair R, Morris K, Scott I, Carroll TA : J Neurosurg 115 (4) : 811-819. Radiotherapy for atypical meningiomas, 2011
PubMed
123. Lee KD, DePowell JJ, Air EL, et al. : Atypical meningiomas : is postoperative radiotherapy indicated?. Neurosurg Focus 35 (6) : E15, 2013
PubMed
124. Park HJ, Kang HC, Kim IH, et al. : The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115 (2) : 241-247, 2013
PubMed
125. Hardesty DA, Wolf AB, Brachman DG, et al. : The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119 (2) : 475-481, 2013
PubMed
126. Choi Y, Lim DH, Jo K, Nam DH, et al. : Efficacy of postoperative radiotherapy for high grade meningiomas. J Neurooncol 119 (2) : 405-412, 2014
 
127. Hammouche S, Clark S, Wong AH, et al. : Long-term survival analysis of atypical meningiomas : survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir (Wien) 156 (8) : 1475-1481, 2014
PubMed
128. Zhao P, Hu M, Zhao M, et al. : Prognostic factors for patients with atypical or malignant meningiomas treated at a single center. Neurosurg Rev 38 (1) : 101-107, 2015
PubMed
129. Sun SQ, Kim AH, Cai C, et al. : Management of atypical cranial meningiomas, part 1 : predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75 (4) : 347-354, 2014
PubMed
130. Sun SQ, Cai C, Murphy RK, et al. : Management of atypical cranial meningiomas, part 2 : predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 75 (4) : 356-363, 2014
PubMed
131. Wang YC, Chuang CC, Wei KC, et al. : Skull base atypical meningioma : long term surgical outcome and prognostic factors. Clin Neurol Neurosurg 128 : 112-116, 2015
PubMed
132. Aghi MK, Carter BS, Cosgrove GR, et al. : Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64 (1) : 56-60, 2009
PubMed
133. Jo K, Park HJ, Nam DH, et al. : Treatment of atypical meningioma. J Clin Neurosci 17 (11) : 1362-136, 2010
PubMed
134. Komotar RJ, Iorgulescu JB, Raper DM, et al. : The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg 117 (4) : 679-686, 2012
PubMed
135. Aizer AA, Arvold ND, Catalano P, et al. : Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol 16 (11) : 1547-1553, 2014
PubMed
136. Harris AE, Lee JY, Omalu B, et al. : The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 60 (4) : 298-305, 2003
PubMed
137. Mattozo CA, De Salles AA, Klement IA, et al. : Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg 106 (5) : 846-854 2007
PubMed
138. Kano H, Takahashi JA, Katsuki T, et al. : Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84 (1) : 41-47, 2007
PubMed
139. Attia A, Chan MD, Mott RT, et al. : Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery. J Neurooncol 108 (1) : 179-185, 2012
PubMed
140. Hanakita S, Koga T, Igaki H, et al. : Role of gamma knife surgery for intracranial atypical (WHO grade II) meningiomas. J Neurosurg 119 (6) : 1410-1414, 2013
PubMed
141. Pasquier B, Gasnier F, Pasquier D, et al. : Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer 58 : 299-305, 1986
PubMed
142. Ludwin Sk, Rubinstein LJ, Russell DS : Papillary meningioma : a malignant variant of meningioma. Cancer 36 : 1363-1373, 1975
PubMed
143. Deen HGJr, Scheithauer BW, Ebersold MJ : Clinical & pathological study of meningiomas of the first two decades of life. J Neurosurg 56 : 317-322, 1982
 
144. Wang DJ, Zheng MZ, Gong Y, et al. : Papillary meningioma: clinical and histopathological observations. Int J Clin Exp Pathol 6 (5) : 878-888, 2013
PubMed
145. Wang XQ, Chen H, Zhao L, et al. : Intracranial papillary meningioma : a clinicopathologic study of 30 cases at a single institution. Neurosurgery 73 (5) : 777-790, 2013
 
146. Kepes JJ, Moral LA, Wilkinson SB, et al. : Rhabdoid transformation of tumor cells in meningiomas : a histologic indication of increased proliferative activity : report of four cases. Am J Surg Pathol 22 (2) : 231-238, 1998
PubMed
147. Perry A, Scheithauer BW, Stafford SL, et al. : "Rhabdoid" meningioma : an aggressive variant. Am J Surg Pathol 22 (12) : 1482-190, 1998
PubMed
148. Kim JK, Jung TY, Jung S, et al. : Meningiomas with rhabdoid or papillary components : prognosis and comparison with anaplastic meningiomas. J Korean Neurosurg Soc 59 (4) : 357-362, 2016
PubMed
149. Durand A, Labrousse F, Jouvet A, et al. : WHO grade II and III meningiomas : a study of prognostic factors. J Neurooncol 95 (3) : 367-375, 2009
PubMed
150. Sughrue ME, Sanai N, Shangari G, et al. : Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg 113 (2) : 202-209, 2010
PubMed
151. Adeberg S, Hartmann C, Welzel T, et al. : Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83 (3) : 859-864, 2012
 
152. Pollock BE, Stafford SL, Link MJ, et al. : Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas : treatment results on the basis of a 22-year experience. Cancer 118 (4) : 1048-1054, 2012
PubMed
153. Zhao P, Hu M, Zhao M, et al. : Prognostic factors for patients with atypical or malignant meningiomas treated at a single center. Neurosurg Rev 38 (1) : 101-107, 2015
PubMed
154. 川原信隆: 髄膜腫Update-分子病態から薬物療法へ-．No Shinkei Geka 44 (5) : 415-430, 2016
 
155. Choy W, Kim W, Nagasawa D, et al. : The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus 30 (5) : E6, 2011
PubMed
156. Riemenschneider MJ, Perry A, Reifenberger G : Histological classification and molecular genetics of meningiomas. Lancet Neurol 5 (12) : 1045-1054, 2006
PubMed
157. Rousseau G, Noguchi T, Bourdon V, et al. : SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC11 : 9, 2011
PubMed
158. Bacci C, Sestini R, Provenzano A, et al. : Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 11 (1) : 73-80, 2010
PubMed
159. Hadfield KD, Smith MJ, Trump D, et al. : SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet 47 (8) : 567-568, 2010
PubMed
160. Smith MJ, O'Sullivan J, Bhaskar SS, et al. : Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet 45 (3) : 295-298, 2013
PubMed
161. Smith MJ, Wallace AJ, Bennett C, et al. : Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol 234 (4) : 436-440, 2014
PubMed
162. Brastianos PK, Horowitz PM, Santagata S, et al. : Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45 (3) : 285-289, 2013
PubMed
163. Clark VE, Erson-Omay EZ, Serin A, et al. : Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339 (6123) : 1077-1080, 2013
 
164. Domingues P, Gonzalez-Tablas M, Otero A, et al. : Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Oncotarget 6 (13) : 10671-10688, 2016
 
165. Goutagny S, Nault JC, Mallet M, et al. : High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24 (2) : 184-189, 2014
PubMed
166. Bostrom J, Meyer-Puttlitz B, Wolter M, et al. : Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159 (2) : 661-669, 2001
PubMed
167. Lekanne Deprez RH, Riegman PH, et al. : Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10 (8) : 1521-1528, 1995
 
168. Zhang X, Jia H, Lu Y, et al. : Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Discov Med 18 (101) : 301-311, 2014
 

第15章 間葉系腫瘍 ( 髄膜腫を除く )

P.614 掲載の参考文献
1. Woodward ER, Wall K, Forsyth J, et al. : VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Brain 130 (Pt 3) : 836-842, 2007
 
2. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH : The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98 (1) : 82-94, 2003
PubMed
3. Jagannathan J, Lonser RR, Smith R, et al. : Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 108 (2) : 210-222, 2008
PubMed
4. Seeger JF, Burke DP, Knake JE, Gabrielsen TO : Computed tomographic and angiographic evaluation of hemangioblastomas. Radiology 138 (1) : 65-73, 1981
PubMed
5. 執印太郎編 : フォン・ヒッペル・リンドウ (VHL) 病 診療ガイドライン, 46頁, 中外医学社, 東京, 2011年
 
6. Ammerman JM, Lonser RR, Dambrosia J, et al. : Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease : implications for treatment. J Neurosurg 105 (2) : 248-255, 2006
PubMed
7. Ampie L, Choy W, Lamano JB, et al. : Safety and outcomes of preoperative embolization of intracranial hemangioblastomas : A systematic review. Clin Neurol Neurosurg 150 : 143-151, 2016
PubMed
8. Weil RJ, Lonser RR, DeVroom HL, et al. : Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98 (1) : 95-105, 2003
PubMed
9. Conway JE, Chou D, Clatterbuck RE, et al. : Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48 (1) : 55-62, 2001
PubMed
10. Lee GJ, Jung TY, Kim IY, et al. : The clinical experience of recurrent central nervous system hemangioblastomas. Clin Neurol Neurosurg 123 : 90-95, 2014
PubMed
11. Hanakita S, Koga T, Shin M, et al. : The long-term outcomes of radiosurgery for intracranial hemangioblastomas. Neuro Oncol 16 (3) : 429-433, 2014
 
12. Kano H, Shuto T, Iwai Y, et al. : Stereotactic radiosurgery for intracranial hemangioblastomas : a retrospective international outcome study. J Neurosurg 122 (6) : 1469-1478, 2015
PubMed
P.618 掲載の参考文献
1. Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, et al. : Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45 (2) : 180-185, 2013
PubMed
2. Chmielecki J, Crago AM, Rosenberg M, et al. : Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45 (2) : 131-132, 2013
PubMed
3. Goellner JR, Laws ER Jr, Soule EH, Okazaki H : Hemangiopericytoma of the meninges. Mayo Clinic experience. Am J Clin Pathol 70 (3) : 375-380, 1978
 
4. Jaaskelainen J, Servo A, Haltia M, et al. : Intracranial hemangiopericytoma : radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol 23 (3) : 227-236, 1985
PubMed
5. Dufour H, Metellus P, Fuentes S, et al. : a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery 48 (4) : 756-762, 2001
 
6. Alen JF, Lobato RD, Gomez PA, et al. : Acta Neurochir (Wien) 143 (6) : 575-586. Intracranial hemangiopericytoma : study of 12 cases, 2001
PubMed
7. Kim JH, Jung HW, Kim YS, et al. : Meningeal hemangiopericytomas : long-term outcome and biological behavior. Surg Neurol 59 (1) : 47-53, 2003
PubMed
8. Ecker RD, Marsh WR, Pollock BE, et al. : Hemangiopericytoma in the central nervous system : treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg 98 (6) : 1182-1187, 2003
PubMed
9. Soyuer S, Chang EL, Selek U, et al. : Intracranial meningeal hemangiopericytoma: the role of radiotherapy : report of 29 cases and review of the literature. Cancer 100 (7) : 1491-1497, 2004
PubMed
10. Payne BR, Prasad D, Steiner M, Steiner L : Gamma surgery for hemangiopericytomas. Acta Neurochir (Wien) 142 (5) : 527-536, 2000
PubMed
11. Fountas KN, Kapsalaki E, Kassam M, et al. : Management of intracranial meningeal hemangiopericytomas : outcome and experience. Neurosurg Rev 29 (2) : 145-53, 2006
PubMed
P.624 掲載の参考文献
1. Sarwar M, McCormick WF : Intracerebral venous angioma. Case report and review. Arch Neurol 35 : 323-325, 1978
PubMed
2. Garner TB, Curling OD, Kelly DLJr., Laster EW : The natural history of intracranial venous angiomas. J Neurosurg 75 : 715-722, 1991
 
3. Simard JM, Garcia-Bengochea F, Ballinger WE, et al. : Cavernous angioma : a review of 126 collected and 12 new clinical cases. Neurosurgery 18 : 162-172, 1986
PubMed
4. Yamasaki T, Handa H, Yamashita J, et al. : Intracranial and orbital cavernous angiomas. A review of 30 cases. J Neurosurg 64 : 197-208, 1986
 
5. Gross BA, Lin N, Du R, Day AL : The natural history of intracranial cavernous malformations. Neurosurg Focus 30 (6) : E24, 2011
PubMed
6. Linskey ME, Sekhar LN : Cavernous sinus hemangiomas : a series, a review, and an hypothesis. Neurosurgery 30 : 101-107, 1992
 
7. Robinson JR, Awad IA, Little JR : Natural history of the cavernous angioma. J Neurosurg 75 : 709-714, 1991
PubMed
8. del Curling ODJr., Kelly DLJr., Elster AD, Craven TE : An analysis of the natural history of cavernous angiomas. J Neurosurg 75 : 702-708, 1991
PubMed
9. Scott RM, Barnes P, Kupsky W, Adelman LS : Cavernous angiomas of the central nervous system in children. J Neurosurg 76 : 38-46, 1992
 
10. Barker CS : Magnetic resonance imaging of intracranial cavernous angiomas : a report of 13 cases with pathological confirmation. Clin Radiol 48 (2) : 117-121, 1993
PubMed
11. Amin-Hanjani S, Ogilvy CS : Overall surgical results of occult vascular malformations. Neurosurg Clin N Am 10 (3) : 475-483, 1999
PubMed
12. Gross BA, Batjer HH, Awad IA, Bendok BR : Brainstem cavernous malformations. Neurosurgery 64 (5) : E805-818, 2009
PubMed
13. Lombardi D, Giovanelli M, de Tribolet N : Sellar and parasellar extra-axial cavernous hemangiomas. Acta Neurochir (Wien) 130 : 47-54, 1994
PubMed
14. Shibata S, Mori K : Effect of radiation therapy on extra-cerebral cavernous hemangioma in the middle fossa. Report of three cases. J Neurosurg 67 : 919-922, 1987
 
15. Wang X, Liu X, Mei G, et al. : Phase II study to assess the efficacy of hypofractionated stereotactic radiotherapy in patients with large cavernous sinus hemangiomas. Int J Radiat Oncol Biol Phys 83 (2) : e223-230, 2012
 
16. Meyer FB, Lombardi D, Scheithauer B, Nichols DA : Extra-axial cavernous hemangiomas involving the dural sinuses. J Neurosurg 73 (2) : 187-192, 1990
PubMed
17. Harris GJ, Jakobiec FA. : Cavernous hemangioma of the orbit. J Neurosurg 51 : 219-228, 1979
PubMed
18. Missori P, Tarantino R, Delfini R, et al. : Surgical management of orbital cavernous angiomas : prognosis for visual function after removal. Neurosurgery 35 : 34-38, 1994
PubMed
19. Garner TB, Curling OD, Kelly DLJr., Laster EW. : The natural history of intracranial venous angiomas. J Neursurg 75 : 715-722, 1991
 
20. Sarwar M, McCormick WF. : Intracerebral venous angioma. Case report and review. Arch Neurol 35 : 323-325, 1978
PubMed
21. Malik GM, Morgan JK, Boulos RS, Ausman JI : Venous angiomas : an underestimated cause of intracranial hemorrhage. Sug Neurol 30 : 350-358, 1988
 
22. Biller J, Toffol GJ, Shea JF, et al. : Cerebellar venous angiomas. A continuing controversy. Arch Neurol 42 : 367-370, 1985
PubMed
P.628 掲載の参考文献
1. Jones HM : Cartilaginous tumours of the head and neck. J Laryngol Otol 87 (2) : 135-151, 1973
PubMed
2. Cianfriglia F, Pompili A, Occhipinti E : Intracranial malignant cartilaginous tumours. Report of two cases and review of literature. Acta Neurochir (Wien) 45 (1-2) : 163-175, 1978
 
3. Grossman RI, Davis KR : Cranial computed tomographic appearance of chondrosarcoma of the base of the skull. Radiology 141 (2) : 403-408, 1981
PubMed
4. Seidman MD, Nichols RD, Raju UB, et al : Extracranial skull base chondrosarcoma. Ear Nose Throat J 68 (8) : 626-632, 1989
PubMed
5. Arlen M, Tollefsen HR, Huvos AG, Marcove RC : Chondrosarcoma of the head and neck. Am J Surg 120 (4) : 456-460, 1970
PubMed
6. Bohman LE, Koch M, Bailey RL, et al : Skull base chordoma and chondrosarcoma : influence of clinical and demographic factors on prognosis : a SEER analysis. World Neurosurg 82 (5) : 806-814, 2014
PubMed
7. Evans HL, Ayala AG, Romsdahl MM : Prognostic factors in chondrosarcoma of bone : a clinicopathologic analysis with emphasis on histologic grading. Cancer 40 (2) : 818-831, 1977
 
8. Muller U, Kubik-Huch RA, Ares C, et al : Is there a role for conventional MRI and MR diffusionweighted imaging for distinction of skull base chordoma and chondrosarcoma?. Acta Radiol 57 (2) : 225-232, 2016
 
9. Yeom KW1, Lober RM, Mobley BC, et al : Diffusion-weighted MRI : distinction of skull base chordoma from chondrosarcoma. AJNR Am J Neuroradiol 34 (5) : 1056-1061, 2013
 
10. Noel G, Feuvret L, Ferrand R, et al : Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery 55 (6) : 1252-1260, 2004
PubMed
11. Tzortzidis F, Elahi F, Wright DC, et al : Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas. Neurosurgery 58 (6) : 1090-1098, 2006
PubMed
12. Coltrera MD, Googe PB, Harrist TJ, et al : Chondrosarcoma of the temporal bone. Diagnosis and treatment of 13 cases and review of the literature. Cancer 58 (12) : 2689-2696, 1986
PubMed
13. Noel G, Gondi V : Proton therapy for tumors of the base of the skull. Chin Clin Oncol 5 (4) : 51, 2016
PubMed
14. Kano H, Sheehan J, Sneed PK, et al : Skull base chondrosarcoma radiosurgery : report of the North American Gamma Knife Consortium. J Neurosurg 123 (5) : 1268-1275, 2015
PubMed
P.631 掲載の参考文献
1. Gerber SS, Plotkin R : Lipoma of the corpus callosum. Case report. J Neurosurg 57 (2) : 281-258, 1982
PubMed
2. Donati F, Vassella F, Kaiser G, Blumberg A : Intracranial lipomas. Neuropediatrics 23 (1) : 32-38, 1992
PubMed
3. Kazner E, Stochdorph O, Wende S, Grumme T : Intracranial lipoma. Diagnostic and therapeutic considerations. J Neurosurg 52 : 234-245, 1980
PubMed

第16章 脊索腫, 過誤腫, 類表皮腫と類皮腫

P.638 掲載の参考文献
1. Ribbert, H : Uber die experimentelle Erzeugung einer Ecchondrosis physalifora. Verhandl. Kong. inn. Med. 13, 455-464, 1895
 
2. Chambers KJ, Lin DT, Meier J, et al. : Incidence and survival patterns of cranial chordoma in the United States. Laryngoscope 124 (5) : 1097-1102, 2014
PubMed
3. Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW : Chordomas and cartilaginous tumors at the skull base. Cancer 32 (2) : 410-420, 1973
PubMed
4. 山家健一, 他 : 頭蓋底に発生する脊髄腫の1例と本邦の文献的考察. 奈良医誌 14 : 241-248, 1963
 
5. McMaster ML, Goldstein AM, Bromley CM, et al. : Chordoma : incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 12 (1) : 1-11, 2001
PubMed
6. Falconer MA, Bailey IC, Duchen LW : Surgical treatment of chordoma and chondroma of the skull base. J Neurosurg 29 (3) : 261-275, 1968
PubMed
7. Brown RV, Sage MR, Brophy BP : CT and MR findings in patients with chordomas of the petrous apex. AJNR Am J Neuroradiol 11 (1) : 121-124, 1990
 
8. Commins D, Baran GA, Molleston M, Vollmer D : Hypothalamic chordoma. Case repor. J Neurosurg 81 (1) : 130-132, 1994
 
9. Oikawa S, Kyoshima K, Goto T, et al. : Histological study on local invasiveness of clival chordoma. Case report of autopsy. Acta Neurochir (Wien). 2001 Oct ; 143 (10) : 1065-1069, 2001
 
10. Tomlinson FH, Scheithauer BW, Forsythe PA, et al. : Sarcomatous transformation in cranial chordoma. Neurosurgery 31 (1) : 13-18, 1992
PubMed
11. Favre J, Deruaz J-P, Uske A, de Tribolet N : Skull base chordomas : presentation of six cases and review of the literature. J Clin Neuroscience 1 : 7-18, 1994
 
12. Forsyth PA, Cascino TL, Shaw EG, et al. : Intracranial chordomas : a clinicopathological and prognostic study of 51 cases. J Neurosurg 78 (5) : 741-747, 1993
 
13. Tewfik HH, McGinnis WL, Nordstrom DG, Latourette HB : Chordoma : evaluation of clinical behavior and treatment modalities. Int J Radiat Oncol Biol Phys 2 (9-10) : 959-962, 1977
 
14. Ikushima I, Korogi Y, Hirai T, et al. : Chordomas of the skull base : dynamic MRI. J Comput Assist Tomogr 20 (4) : 547-550, 1996
PubMed
15. Tan WS, Spigos D, Khine N : Chordoma of the sellar region. J Comput Assist Tomogr 6 (1) : 154-158, 1982
PubMed
16. Al-Mefty O, Borba LA : Skull base chordomas : a management challenge. J Neurosurg 86 (2) : 182-189, 1997
PubMed
17. Gay E, Sekhar LN, Rubinstein E, et al. : Chordomas and chondrosarcomas of the cranial base : results and follow-up of 60 patients. Neurosurgery 36 (5) : 887-896, 1995
PubMed
18. Maira G, Pallini R, Anile C, et al. : Surgical treatment of clival chordomas : the transsphenoidal approach revisited. J Neurosurg 85 (5) : 784-792, 1996
PubMed
19. Colli BO, Al-Mefty O : Chordomas of the skull base : follow-up review and prognostic factors. Neurosurg Focus 10 (3) : E1, 2001
PubMed
20. Stippler M, Gardner PA, Snyderman CH, et al. : Endoscopic endonasal approach for clival chordomas. Neurosurgery 64 (2) : 268-277, 2009
PubMed
21. Jahangiri A, Chin AT, Wagner JR, et al.: Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities. Neurosurgery 76 (2) : 179-185, 2015
PubMed
22. Komotar RJ, Starke RM, Raper DM, et al. : The endoscope-assisted ventral approach compared with open microscope-assisted surgery for clival chordomas. World Neurosurg 76 (3-4) : 318-327, 2011
PubMed
23. Austin-Seymour M, Munzenrider J, Goitein M, et al. : Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70 (1) : 13-17, 1989
PubMed
24. Berson A, Castro JR, Petti P, et al. : Charged particle irradiation of chordoma and chondrosar Radiat Oncol Biol Phys 15 : 559-565, 1988
 
25. Hug EB, Loredo LN, Slater JD, et al. : Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91 (3) : 432-439, 1999
PubMed
26. Noel G, Gondi V : Proton therapy for tumors of the base of the skull. Chin Clin Oncol 5 (4) : 51, 2016
PubMed
27. Tzortzidis F, Elahi F, Wright D, et al. : Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59 (2) : 230-237, 2006
PubMed
28. Mizoe JE, Hasegawa A, Takagi R, et al. : Carbon ion radiotherapy for skull base chordoma. Skull Base 19 (3) : 219-224, 2009
 
29. Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC : Stereotactic radiosurgery for chordoma and chondrosarcoma : further experiences. Int J Radiat Oncol Biol Phys 41 (2) : 387-392, 1998
PubMed
30. Di Maio S, Yip S, Al Zhrani GA, et al. : Novel targeted therapies in chordoma : an update. Ther Clin Risk Manag 11:873-883, 2015 coma of the base of skull and cervical spine : the lawrence berkelley laboratory experience. Int J
 
P.643 掲載の参考文献
1. Cheng K, Sawamura Y, Yamauchi T, Abe H : Asymptomatic large hypothalamic hamartoma associated with polydactyly in an adult. Neurosurgery 32 (3) : 458-460, 1993
 
2. Sasaki T, Matsuno A, Inoh Y, et al. : A rare case of hamartoma in the lateral ventricle : case report. Surg Neurol 47 (1) : 23-27, 1997
PubMed
3. Valdueza JM, Cristante L, Dammann O, et al. : Hypothalamic hamartomas : with special reference to gelastic epilepsy and surgery. Neurosugery 34 (6) : 949-958, 1994
 
4. Judge DM, Kulin HE, Page R, et al. : Hypothalamic hamartoma : a source of luteinizing-hormone releasing factor in precocious puberty. N Engl J Med 296 (1) : 7-10, 1977
PubMed
5. Frank G, Cacciari E, Cristi G, et al. : Hamartomas of the tuber cinereum and precocious puberty. Child's Brain 9 (3-4) : 222-231, 1982
 
6. Berkovic SF, Andermann F, Melanson D, et al. : Hypothalamic hamartomas and ictal laughter : evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol 23 : 429-439, 1988
PubMed
7. Burton EM, Ball WS Jr, Crone K, Dolan LM : Hamartoma of the tuber cinereum : a comparison of MR and CT findings in four cases. AJNR Am J Neuroradiol 10 (3) : 497-501, 1989
PubMed
8. Hahn FJ, Leibrock LG, Huseman CA, Makos MM : The MR appearance of hypothalamic hamartoma. Neuroradiology 30 (1) : 65-68, 1988
PubMed
9. Arita K, Ikawa F, Kurisu K, et al. : The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg 91 (2) : 212-220, 1999
PubMed
10. Kameyama S, Murakami H, Masuda H, Sugiyama I : Minimally invasive magnetic resonance imaging-guided stereotactic radiofrequency thermocoagulation for epileptogenic hypothalamic hamartomas. Neurosurgery 65 (3) : 438-449, 2009
PubMed
11. Feuillan PP, Jones JV, Barnes K, et al. : Reproductive axis after discontinuation of gonadotropinreleasing hormone analog treatment of girls with precocious puberty : long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 84 (1) : 44-49, 1999
PubMed
12. Feuillan PP, Jones JV, Barnes KM, et al. : Boys with precocious puberty due to hypothalamic hamartoma : reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy. J Clin Endocrinol Metab 85 (11) : 4036-4038, 2000
PubMed
13. Mittal S, Mittal M, Montes JL, et al. : Hypothalamic hamartomas. Part 1. Clinical, neuroimaging, and neurophysiological characteristics. Neurosurg Focus 34 (6) : E6, 2013
PubMed
14. Albright AL, Lee PA : Neurosurgical treatment of hypothalamic hamartomas causing precocious puberty. J Neurosurg 78 : 77-82, 1993
PubMed
15. Mittal S, Mittal M, Montes JL, et al. : Hypothalamic hamartomas. Part 2. Surgical considerations and outcome. Neurosurg Focus 34 (6) : E7, 2013
PubMed
16. Likavec AM, Dickerman RD, Heiss JD, Liow K : Retrospective analysis of surgical treatment outcomes for gelastic seizures : a review of the literature. Seizure 9 (3) : 204-207, 2000
PubMed
17. Harvey AS, Freeman JL, Berkovic SF, Rosenfeld JV : Transcallosal resection of hypothalamic hamartomas in patients with intractable epilepsy. Epileptic Disord 5 (4) : 257-265, 2003
PubMed
18. Procaccini E, Dorfmuller G, Fohlen M, et al. : Surgical management of hypothalamic hamartomas with epilepsy : the stereoendoscopic approach. Neurosurgery 59 (4 Suppl 2) : ONS336-344, 2006
 
19. Ng YT, Rekate HL, Prenger EC, et al. : Transcallosal resection of hypothalamic hamartoma for intractable epilepsy. Epilepsia 47 (7) : 1192-202, 2006
PubMed
20. Regis J, Scavarda D, Tamura M, et al. : Epilepsy related to hypothalamic hamartomas : surgical management with special reference to gamma knife surgery. Childs Nerv Syst 22 (8) : 881-895, 2006
PubMed
21. Kameyama S, Shirozu H, Masuda H, I et al. : MRI-guided stereotactic radiofrequency thermocoagulation for 100 hypothalamic hamartomas. J Neurosurg 124 (5) : 1503-1512, 201610. Mittal S, Mittal M, Montes JL, Farmer JP, Andermann F : Hypothalamic hamartomas. Part 1. Clinical, neuroimaging, and neurophysiological characteristics. Neurosurg Focus 34 (6) : E6, 2013
 
22. Kang S, Graham JM Jr, Olney AH, Biesecker LG : GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 15 (3) : 266-268, 1997
PubMed
23. Hildebrand MS, Griffin NG, Damiano JA, et al. : Mutations of the Sonic Hedgehog pathway underlie hypothalamic hamartoma with gelastic epilepsy. Am J Hum Genet 99 (2) : 423-429, 2016
PubMed
P.649 掲載の参考文献
1. Vinchon M, Pertuzon B, Lejeune JP, et al. : Intradural epidermoid cysts of the cerebellopontine angle : diagnosis and surgery. Neurosurgery 36 (1) : 52-56, 1995
PubMed
2. Ciappetta P, Artico M, Salvati M, et al. : Intradiploic epidermoid cysts of the skull : report of 10 cases and review of the literature. Acta Neurochir (Wien) 102 (1-2) : 33-37, 1990
 
3. Miyazawa N, Yamazaki H, Wakao T, Nukui H : Epidermoid tumors of Meckel's cave : case report and review of the literature. Neurosurgery 25 (6) : 951-955, 1989
 
4. Lunardi P, Missori P, Gagliardi FM, Fortuna A : Epidermoid tumors of the 4th ventricle : report of seven cases. Neurosurgery 27 (4) : 532-534, 1990
PubMed
5. Sambasivan M, Nayar A : Epidermoid cyst of the pineal region. J Neurol Neurosurg Psychiatry 37 (12) : 1333-1335, 1974
PubMed
6. Michael LM 2nd, Moss T, Madhu T, Coakham HB : Malignant transformation of posterior fossa epidermoid cyst. Br J Neurosurg 19 (6) : 505-510, 2005
 
7. Abramson RC, Morawetz RB, Schlitt M : Multiple complications from an intracranial epidermoid cyst : case report and literature review. Neurosurgery 24 (4) : 574-578, 1989
PubMed
8. van der Graaff M, Davies G : Status epilepticus due to a ruptured dermoid cyst. J Neurol Neurosurg Psychiatry 62 (3) : 222, 1997
PubMed
9. Iwasaki K, Kondo A, Otsuka S, et al. : Painful tic convulsif caused by a brain tumor : case report and review of the literature. Neurosurgery 30 (6) : 916-919, 1992
PubMed
10. Ochi M, Hayashi K, Hayashi T, Morikawa M, Ogino A, Hashmi R, Iwanaga M, Yasunaga A, Shibata S : Unusual CT and MR appearance of an epidermoid tumor of the cerebellopontine angle. AJNR Am J Neuroradiol 19 (6) : 1113-1115, 1998
 
11. Obana WG, Wilson CB : Epidermoid cysts of the brain stem. Report of three cases. J Neurosurg 74 (1) : 123-128, 1991
 
12. Horowitz BL, Chari MV, James R, Bryan RN : MR of intracranial epidermoid tumors : correlation of in vivo imaging with in vitro 13C spectroscopy. AJNR Am J Neuroradiol 11 (2) : 299-302, 1990
PubMed
13. Wilms G, Plets C, Marchal G, Demaerel P : Simultaneous occurrence of epidermoid and dermoid cysts in the posterior fossa : CT and MR findings. AJNR Am J Neuroradiol 11 (6) : 1257-1258, 1990
 
14. Wilms G, Casselman J, Demaerel P, et al. : CT and MRI of ruptured intracranial dermoids. Neuroradiology 33 (2) : 149-151, 1991
 
15. Smith AS, Benson JE, Blaser SI, et al. : Diagnosis of ruptured intracranial dermoid cyst : value MR over CT. AJNR Am J Neuroradiol 12 (1) : 175-180, 1991
PubMed
16. Gao PY, Osborn AG, Smirniotopoulos JG, Harris CP : Radiologic-pathologic correlation. Epidermoid tumor of the cerebellopontine angle. AJNR Am J Neuroradiol 13 (3) : 863-872, 1992
PubMed
17. Yasargil MG, Abernathey CD, Sarioglu AC : Microneurosurgical treatment of intracranial dermoid and epidermoid tumors. Neurosurgery 24 (4) : 561-567, 1989
PubMed
18. Samii M, Tatagiba M, Piquer J, Carvalho GA : Surgical treatment of epidermoid cysts of the cerebellopontine angle. J Neurosurg 84 (1) : 14-19, 1996
PubMed
19. Caldarelli M, Massimi L, Kondageski C, Di Rocco C : Intracranial midline dermoid and epidermoid cysts in children. J Neurosurg 100 (5 Suppl Pediatrics) : 473-480, 2004
 
20. Lunardi P, Fortuna A, Cantore G, Missori P : Long-term evaluation of asymptomatic patients operated on for intracranial epidermoid cysts. Comparison of the diagnostic value of magnetic resonance imaging and computer-assisted cisternography for detection of cholesterin fragments. Acta Neurochir (Wien) 128 (1-4) : 122-125, 1994
 
21. Gormley WB, Tomecek FJ, Qureshi N, Malik GM : Craniocerebral epidermoid and dermoid tumours : a review of 32 cases. Acta Neurochir (Wien) 128 (1-4) : 115-121, 1994
PubMed
22. Nishio S, Takeshita I, Morioka T, Fukui M : Primary intracranial squamous cell carcinomas : report of two cases. Neurosurgery 37 (2) : 329-332, 1995
PubMed
23. Murase S, Yamakawa H, Ohkuma A, et al. : Primary intracranial squamous cell carcinoma--case report. Neurol Med Chir (Tokyo) 39 (1) : 49-54, 1999
PubMed

第17章 下垂体腺腫

P.689 掲載の参考文献
1. DeLellis RA, Lloyd RV, Heitz PU, Eng C, (Eds) : WHO/IARC Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs, 3rd Edition. International Agency for Reserach on Cancer (IARC), Lyon, 2004
 
2. Mindermann T, Wilson CB : Pediatric pituitary adenomas. Neurosurgery 36 : 259-269, 1995
PubMed
3) Saeger W, Ludecke DK, Buchfelder M, et al. : Pathohistological classification of pituitary tumors : 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156 (2) : 203-216, 2007
PubMed
4. Tjornstrand A, Gunnarsson K, Evert M, et al. : The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol 171 (4) : 519-526, 2014
PubMed
5. Raappana A, Koivukangas J, Ebeling T, Pirila T : Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab 95 (9) : 4268-4275, 2010
PubMed
6. Teramoto A, Hirakawa K, Sanno N, Osamura Y : Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193 (1) : 161-164, 1994
PubMed
7. Daly AF, Vanbellinghen JF, Khoo SK, et al. : Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas : analysis in 73 families. J Clin Endocrinol Metab 92 (5) : 1891-1896, 2007
PubMed
8. 佐野壽昭, 長村義之 : ヒト下垂体腺腫の機能病理. 内分泌の進歩 8 : 892-897, 1991
 
9. Hardy J : Transsphenoidal microsurgical treatment of pituitary tumors. In "Recent advances in the diagnosis and treatment of pituitary tumors (LinfoosJ ed)", Raven Press, New York, 375-388, 1979
 
10. Knosp E, Steiner E, Kitz K, Matula C : Pituitary adenomas with invasion of the cavernous sinus space : a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33 : 610-618, 1993
PubMed
11. Osamura RY, Kajiya H, Takei M, et al. : Pathology of the human pituitary adenomas. Histochem Cell Biol 130 (3) : 495-507, 2008
PubMed
12. Scheithauer BW, Kovacs KT, Laws ERJr., Randall RV : Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65 : 733-744, 1986
 
13. Selman W, Laws ERJr., Scheithauer BW, Carpenter SM : The occurence of dural invasion in pituitary adenomas. J Neurosurg 64 : 402-407, 1986
 
14. Lundin P, Nyman R, Burman P, et al. : MRI of pituitary macroadenomas with reference to hormonal activity. Neuroradiology 34 : 43-51, 1992
PubMed
15. Teramoto A, Yoshida Y, Sanno N, Nemoto S : Cavernous sinus sampling in patients with adrenocorticotrophic hormone-dependent Cushing's syndrome with emphasis on inter- and intracavernous adrenocorticotrophic hormone gradients. J Neurosurg 89 (5) : 762-768, 1998
PubMed
16. Berkmann S, Schlaffer S, Nimsky C, et al. : Follow-up and long-term outcome of nonfunctioning pituitary adenoma operated by transsphenoidal surgery with intraoperative high-field magnetic resonance imaging. Acta Neurochir (Wien) 156 (12) : 2233-2243, 2014
PubMed
17. Netuka D, Majovsky M, Masopust V, et al. : Intraoperative magnetic resonance imaging during endoscopic transsphenoidal surgery of growth hormone-secreting pituitary adenomas. World Neurosurg 91 : 490-496, 2016
PubMed
18. Hughes MN, Llamas KJ, Yelland ME, Tripcony LB : Pituitary adenomas : Long-term results for radiotherapy alone and post operative radiotherapy. Int J Radiat Oncol Biol Phys 27 : 1035-1043, 1993
PubMed
19. Rush SC, Newall J : Pituitary adenoma : The efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys 17 : 165-169, 1989
PubMed
20. Tsang RW, Brierley JD, Panzarella T, et al. : Radiation therapy for pituitary adenoma : treatent outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30 : 557-565, 1994
 
21. Flickinger JC, Nelson PB, Martinez AJ, et al. : Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63 : 2409-2414, 1989
PubMed
22. Fisher BJ, Gaspar LE, Noone B : Giant pituitary adenomas : role of radiotherapy. Int J Radiat Oncol Biol Phys 25 : 677-681, 1993
PubMed
23. Creo AL, Lteif AN : Pituitary gigantism : a retrospective case series. J Pediatr Endocrinol Metab 29 (5) : 597-602, 2016
 
24. Ben-Shlomo A, Melmed S : Acromegaly. Endocrinol Metab Clin North Am 37 (1) : 101-122, 2008
PubMed
25. Arita K, Kurisu K, Tominaga A, et al. : Mortality in 154 surgically treated patients with acromegaly--a 10-year follow-up survey. Endocr J 50 (2) : 163-172, 2003
PubMed
26. Dekkers OM, Biermasz NR, Pereira AM, et al. : Mortality in acromegaly : a metaanalysis.. J Clin Endocrinol Metab 93 (1) : 61-67, 2008
PubMed
27. Orme SM, McNally RJ, Cartwright RA, Belchetz PE : Mortality and cancer incidence in acromegaly : a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83 (8) : 2730-2734, 1998
 
28. Sarwar KN, Huda MS, Van de Velde V, et al. : The prevalence and natural history of pituitary hemorrhage in prolactinoma. J Clin Endocrinol Metab 98 (6) : 2362-2367, 2013
 
29. Berinder K, Akre O, Granath F, Hulting AL : Cancer risk in hyperprolactinemia patients : a population-based cohort study. Eur J Endocrinol 165 (2) : 209-215, 2011
PubMed
30. Schlechte J, Dolan K, Sherman B, et al. : The natural history of untreated hyperprolactinemia : a prospective analysis. J Clin Endocrinol Metab 68 (2) : 412-418, 1989
PubMed
31. Sisam DA, Sheehan JP, Sheeler LR : The natural history of untreated microprolactinomas. Fertil Steril 48 (1) : 67-71, 1987
PubMed
32. Randall RV, Laws ERJr., Abboud CF, et al. : Transsphenoidal microsurgicsal treatment of prolactin-producing pituitary adenomas. Results in 100 cases. Mayo Clin Proc 58 : 108-121, 1983
 
33. Serri O, Raiso E, Beauregard H, et al. : Recurrence of hyperprolactinemia after selective transsphennoidal adenomectomy in women with prolactinoma. N Eng J Med 309 : 280-283, 1983
 
34. Delgrange E, Maiter D, Donckier J : Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Eur J Endocrinol 134 (4) : 454-456, 1996
PubMed
35. Colao A, Di Sarno A, Cappabianca P, et al. : Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349 (21) : 2023-2033, 2033
 
36. Ono M, Miki N, Kawamata T, et al. : Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J Clin Endocrinol Metab 93 (12) : 4721-4727, 2008
PubMed
37. Ono M, Miki N, Amano K, et al. : Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 95 (6) : 2672-2679, 2010
PubMed
38. 小野昌美, 三木伸泰, 市原淳弘 : プロラクチン産生下垂体腫瘍の治療 1) 最新の薬物治療. 内分泌・糖尿病・内分泌内科 34 (2) 118-124, 2012
 
39. Kreutzer J, Buslei R, Wallaschofski H, et al. : Operative treatment of prolactinomas : indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158 (1) : 11-18, 2008
 
40. Laws ERJr., Fode NC, Randall RV, et al. : Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors. J Neurosurg 58 : 685-688, 1983
 
41. Miyake A, Ikegami M, Chen CF, et al. : Mass screening for hyperprolactinemia and prolactinoma in men. J Endocrinol Invest 11 (5) : 383-384, 1988
 
42. Wolfsberger S, Czech T, Vierhapper H, et al. : Microprolactinomas in males treated by transsphenoidal surgery. Acta Neurochir (Wien) 145 (11) : 935-940, 2003
PubMed
43. Franks S, Jacobs HS, Martin N, Nabarro JDN : Hyperprolactinemia and impotence. Cli Endocrinol 8 : 277-287, 1978
 
44. Colao A, Sarno AD, Cappabianca P, et al. : Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 148 (3) : 325-331, 2003
PubMed
45. Teperman L, Futterweit W, Zappulla R, Malis LI : Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia : a case comparison study of twenty patients. Neurosurgery 7 : 571-573, 1980
PubMed
46. Coulam CB, Annegers JF, Abboud CF, et al. : Pituitary adenoma and oral contraceptives : a casecontrol study. Fertil Steril 31 (1) : 25-28, 1979
PubMed
47. Lindholm J, Juul S, Jorgensen JO, et al. : Incidence and late prognosis of Cushing's syndrome : a population-based study. J Clin Endocrinol Metab 86 (1) : 117-123, 2001
PubMed
48. Biller BM, Grossman AB, Stewart PM, et al. : Treatment of adrenocorticotropin-dependent Cushing's syndrome : a consensus statement. J Clin Endocrinol Metab 93 (7) : 2454-2462, 2008
 
49. Yap LB, Turner HE, Adams CB, Wass JA : Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease : a single centre audit. Clin Endocrinol (Oxf) 56 (1) : 25-31, 2002
 
50. Hammer GD, Tyrrell JB, Lamborn KR, et al. : Transsphenoidal microsurgery for Cushing's disease : initial outcome and long-term results. J Clin Endocrinol Metab 89 (12) : 6348-6357, 2004
PubMed
51. Patil CG, Prevedello DM, Lad SP, V et al. : Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 93 (2) : 358-362, 2008
 
52. Estrada J, Boronat M, Mielgo M, et al. : The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med 336 (3) : 172-177, 1997
 
53. Dekkers OM, Biermasz NR, Pereira AM, et al. : Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92 (3) : 976-981, 2007
PubMed
54. van Aken MO, Pereira AM, Biermasz NR, et al. : Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90 (6) : 3279-3286, 2005
PubMed
55. Teramoto A, Sanno N, Tahara S, Osamura YR : Pathological study of thyrotropin-secreting pituitary adenoma : plurihormonality and medical treatment. Acta Neuropathol 108 (2) : 147-153, 2004
PubMed
56. Malchiodi E, Profka E, Ferrante E, et al. : Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab 99 (6) : 2069-2076, 2014
PubMed
57. Comi RJ, Gesundheit N, Murray L, et al. : Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317 (1) : 12-17, 1987
PubMed
58. Kovacs K, Horvath E, Ryan N, Ezrin C : Null cell adenoma of the human pituitary. Virchows Arch. A. Path. Anat. Histol. 387 : 165-174, 1980
 
59. Trouillas J, Girod C, Sassolas G, et al. : Human pituitary gonadotropic adenoma : histological, immunocytochemical, and hormonal studies in eight cases. J Pathol 135 : 315-336, 1981
 
60. Young WF Jr, Scheithauer BW, Kovacs KT, et al. : Gonadotroph adenoma of the pituitary gland : a clinicopathologic analysis of 100 cases. Mayo Clin Proc 71 (7) : 649-956, 1996
PubMed
61. Ambrosi B, Bassetti M, Ferrario R, et al. : Precocious puberty in a boy with a PRL-, LH- and FSHsecreting pituitary tumour : hormonal and immunocytochemical studies. Acta Endocrinol (Copenh) 122 (5) : 569-576, 1990
 
62. Chanson P, Brochier S : Non-functioning pituitary adenomas. J Endocrinol Invest 28 (11 Suppl International) : 93-99, 2005
 
63. Maruyama T, Masuda H, Uchida H, et al. : Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation. Obstet Gynecol 105 (5 Pt 2) : 1215-1218, 2005
 
64. Wichers-Rother M, Hoven S, Kristof RA, et al. : Non-functioning pituitary adenomas : endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112 (6) : 323-327,2004
PubMed
65. Ferrante E, Ferraroni M, Castrignano T, et al. : Non-functioning pituitary adenoma database : a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 155 (6) : 823-829, 2006
PubMed
66. Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, et al. : Natural history of nonfunctioning pituitary adenomas and incidentalomas : a systematic review and metaanalysis. J Clin Endocrinol Metab 96 (4) : 905-912, 2011
PubMed
67. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M : Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) 146 (1) : 27-35, 2004
 
68. Alfons CM. van den Bergh, Gerrit van den Berg, et al. : Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma : Beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67 : 863-869, 2007
 
69. Ntali G, Capatina C, Fazal-Sanderson V, et al. : Mortality in patients with non-functioning pituitary adenoma is increased : systematic analysis of 546 cases with long follow-up. Eur J Endocrinol 174 (2) : 137-145, 2016
PubMed
70. Scheithauer BW, Kovacs KT, Laws ERJr., Randall RV : Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65 : 733-744, 1986
 
71. Selman W, Laws ERJr., Scheithauer BW, Carpenter SM : The occurence of dural invasion in pituitary adenomas. J Neurosurg 64 : 402-407, 1986
 
72. Miermeister CP, Petersenn S, Buchfelder M, et al. : Histological criteria for atypical pituitary adenomas-data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun 3 : 50, 2015
PubMed
73. Hansen TM, Batra S, Lim M, et al. : Invasive adenoma and pituitary carcinoma : a SEER database analysis. Neurosurg Rev 37 (2) : 279-285, 2014
PubMed
74. Ragel BT, Couldwell WT : Pituitary carcinoma : a review of the literature. Neurosurg Focus 16 (4) : E7, 2004
PubMed
75. Raverot G, Sturm N, de Fraipont F, et al. : Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas : a French multicenter experience. J Clin Endocrinol Metab 95 (10) : 4592-4599, 2010
PubMed
76. Syro LV, Ortiz LD, Scheithauer BW, et al. : Treatment of pituitary neoplasms with temozolomide : a review. Cancer 117 (3) : 454-462, 2011
PubMed
77. Ji Y, Vogel RI, Lou E : Temozolomide treatment of pituitary carcinomas and atypical adenomas : systematic review of case reports. Neurooncol Pract 3 (3) : 188-195, 2016
PubMed
78. Hirohata T, Asano K, Ogawa Y, et al. : DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide : the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab 98 (3) : 1130-1136, 2013
PubMed
79. Hardy J : Transphenoidal microsurgery of the normal and pathological pituitary Clin Neurosurg 16 : 185-217, 1969
PubMed
80. McCormick WF, Halmi NS : Absence of chromophobe adenomas from a large series of pituitary tumors. Arch Pathol 92 (4) : 231-238, 1971 PMID : 410615
 
81. Oyama K, Sanno N, Tahara S, Teramoto A : Management of pituitary incidentalomas : according to a survey of pituitary incidentalomas in Japan. Semin Ultrasound CT MR 26 (1) : 47-50, 2005
PubMed
82. 厚生労働科学研究費補助金難治性疾患克服研究事業 間脳下垂体機能障害に関する調査研究班 平成13年度総括・分担研究報告書, 2002年
 
83. Mindermann T, Wilson CB : Pediatric pituitary adenomas. Neurosurgery 36 : 259-269, 1995
PubMed
84. Dyer EH, Civit T, Visot A, et al. : Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 34 : 207-212, 1994
PubMed
85. Partington MD, Davis DH, Laws ER, Scheithauer BW : Pituitary adenomas in childhood and adolescence. J Neurosurg 80 : 209-216, 1994
PubMed
86. Tatsumi K, Miyai K, Notomi T, et al. : Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1 (1) : 56-58, 1992
PubMed
87. Asa SL, Puy LA, Lew AM, et al. : Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77 (5) : 1275-1280, 1993
PubMed
88. Friend KE, Chiou YK, Laws ER Jr, et al. : Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 77 (5) : 1281-1286, 1993
PubMed
89. Pellegrini-Bouiller I, Morange-Ramos I, Barlier A, Gunz G, et al. : Pit-1 gene expression in human pituitary adenomas. Horm Res 47 (4-6) : 251-258, 1997
 
90. Salenave S, Boyce AM, Collins MT, Chanson P : Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99 (6) : 1955-1969, 2014
PubMed
91. Goudet P, Dalac A, Le Bras M, et al. : MEN1 disease occurring before 21 years old : a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines. J Clin Endocrinol Metab 100 (4) : 1568-1577, 2015
 
92. de Laat JM, Dekkers OM, Pieterman CR, et al. : Long-term natural course of pituitary tumors in patients with MEN1 : Results from the Dutch MEN1 Study Group (DMSG). J Clin Endocrinol Metab 100 (9) : 3288-3296, 2015
 
93. Lee M, Pellegata NS : Multiple endocrine neoplasia type 4. Front Horm Res 41 : 63-78, 2013
PubMed
94. Vierimaa O, Georgitsi M, Lehtonen R, et al. : Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 (5777) : 1228-1230, 2006
PubMed
95. Daly AF, Vanbellinghen JF, Khoo SK, et al. : Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas : analysis in 73 families. J Clin Endocrinol Metab 92 (5) : 1891-1896, 2007
PubMed
96. Cazabat L, Bouligand J, Salenave S, et al. : Germline AIP mutations in apparently sporadic pituitary adenomas : prevalence in a prospective single-center cohort of 443 patients. J Clin Endocrinol Metab 97 (4) : E663-670, 2012
 

第18章 Craniopharyngioma

P.703 掲載の参考文献
1. Hunter IJ : Squamous metaplasia of cells of the anterior pituitary gland. J Path Bact 69 : 141-145, 1955
PubMed
2. Banna M : Craniopharyngiomas based on 160 cases : review article. Br J Radiol 49 : 206-223, 1976
 
3. Freeman MP, Kessler RM, Allen JH, Price AC : Craniopharyngioma : CT and MR imaging in nine cases. J Comp Assisted Tomography 11 : 810-814, 1987
 
4. Adamson TE, Wiestler OD, Kleihues P, Yasargil MG : Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73 : 12-17, 1990
PubMed
5. Weiner HL, Wisoff JH, Rosenberg ME, et al. : Craniopharyngiomas : A clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35 : 1001-1011, 1994
PubMed
6. Crotty TB, Scheithauer BW, Young WF, et al. : Papillary craniopharngioma : a clinicopathological study of 48 cases. J Neurosurg 83 : 206-214, 1995
 
7. 赤池光司, 高橋宏, 石島武一, 他 : 悪性化を示した頭蓋咽頭腫の一例. 脳神経外科 15 : 843-848, 1987
 
8. 福田芳郎, 和田了, 植木利公, 他 : 術後20年の経過で悪性化した頭蓋咽頭腫の一剖検例. Neuropathol 9 : 65-70, 1988
 
9. Carmel PW, Antunes JL, Chang CH : Craniopharyngiomas in children. Neurosurgery 11 : 382-389, 1982
PubMed
10. Wen B-C, Hussey DH, Staples J, et al. : A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int J Radiat Oncol Biol Phys 16 : 17-24, 1989
 
11. Hetelekidis S, Barnes PD, Tao ML, et al. : 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27 : 189-195, 1993
PubMed
12. Hoffman HJ, Silva MD, Humphreys RP, et al. : Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76 : 47-52, 1992
 
13. Lyen KR, Grant DB : Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57 : 837-841, 1982
PubMed
14. Baskin DS, Wilson CB : Surgical management of craniopharyngiomas. J Neurosurg 65 : 22-27, 1986
PubMed
15. Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM : Endocrine and neurologic outcome in childhood craniopharyngioma : Review of effect of treatment in 42 patients. J Pediatr 97 : 728-735, 1980
PubMed
16. Regine WF, Kramer S : Pediatric craniopharyngiomas : long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys 24 : 611-617, 1992
PubMed
17. Stripp DC, Maity A, Janss AJ, et al : Surgery with or without radiation therapy in the management of craniopharyngioma in children and young adults. Int J Radiat Oncol Biol Phys 58 : 714-720, 2004
PubMed
18. Tomita T, Bowman RM : Craniopharyngiomas in children : surgical experience at Children's Memorial Hospital. Childs Nerv Syst 21 : 729-746, 2005
 
19. Puget S, Garnett M, Wray A, et al. : Pediatric craniopharyngiomas : classification and treatment according to the degree of hypothalamic involvement. J Neurosurg (1 Suppl Pediatrics) 106 : 3-12, 2007
 
20. Cabezudo JM, Vaquero J, Garcia-de-Sola R, et al. : Computed tomography with craniopharyngiomas : a review. Surg Neurol 15 : 422-427, 1981
PubMed
21. Sung DI, Chang CH, Harisiadis L, Carmel PW : Treatment results of craniopharyngiomas. Cancer 47 : 847-852, 1981
 
22. Duff JM, Meyer FB, Ilstrup DM, et al. : Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46 : 291-305, 2000
 
23. Lin LL, Naqa IE, Leonard JR, et al. : Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatrics 1 : 126-130, 2008
 
24. Vinchon M, Dhellemmes P : Craniopharyngiomas in children : recurrence, reoperation and outcome. Childs Nerv Syst 24 : 211-217, 2008
PubMed
25. Muller HL, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sorensen N : Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr 218 (6) : 315-320, 2006
PubMed
26. Muller HL : Childhood craniopharyngioma. Horm Res 69 : 193-202, 2008
PubMed
27. Kobayashi T, Kida Y, Hasegawa T : Long-term results of gamma knife surgery for craniopharyngioma. Neurosurg Focus 14 (5) : Article 13, 2003
 
28. Gopalan R, Dassoulas K, Rainey J, et al. : Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas. Neurosurg Focus 24 (5) : E5, 2008
PubMed
29. Hasegawa T, Kobayashi T, Kida Y : Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery : evaluation in 100 patients with craniopharyngioma. Neurosurgery 66 (4) : 688-694, 2010
PubMed
30. Lee CC, Yang HC, Chen CJ, et al. : Gamma Knife surgery for craniopharyngioma : report on a 20-year experience. J Neurosurg 121 Suppl : 167-178, 2014
 
31. Sterkenburg AS, Hoffmann A, Gebhardt U, et al. : Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma : newly reported longterm outcomes. Neuro Oncol 17 (7) : 1029-1038, 2015
PubMed
32. Muller HL, Gebhardt U, Etavard-Gorris N, et al. : Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr 216 (6) : 343-348, 2004
PubMed
33. Hoffmann A, Boekhoff S, Gebhardt U, et al. : History before diagnosis in childhood craniopharyngioma : associations with initial presentation and long-term prognosis. Eur J Endocrinol 173 (6) : 853-862, 2015
PubMed
35. Lopez-Serna R, Gomez-Amador JL, Barges-Coll J, et al. : Treatment of craniopharyngioma in adults : systematic analysis of a 25-year experience. Arch Med Res. 2012 Jul ; 43 (5) : 347-355, 2012
PubMed
36. Mortini P, Losa M, Pozzobon G, et al. : Neurosurgical treatment of craniopharyngioma in adults and children : early and long-term results in a large case series. J Neurosurg 114 (5) : 1350-1359, 2011
 
37. Kim YH, Kim CY, Kim JW, et al. : Longitudinal analysis of visual outcomes after surgical treatment of adult craniopharyngiomas. Neurosurgery 71 (3) : 715-721, 2012
PubMed
38. Pratheesh R, Swallow DM, Rajaratnam S, et al. : Incidence, predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma : a comparison with adults. Childs Nerv Syst 29 (6) : 941-949, 2013
PubMed
39. Erfurth EM, Holmer H, Fjalldal SB : Mortality and morbidity in adult craniopharyngioma. Pituitary 16 (1) : 46-55, 2013
PubMed
40. Patel KS, Raza SM, McCoul ED, et al. : Long-term quality of life after endonasal endoscopic resection of adult craniopharyngiomas. J Neurosurg 123 (3) : 571-580, 2016
 
34 Zoicas F, Schofl C : Craniopharyngioma in adults. Front Endocrinol (Lausanne) 3 : 46, 2012
PubMed

第19章 神経鞘腫

P.720 掲載の参考文献
1. Khrais T, Romano G, Sanna M : Nerve origin of vestibular schwannoma : a prospective study. J Laryngol Otol 122 (2) : 128-31, 2008
PubMed
2. Samii M, Migliori MM, Tatagiba M, Babu R : Surgical treatment of trigeminal schwannomas. J Neurosurg 82 (5) : 711-718, 1995
PubMed
3. Konovalov AN, Spallone A, Mukhamedjanov DJ, et al. : Trigeminal neurinomas. A series of 111 surgical cases from a single institution. Acta Neurochir (Wien) 138 (9) : 1027-1035, 1996
PubMed
4. Tan LC, Bordi L, Symon L, Cheesman AD. : Jugular foramen neuromas : a review of 14 cases. Surg Neurol 34 (4) : 205-211, 1990
PubMed
5. Samii M, Babu RP, Tatagiba M, Sepehrnia A. : Surgical treatment of jugular foramen schwannomas. J Neurosurg 82 (6) : 924-932, 1995
PubMed
6. Symon L, Cheesman AD, Kawauchi M, Bordi L : Neuromas of the facial nerve : a report of 12 cases. Br J Neurosurg 7 (1) : 13-22, 1993
PubMed
7. Kida Y, Yoshimoto M, Hasegawa T : Radiosurgery for facial schwannoma. J Neurosurg 106 (1) : 24-29, 2007
PubMed
8. Bridger MW, Farkashidy J : The distribution of neuroglia and schwann cells in the 8th nerve of man. J Laryngol Otol 94 (12) : 1353-1362, 1980REFERENCES
 
9. Pool JL : Suboccipital surgery for acoustic neurinomas : advantages and disadvantages. J Neurosurg 24 (2) : 483-492, 1966
PubMed
10. Yokoh A, Kobayashi S, Tanaka Y, Gibo H, Sugita K : Preservation of cochlear nerve function in acoustic neurinoma surgery. Acta Neurochir (Wien) 123 (1-2) : 8-13, 1993
PubMed
11. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J : Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54 (1) : 71-76, 2000
PubMed
12. Bederson JB, von Ammon K, Wichmann WW, Yasargil MG : Conservative treatment of patients with acoustic tumors. Neurosurgery 28 (5) : 646-650, 1991
PubMed
13. Deen HG, Ebersold MJ, Harner SG, et al. : Conservative management of acoustic neuroma : an outcome study. Neurosurgery 39 (2) : 260-264, 1996
PubMed
14. Kameyama S, Tanaka R, Honda Y, et al. : The long-term growth rate of residual acoustic neurinomas. Acta Neurochir (Wien) 129 (3-4) : 127-130, 1994
 
15. Yamakami I, Uchino Y, Kobayashi E, Yamaura A : Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas : a systematic review of outcome and risk of three therapeutic options. Neurol Res 25 (7) : 682-690, 2003
PubMed
16. Yoshimoto Y : Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103 (1) : 59-63, 2005
PubMed
17. Sughrue ME, Yang I, Aranda D, Lobo K, et al. : The natural history of untreated sporadic vestibular schwannomas : a comprehensive review of hearing outcomes. J Neurosurg 112 (1) : 163-167, 2010
PubMed
18. Sughrue ME, Kane AJ, Kaur R, Barry JJ, et al. : A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg 114 (2) : 381-385, 2011
 
19. Pollock BE, Driscoll CL, Foote RL, et al. : Patient outcomes after vestibular schwannoma management : a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59 (1) : 77-85, 2006
PubMed
20. Myrseth E, Moller P, Pedersen PH, Lund-Johansen M : Vestibular schwannoma : surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 64 (4) : 654-661, 2009
 
21. Aguiar PH, Tatagiba M, Samii M, et al. : The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1. Acta Neurochir (Wien) 134 (1-2) : 40-45, 1995
PubMed
22. Martuza RL, Ojemann RG : Bilateral acoustic neuromas : clinical aspects, pathogenesis, and treatment. Neurosurgery 10 (1) : 1-12, 1982
PubMed
23. Samii M, Matthies C, Tatagiba M : Management of vestibular schwannomas (acoustic neuromas) : auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40 (4) : 696-705, 1997
PubMed
24. Brackmann DE, Fayad JN, Slattery WH 3rd, et al. : Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 49 (2) : 274-280, 2001
PubMed
25. Mathieu D, Kondziolka D, Flickinger JC, et al. : Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2 : an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60 (3) : 460-468, 2007
PubMed
26. Phi JH, Kim DG, Chung HT, et al. : Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2 : tumor control and hearing preservation. Cancer 115 (2) : 390-398, 2009
PubMed
27. Ross DL, Tew JM Jr, Benton C, Eisentrout C : Trigeminal schwannoma in a child. Neurosurgery 15 (1) : 108-110, 1984
 
28. Pollack IF, Sekhar LN, Jannetta PJ, Janecka IP : Neurilemomas of the trigeminal nerve. J Neurosurg 70 (5) : 737-745, 1989
PubMed
29. Yonas H, Jannetta PJ : Neurinoma of the trigeminal root and atypical trigeminal neuralgia : their commonality. Neurosurgery 6 (3) : 273-277, 1980
PubMed
30. Fukaya R, Yoshida K, Ohira T, Kawase T : Trigeminal schwannomas : experience with 57 cases and a review of the literature. Neurosurg Rev 34 (2) : 159-171, 2010
 
31. Wanibuchi M, Fukushima T, Zomordi AR, et al. : Trigeminal schwannomas : skull base approaches and operative results in 105 patients. Neurosurgery 70 (1 Suppl Operative) : 132-143, 2012
 
32. Chen LF, Yang Y, Yu XG, et al. : Operative management of trigeminal neuromas : an analysis of a surgical experience with 55 cases. Acta Neurochir (Wien) 156 (6) : 1105-1114, 2014
 
33. Sakamoto GT, Borchers DJ 3rd, Xiao F, et al. : Cyberknife radiosurgery for trigeminal schwannomas. Neurosurgery 64 (2 Suppl) : A14-18, 2009
 
34. Hasegawa T, Kato T, Iizuka H, Kida Y : Long-term results for trigeminal schwannomas treated with gamma knife surgery. Int J Radiat Oncol Biol Phys 87 (5) : 1115-1121, 2013
PubMed
35. Sherman JD, Dagnew E, Pensak ML, et al. : Facial nerve neuromas : report of 10 cases and review of the literature. Neurosurgery 50 (3) : 450-456, 2002
PubMed
36. Chung JW, Ahn JH, Kim JH, et al. : Facial nerve schwannomas : different manifestations and outcomes. Surg Neurol 62 (3) : 245-252, 2004
PubMed
37. Wilkinson EP, Hoa M, Slattery WH 3rd, et al. : Evolution in the management of facial nerve schwannoma. Laryngoscope 121 (10) : 2065-2074, 2011
PubMed
38. Lee WS, Kim J : Revised surgical strategy to preserve facial function after resection of facial nerve schwannoma. Otol Neurotol 32 (9) : 1548-1553, 2011
PubMed
39. Madhok R, Kondziolka D, Flickinger JC, Lunsford LD : Gamma knife radiosurgery for facial schwannomas. Neurosurgery 64 (6) : 1102-1105, 2009
PubMed
40. Takahashi T, Tominaga T, Sato Y, et al. : Hypoglossal neurinoma presenting with intratumoral hemorrhage. J Clin Neurosci 9 (6) : 716-719, 2002
PubMed
41. Sato M, Kanai N, Fukushima Y, et al. : Hypoglossal neurinoma extending intra- and extracranially : case report. Surg Neurol 45 (2) : 172-175, 1996
PubMed
42. Tatagiba M, Koerbel A, Roser F : The midline suboccipital subtonsillar approach to the hypoglossal canal : surgical anatomy and clinical application. Acta Neurochir (Wien) 148 (9) : 965-969, 2006
 
43. Piccirilli M, Anichini G, Fabiani F, Rocchi G : Neurinoma of the hypoglossal nerve in the submandibular space : case report and review of the literature. Acta Neurochir (Wien) 149 (9) : 949-952, 2007
PubMed
44. Ramina R, Maniglia JJ, Fernandes YB, et al. : Tumors of the jugular foramen : diagnosis and management. Neurosurgery 57 (1 Suppl) : 59-68, 2005
 
45. Sanna M, Bacciu A, Falcioni M, Taibah A : Surgical management of jugular foramen schwannomas with hearing and facial nerve function preservation : a series of 23 cases and review of the literature. Laryngoscope 116 (12) : 2191-2204, 2006
PubMed
46. Bulsara KR, Sameshima T, Friedman AH, Fukushima T : Microsurgical management of 53 jugular foramen schwannomas : lessons learned incorporated into a modified grading system. J Neurosurg 109 (5) : 794-803, 2008
PubMed
47. Agrawal A, Pandit L, Bhandary S, et al. : Glossopharyngeal schwannoma : diagnostic and therapeutic aspects. Singapore Med J 48 (7) : e181-185, 2007
PubMed
48. Sweasey TA, Edelstein SR, Hoff JT : Glossopharyngeal schwannoma : review of five cases and the literature. Surg Neurol 35 (2) : 127-130, 1991
PubMed
49. Ishihara M, Miyagawa-Hayashino A, Nakashima Y, et al. : Intracerebral schwannoma in a child with infiltration along perivascular spaces resembling meningioangiomatosis. Pathol Int 59 (8) : 583-587, 2009
 
50. Bristol RE, Coons SW, Rekate HL, Spetzler RF : Invasive intracerebral schwannoma mimicking meningioma in a child. Childs Nerv Syst 22 (11) : 1483-1486, 2006
 
51. Scott WW, Koral K, Margraf LR, et al. : Intracerebral schwannomas : a rare disease with varying natural history. J Neurosurg Pediatr 12 (1) : 6-12, 2013
PubMed
52. Zagardo MT, Castellani RJ, Rees JH, et al. : Radiologic and pathologic findings of intracerebral schwannoma. AJNR Am J Neuroradiol 19 (7) : 1290-1293, 1998
 
53. Casadei GP, Komori T, Scheithauer BW, et al. : Intracranial parenchymal schwannoma. A clinicopathological and neuroimaging study of nine cases. J Neurosurg 79 (2) : 217-222, 1993
 

第20章 転移性脳腫瘍

P.737 掲載の参考文献
1. Takakura K, Sano K, Hojo S, Hirano A : Metastatic tumors of the central nervous system. Igakushoin, Tokyo-NewYork, 1982
 
2. Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. : Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22 (14) : 2865-2872, 2004
PubMed
3. Baumert BG, Rutten I, Dehing-Oberije C, et al. : A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66 (1) : 187-194, 2006
PubMed
4. Kamp MA, Grosser P, Felsberg J, et al. : 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154 (2) : 223-228, 2002
 
5. 松谷雅生, 中村治 : 乳癌脳転移の病態とquality of life-肺がん脳転移治療経験よりの考祭-. 乳癌の臨床 3 (4) : 513-521, 1988
 
6. 松谷雅生 : 脳転移の治療-肺癌脳転移を中心として-. 外科治療 63 (2) : 150-154, 1990
 
7. 山下純宏, 大塚信一, 山崎俊樹, 他 : 肺癌脳転移116例の臨床的検討-手術および放射線治療の相対的役割. 日癌治 18 (5) : 1124-1134, 1983
 
8. White KT, Fleming TR, and Laws ER Jr. : Single metastasis to the brain. Surgical treatment in 122 consecutive patient. Mayo Clin Proc 56 : 424-428, 1981
 
9. Gagliardi FM, Mercuri S : Single metastasis in the brain : late results in 325 cases. Acta Neurochir 68 : 253-262, 1983
PubMed
10. Egawa S, Tukiyama I, Akine Y, et al. : Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 12 : 1621-1625, 1986
PubMed
11. Moore TN, Livingston R, Heilbrun L, et al. : The effectiveness of prophylactic brain irradiation in small cell carcinoma of the lung : a Southwest Oncology Group study. Cancer 41 (6) : 2149-2153, 1978
 
12. Komarnicky LT, Phillips TL, Martz K, A et al. : A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 20 (1) : 53-58, 1991
 
13. Patchell RA, Tibbs PA, Walsh JW, et al. : A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 : 494-500, 1990
 
14. Vecht CJ, Haaxma-Reiche H, Noordijk EM, P et al. : Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 33 (6) : 583-590, 1993
 
15. Mintz AH, Kestle J, Rathbone MP, et al. : A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78 (7) : 1470-1476, 1996
PubMed
16. Asai A, Matsutani M, Kohno T, et al. : Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63 : 1962-1974, 1989
PubMed
17. Nakamura O, Matsutani M, Shitara N, et al : New treatment protocol by intra-operative radiation therapy for metastatic brain tumours. Acta Neurochir (Wien) 131 (1-2) : 91-96, 1994
 
18. Andrews DW, Scott CB, Sperduto PW, et al. : Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases : phase III results of the RTOG 9508 randomised trial. Lancet 363 : 1665-1672, 2004
PubMed
19. Aoyama H, Shirato H, Tago M, et al. : Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases : a randomized controlled trial. JAMA 295 (21) : 2483-2491, 2006
PubMed
20. Kocher M, Soffietti R, Abacioglu U, et al. : Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases : results of the EORTC 22952-26001 study. J Clin Oncol 29 (2) : 134-141, 2011
 
21. Chang EL, Wefel JS, Hess KR, et al. : Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation : a randomised controlled trial. Lancet Oncol 10 (11) : 1037-1044, 2009
PubMed
22. Sahgal A, Aoyama H, Kocher M, et al. : Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91 (4) : 710-717, 2015
PubMed
23. Yamamoto M, Serizawa T, Shuto T, et al. : Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901) : a multi-institutional prospective observational study. Lancet Oncol 15 (4) : 387-395, 2014
 
24. Iuchi T, Shingyoji M, Sakaida T, et al. : Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer 82 (2) : 282-287, 2013
PubMed
25. Cameron D, Casey M, Press M, L et al. : A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analyses. Breast Cancer Res Treat 112 (3) : 533-543, 2008
 
26. 特定非営利活動法人 日本脳腫瘍学会 編集 : 脳腫瘍診療ガイドライン 1. 金原出版, pp.133, 東京, 2016
 
27. 松谷雅生, 河野武, 長島正, 他 : 肺癌脳転移の手術, 放射線治療. 日癌治 18 : 1979-1986, 1983
 
28. Mandell L, Hilaris B, Sullivan M, et al. : The treatment of single brain meatstasis from non-oat cell lung carcinoma. Cancer 58 : 641-649, 1986
 
29. DiStefano A, Yap HY, Hortobagyi GN, Blumenschein GR : The natural history of breast cancer patients with brain metastases. Cancer 44 (5) : 1913-1918, 1979
 
30. Tsukada Y, Fouad A, Pickren JW, Lane WW : Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52 : 2349-2354, 1983
PubMed

書評

最近チェックした商品履歴

Loading...